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Donor-Acceptor (DA) cyclopropanes are considered to be well-understood 
compounds with predictable chemistry. This dissertation focuses on our recent advances 
and synthetic applications of DA cyclopropanes principally involving 1,3-dipole 
intermediates revealed by reactions with Lewis acids. Particular emphasis is placed on 
reactions involving sugar-derived substrates. 
Chapter one is an overview of the literature preparations and synthetic 
applications of DA cyclopropanes. It begins with general DA cyclopropanes but is mostly 
focused on carbohydrate-derived cyclopropanes. 
Chapter two describes our intramolecular glucal cyclopropanation approach 
toward lactonized cyclopropanes 2.5a-c, their transformations under mild conditions, and 
their application to the quasi formal synthesis of the natural product xylobovide 2.34a. 
Chapter three investigates the different chemical behaviors of glucal-derived 
lactonized cyclopropane 2.5a under the influence of a variety of different Lewis acids.  
Use of boron trifluoride etherate (BF3•OEt2) leads to regioselective mono-desilylation of 





results in anhydro-sugar 3.8 formation; and titanium tetrachloride (TiC4) facilitates 
stereoselective allylation and glycosidation. 
Chapter four discuses our recently discovered formal [3+2] dipolar cycloaddition 
reactions of DA cyclopropanes with a wide variety of dipolarophiles including silyl enol 
ethers, imines, aldehydes and nitriles. The extension of nitrile cyclization to general non-
carbohydrate derived DA cyclopropanes leads to the discovery of a novel synthetic 
methodology toward pyrroles, bipyrroles and thienylpyrroles. Finally, the [3+2] 
cycloaddition has also been extended to heterocycles including pyridines, quinolines and 
indoles.  
Chapter five summarizes the investigation of regio-selective mono-desilylation of 
di-tert-butylsilylene ethers as a new protocol for selective hydroxy protection. Under 
optimized conditions, the reaction demonstrates high regioselectivity as well as strong 
functional group compatibility, and proves promising as a new protocol for selectively 
manipulating 1,3-diols. 
Chapter six provides the experimental procedures and characterization of all the 
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Chapter 1: History of DA cyclopropanes 
Synthetic preparation methods and reactivity of donor-acceptor (DA) 
cyclopropanes have been widely documented and thoroughly reviewed.1 This chapter is a 
brief survey of the new advances and synthetic applications of DA cyclopropanes 
principally involving 1,3-dipole intermediates revealed by reaction with Lewis acids. 
Particular emphasis is placed on reactions involving sugar-derived substrates. 
1.1 GENERAL DA CYCLOPROPANES  
The high degree of reactivity presented in cyclopropanes makes them versatile 
building blocks in modern organic synthesis.2 While unactivated cyclopropanes have 
been directly employed for certain useful chemical transformations,3 most of the 
cyclopropane based synthetic methodologies have relied on activation from additional 
functional groups. Cyclopropanes substituted with electron accepting groups can react as 
homo Michael acceptors in nucleophilic ring openings (Figure 1.1, Eq A). On the other 
hand, donor substituted cyclopropanes can be cleaved by electrophiles to afford cation 
equivalents for further transformations (Figure 1.1, Eq B).4 
Vicinal donor–acceptor (DA) cyclopropanes are particularly useful synthetic 
building blocks because the reactivity imparted to the cyclopropane by the substituents is 
amplified by a synergistic electron “push-pull” relationship. Under Lewis acidic 
conditions, the doubly activated cyclopropanes undergo formal retro-aldol rearrangement 
to 1,3-zwitterionic intermediates that can be considered as 1,3-dipole equivalents (Figure 







































A = Electron Acceptor: CO2R, C(O)R, CN, etc 
 
D = Electron Donor: OR, OSiR3, NR1R2, SR, etc 
 
Figure 1.1: Substituent activated cyclopropanes 
The ultimate fate of the 1,3- zwitterion is highly dependent on the nature of the 
reaction conditions, and the intermediates can react in an intramolecular fashion by 
hydride or proton transfers to give γ-alkoxy α,β-unsaturated esters 1.2 or saturated γ-
oxoesters 1.3  (Scheme 1.1).5 Siloloxy substituted DA cyclopropanes are particularly 
susceptible to give the simple protonolysis products 1.3.6 Intermolecular reactions can 
occur at just one or both sites of the dipole.1 Examples of α addition from electrophilic 
trapping of enolates to afford 1.4,7 and nucleophilic addition to the intermediate 
oxocarbenium ions to give 1.5 are both known.8 Combining the dual reactivity of the 1,3-
dipole results in formal [3+2] cycloadditions to furnish highly functionalized carbon or 
heterocyclopentane derivatives 1.6a,b.9 These latter transformations involving DA 
cyclopropanes are powerful synthetic transformation for accessing products often not 
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1.2 CARBOHYDRATE-DERIVED DONOR CYCLOPROPANES 
Carbohydrates are an indispensable source of materials for asymmetric synthesis 
supported by a history of well-documented functional group transformations.10 One 
challenge in carbohydrate chemistry includes developing economical and stereoselective 
methods for the introduction of new carbon-carbon bonds bearing suitable functional 
handles.11 Carbon-branched sugars12 are found in numerous natural products and have 
been used as starting materials for indole alkaloid syntheses,13 commonly occur in the 
glycon portion of many antibiotics,14 and have been studied during the elucidation of 
biochemical pathways.15 Additionally, naturally occurring macrolides often contain 
branched polyol sequences, a structural motif that portends an origin from a C-branched 
sugar.16 
One of the most important advances in cyclopropane chemistry over the last 
decade has been the integration of cyclopropanes and carbohydrates.17 Carbohydrates 
have an exciting history in organic and medicinal chemistry.18 Not only are they 
ubiquitous natural products occurring throughout the biosphere, but also they provide key 
functional subunits for rational drug designs.19 They are inexpensive yet powerful 
members of the chiral pool, which makes them irresistible platforms for asymmetric 
synthesis.20,21,22 The cyclopropanation of glycals affords unique bicyclic structures 
combining the high reactivity of cyclopropanes together with the extreme optical purity 
and functional density associated with sugars.17 The electron donating effect from the 
pyran ring oxygen conveniently helps one predict cyclopropane reactivity for accessing 






1.2.1 Preparation of carbohydrate-derived donor cyclopropanes 
Despite the considerable synthetic potential of cyclopropanated carbohydrates, the 
area remained dormant until the last two decades, when efficient and reliable procedures 
for carbohydrate cyclopropanation were established. Vasella has pioneered this area with 
an effective synthetic approach toward monosaccharide-derived spirocyclic 
cyclopropylamines through diazo ester cyclopropanation of C(1) exocyclic methylene 
glycals or cycloaddition of glycal-derived C(1) diazirine with acrylates.23 The 
spirocyclopropanes from this method display activity as glycosidase inhibitors. Most of 
the work in carbohydrate cyclopropanation has, however, been focused on 
cyclopropanation of the C(1)-C(2) enol ether component of glycal scaffolds. These 
methods can be classified into three main categories according the cyclopropanation 
reagents: Simmons-Smith reaction (Section 1.2.1.1); dihalocarbene cycloaddition 
(Section 1.2.1.2) and diazo ester cyclopropanation (Section 1.2.1.3).  
 
1.2.1.1 Simmons-Smith cyclopropanation 
The classic Simmons-Smith reaction is an efficient method for facially selective 
conversion of alkenes to cyclopropanes. The reaction is believed to proceed through a 
“butterfly-type” transition state that involves partial delivery of a methylene group 
between IZnCH2I and the double bond.24 When faced with allylic alcohols/ethers, the 
organozinc species stereoselectively adds to the double bond on the face syn to the allylic 
hydroxy/alkoxyl group, presumably due to the strong chelating effect of the allylic 
oxygen to the dimeric organozinc reagents. 
An early example of Simmons-Smith glycal cyclopropanation was reported by 





protected glycals 1.7, 1.9, 1.11 was achieved by treatment with CH2I2/Zn/CuCl activated 
by acetyl chloride (Scheme 1.2). This process proved efficient both in terms of reaction 
yield (> 80%) and facial selectivity. In the examples reported the C(3) substituent 
appeared responsible for complete control over facial selectivity to provide exclusively 
the syn diastereoisomer. The directing effect of the allylic oxygen overrode potential 












































Scheme 1.2: Glycal cyclopropanation employing CH2I2/Zn/CuCl 
The Furukawa modification26 of the Simmons-Smith reaction employing diethyl 
zinc instead of Zn(Cu), and provides more reproducible results under milder reaction 
conditions. This reagent combination displayed high compatibility with different 
protecting groups (Table 1.1), and demonstrated the same level of facial selectivity even 





The cyclopropanated glycals were mostly received in 88 – 96% yield, but when faced 
with steric challenges, the reaction provided only a moderate  yield (33%, entry 5). When 
the steric effect became extreme such as in tri-tert-butyldimethylsilyl glycal, the 













Entry R1 R2 R3 Product Yield 
1 Bn Bn Bn 1.8a 92% 
2 Me Me Me 1.8b 94% 
3 TBS H H 1.8c 88% 
4 -Si(tBu)2- H 1.8d 96% 
5 -C(Me)2- H 1.8f 33% 
6 TBS TBS TBS - 0% 
Table 1.1: Glucal cyclopropanation employing CH2I2/Et2Zn 
 An unexpected trans selective example was observed by Lorica and co-workers 
on 3,4,6-triacetyl glycal 1.13 under classic Simmons-Smith conditions (Scheme 1.3).28 
The opposite diastereoselectivity was attributed to the steric hindrance of the upper face 

















Scheme 1.3: Trans glucal cyclopropanation  
In addition to glycal substrates, allylic alcohol directed cyclopropanation was 
investigated with 2,3- and 4,5-unsaturated carbohydrate derivatives (Scheme 1.4).29  
Fraser-Reid and coworkers developed a strategy to access both facial diastereomers in the 
cyclopropanation of Ferrier rearrangement products 1.15.30 Reaction with 1.15 provided 
the expected directed addition product 1.16a, but the directing effect of the C(4) hydroxyl 
group was circumvented by prior oxidation. Note that the acetal ethoxy group does not 


























1.2.1.2 Dihalocarbene cyclopropanation 
Another strategy for trans cyclopropanation of allylic hydroxy/alkoxyl substituted 
carbohydrates was realized through dihalocarbene cycloaddition. In 1967, Brimacombe 
and co-workers reported the first carbohydrate cyclopropanation of a trimethyl glycal 
(Table 1.2, entry 1) through dichlorocarbene-glycal cycloaddition.31 However, only 
recently was a general methodology developed by Nagarajan for trans cyclopropanation, 
as illustrated by reaction with a series of protected glycal substrates: galactal, rhamnal 
and xylal (entries 2-5).32 The glycals were converted to the corresponding 
dichlorocyclopropanes 1.17 generally in > 80% yield by treatment with CHCl3 in the 















"   CCl2
"
1.18  
Entry R1 R2 R3 Yield 
1a MeOCH2 (β) MeO (α) MeO (β) 82% 
2b BnOCH2 (β) BnO (α) BnO (β) 84% 
3b BnOCH2 (β) BnO (β) BnO (β) 92% 
4b Me (α) BnO (β) BnO (α) 95% 
5b H BnO (α) BnO (β) 55%
 
  a see reference 31; b see reference 32.  






Like other olefin-dihalocarbene cycloadditions, the stereochemistry in this 
process is governed by steric approach control, with the substituent at C(3) being of 
primary importance. An important aspect of this chemistry is the ease with which 
reductive dehalogenation can be achieved to afford products 1.18 with stereochemistry 
complementary to that obtained by Simmons-Smith and related processes. 
 
1.2.1.3 Diazo ester cyclopropanation 
Transition metal catalyzed diazo ester cyclopropanation has also been 
investigated on carbohydrate substrates.34,35,36 The lack of cyclopropane functionality in 
the products prepared through Simmons-Smith or dihalocarbene cycloadditions limits 
opportunities for subsequent synthetic elaboration. In this regard, the products from 
reaction with diazoesters are doubly activated DA cyclopropanes, and the ester provides a 
well-situated functional handle suitable for further modification. The first literature 
example of carbohydrate-diazo ester cyclopropanation was reported in 1981,34 but 
detailed studies of transition metal catalyzed diazoester carbohydrate cyclopropanations 
were not reported until over a decade later by Henry and Fraser-Reid.35 They found that 
the cyclopropanation of tri-O-tert-butyldimethylsilyl-D-glucal with copper powder 
provided exclusive β facial selectivity giving the cis cyclopropane product in 92% yield 
(Table 1.3, entry 1). The cyclopropanation of the tri-benzyl protected analog was also 














































Protecting Groups Product Ratio  
Entry R1 R2 R3 
Catalyst Yield 
1.20a 1.20b 1.20c 1.20d
1a TBS TBS TBS Cu0 92% 0 100 0 0 
2b TBS TBS TBS Rh2(OAc)4 81% 97 3 0 0 
3b TBS Ac Ac Rh2(OAc)4 93% 94 2 2 3 
4b TIPS TIPS TIPS Rh2(OAc)4 66% 91 3 3 3 
5b Bn Bn Bn Rh2(OAc)4 44% 76 8 8 8 
6b Ac Ac Ac Rh2(OAc)4 73% 81 6 4 9 
7b Ac Ac Ac Cu(acac)2 4% 70 12 6 12 
 
a see reference 35; b see reference 36. 





When applied to galactal 1.21 and L-rhamnal 1.23 derivatives (Scheme 1.5), the 
cyclopropanation products 1.22 and 1.24 were obtained with α facial selectivity 
predominating. While yields were consistently excellent with these substrates (>  85%), 

















































Scheme 1.5: Diazo ester cyclopropanation of galactal and L-rhamnal 
Shortly thereafter, Hoberg and Claffey reported their results from an independent 
investigation of this reaction using other carbohydrate substrates and transition metal 
catalysts.36 As illustrated in Table 1.3 (entries 2 – 7), many commonly used protecting 
groups such as TBS, TIPS, benzyl ether, acetyl and acetonide were found compatible 
with the cyclopropanation conditions. However, unlike Fraser-Reid’s results in which β-
facial selectivity predominated (Table 1.3, entry 1), in Hoberg’s examples the α 
diastereomers were obtained (in good to excellent yield as well). The similar α-facial 
selectivity was also observed in the cyclopropanation of tri-acetyl galactal 1.25 and L-





observed facial selectivity to a steric control process,17 and the blocking effect from 
larger protecting groups (especially the C(3) protection) was believed to enforce trans 

















































Scheme 1.6: Hoberg’s diazoester glucal cyclopropanation 
These studies and work by van Boon37 and coworkers on the cyclopropanation of 
furanose and pyranose ring systems (Scheme 1.7) revealed that among the homogeneous 
catalysts examined Rh2(OAc)4 resulted in the highest efficiency. Judicious employment 
of either Rh2(OAc)4 or Cu(0) catalysts in the cyclopropanation of glycals with ethyl 































1.32 (52%)  
Scheme 1.7: Diazo ester cyclopropanation of furanose and pyranose 
1.2.2 Important reactions of carbohydrate-derived cyclopropanes and related 
compounds 
The potential reactivity and high optical purity of carbohydrate-derived 
cyclopropanes makes this class of compounds stand out as attractive and economical 
materials for developing new asymmetric synthetic methodologies. In pioneering efforts, 
several groups have persistently sought strategies to exploit 1,2-cyclopropanated 
carbohydrates, and a consistent theme emerging from those works is the need for general 
and predictable cyclopropane ring opening processes. The primary synthetic strategies 
thus far have invoked two types of cyclopropane ruptures (Scheme 1.8): electrophilic 
cyclopropane ring opening at the C(1)-C(7) position (pathway A) or Lewis acid assisted 

























































Scheme 1.8: Two main transformations of glycal-derived DA cyclopropanes 
1.2.2.1 Electrophilic C(1)-C(7) cyclopropane ring cleavage 
The ring opening of carbohydrate derived cyclopropanes along pathway A 
provides C(2) branched glycosides 1.33 (Scheme 1.8). The reaction normally proceeds 
through electrophilic cyclopropane methylene activation by an electron deficient species 
that leads directly to formation of the oxonium ion intermediate. An example of 





via mercury(II) salt activation (Scheme 1.9).38 This regioselectivity was thought to 

















Scheme 1.9: Mercury (II) activation of pyran-derived cyclopropane 
This strategy was later adapted by Heathcock to access C(2) methyl glucal 1.39 
(Scheme 1.10).39 Treatment of 1.8a with mercury(II) trifluoroacetate in presence of water 
afforded hemiacetal 1.38, which after subsequent Bu3SnH reduction and elimination 
























Scheme 1.10: Mercury (II) mediated C(2) glucal preparation 
A conceptually equivalent transformation has been recently developed by 
Danishefsky and coworkers using N-iodosuccinimide (NIS) to access the geminal methyl 
groups in the synthesis of cytotoxic agents epothilone B (Scheme 1.11).40, 41 Importantly, 
the high efficiency observed in the preparation of the intermediate 1.41 using NIS 

















1.40 1.41, X = I
















Epothilone B  
Scheme 1.11: NIS mediated application in epothilone synthesis 
Fascinated by these results, several applications of and modifications to the NIS 
strategy have been reported.42,43,44 Compared with the organomercury intermediate 1.36, 
the iodomethene appendage obtained directly from the NIS protocol opened a window for 
more environmentally responsible C(2) elaboration. Nagarajan and coworkers43 
discovered sharply different cyclopropane reactivity between the diastereomers 1.43 and 
1.8a (Scheme 1.12). Reaction of the α cyclopropane 1.43 with either NIS or NBS 
occurred rapidly and provided an anomeric mixture of 1.44 in ~90% yield. In contrast, 
reaction under otherwise identical conditions with the β cyclopropane 1.8a results in 
slower formation of 1.45 with pronounced anomeric selectivity. The same trend in 
reactivity was also observed on diastereomeric substrates 1.46 and 1.48 in which the free 





differences in reactivity were accredited to steric hindrance on the β-cyclopropanes 1.8a 
and 1.48 toward the approaching electrophilic activator. The most reactive α 
cyclopropane 1.46 not only has the advantage of the least C(3) steric hindrance, but is 
equipped with a free hydroxy ideally positioned for “SN2-like” participation. The β-
cyclopropane 1.48 is not disposed for direct substitution and is blocked from the 












 NIS or NBS







































 NIS or NBS
1.8a 1.45, X = I or Br
(40-70%)
 





In addition to investigations on 1,2-disubstituted cyclopropanes as shown in 
Scheme 1.12, the electrophilic ring cleavage strategy was applied to substrates prepared 
through diazo ester cyclopropanation. In an early example reported by Hoberg,36 the 1-
bromopyran derivative 1.51 was prepared in moderate yield (38%) by treating 1.50 with 
30% HBr in acetic acid, but the reaction was inevitably accompanied with C(3) “SN2-


















Scheme 1.13: Bromo-acetal formation   
In similar example, Fraser-Reid used the carboxylate substitution on 1.52 to his 
advantage in a highly selective cyclopropylcarbinyl-homoallyl rearrangement (Scheme 
1.14).34 Ester reduction by lithium aluminum hydride (LiAlH4) followed by standard 
Mitsunobu manipulation employing benzoic acid as the nucleophile gave 66-90% yield 




























Scheme 1.14: Cyclopropane ring opening via Mitsunobu activation 
Very recently an efficient method for the synthesis of C(2) branched glycol-amino 
acids 1.57 has been developed by Chandrasekaran thorough direct NIS mediated ring 
























Scheme 1.15: Application in glycol-amino acid preparation  
Although electrophilic ring opening reactions of carbohydrate-derived 
cyclopropanes provide access to C(2) branched glycosides, literature examples have 





glycosyl acceptors. The resulting acetals or hemiacetals offer a transitional intermediate 
for further C(1) transformations, but direct formation of C(1) C-branched glycosides 
remained elusive. Moreover, due to the limited assortment of electrophilic activators 
(e.g., Hg(II), or NIS/NBS), the resultant  C(2) moieties were susceptible to few synthetic 
transformations. 
1.2.2.2 Pyran ring expansion 
Another transformation of 1,2-cyclopropanated carbohydrates that has been 
actively investigated is pyran ring enlargement, a process driven primarily by release of 
cyclopropyl ring strain. The logistics of the σ-Ferrier rearrangement can be rationalized 
based on conformation models (Figure 1.2). In the glycal-derived bicyclic substrate, the 
fused cyclopropane distorts the pyran skeleton and prevents it from adapting an ideal 
chair conformation. The pseudo equatorial C(3) substituent will retain an orientation 
reasonably anti-parallel to the C(1)-C(2) bond. This bonding alignment therefore 
accommodates a manifold for smooth elimination facilitated by Lewis acid activation of 










Figure 1.2: Rationale for pyran ring expansion 
Hoberg has carried out detailed investigations on this variant of the σ-Ferrier 





cleaved exclusively at the C(1)-C(2) bond as a result of collaboration between the 
“donating” pyran oxygen and the quasi “accepting” effect from the departing C(3) 
substituent. Depending on substrate protective groups and reaction conditions, the 
intermediate oxonium ion can be converted preferentially into one of three oxapenes: 
1.59, 1.60 or 1.61. In examples where labile C(6) silyloxy protecting groups were 
present, intramolecular ring closure occurred faster than external nucleophilic substitution 
to provide anhydro-sugars 1.59 in up to 78% yield. To facilitate intermolecular attack at 
the C(1) oxonium ion, C(6) deoxygenation or more robust protection (e.g., R1 = R2 = 
tBu2Si) was required. Successful exogenous nucleophiles capable of C(1) 
functionalization include allylsilanes, silyl ketene acetals and silylthiazole. The reactions 
offered products 1.60 with moderate facial selectivity (2:1) in 67-93% yield (elimination 
to 1.61 was competitive). In the examples with sufficient suppression of intramolecular 
nucleophilic addition, the absence of external nucleophiles lured the oxocarbenium ion 
intermediate preferentially into a C(2) deprotonation pathway, which led to the 





























Similar ring expansion-nucleophilic addition sequences have been reported,46 and 
Sugita and coworkers described an interesting reaction of cyclopropanated pyranones 
1.62 with a variety of silyl enol ethers and silyl ketene acetals (Scheme 1.17).47 
Compared with the more rigid planar 4,6-di-tert-butylsilylene ether on substrate 1.58 (R1 














Scheme 1.17: C(1) Functionalization of cyclopropanated pyranones 
A mechanistically distinct transformation has been explored by Nagarajan for 
solvolytic ring-expansion of dihalocyclopropanated sugars to prepare the corresponding 
halogen substituted anomeric oxepane product 1.65 (Scheme 1.18).32b A significant 
difference in this process is that conversion to the 2-halo allylic cationic intermediate is 
initiated by base. The addition regiochemistry was attributed to the preferential 


























R = H, BnO
(55-70%)
 
Scheme 1.18: Application in anomeric oxepane preparation 
Glucal-derived DA cyclopropanes prepared through diazo ester cyclopropanation 
reportedly refuse to participate in the pyran ring expansion (c.f., Scheme 1.13).36 The 
different reactivity of those cyclopropanes was believed to originate from deactivation of 
the cyclopropane by the ester group,36 a postulate that is entirely consistent with Sugita’s 
observation on 2,3-methamochromanones 1.66 (Scheme 1.19).48 These studies elegantly 
compared the electron withdrawing ability of the ketone vs. a geminal ester substituent 
under Lewis acidic conditions (BF3•OEt2, TMSOTf or SnCl4). The unsubstituted 
cyclopropane expanded to the 6,7 bicyclic intermediate 1.67, which after formal dipolar 
cycloaddition with silyl enol ethers afforded the oxepanone derivatives 1.69 in 40-95% 
yield. In contrast, the dicarboxylate substituted cyclopropane maintained the 
methanochromanone core and underwent exo ring cleavage to a zwitterionic intermediate 
1.68. A subsequent cyclization with carbonyl compounds provided mainly the trans fused 
















R = H R = CO2Et





















Chapter 2: Intramolecular Glycal Cyclopropanation 
2.1 INTRODUCTION 
A recurring objective of carbohydrate cyclopropanation investigations has been 
development of new ways for accessing highly functionalized C(1) and C(2) branched 
glycosides. Glycal-derived cyclopropanes bearing an ester electron withdrawing group 
are poised for more elaborate transformations (e.g., Scheme 1.15) compared to their 
unsubstituted counterparts.  In this regard, the reported methods to control the facial and 
endo/exo selectivity of diazoester glycal cyclopropanation through catalyst selection 
(e.g., Section 1.2.1.3) is an important accomplishment. However, in our experience, 
achieving stereo-complementary results with a variety of protected glucal substrates 
proved elusive. 
To circumvent potential difficulties in stereochemical control endemic to glycal 
cyclopropanation, we recently established an intramolecular version of this reaction as 
depicted in Scheme 2.1.49  This strategy takes advantage of a molecular tether for 
obtaining absolute control over cyclopropanation facial selectivity. The unique 
conformation and strain inherent to the products results in new cyclopropane reactivity, 
which will be described in subsequent sections. Due to the ease of substrate preparation 
and complete diastereoselectivity, this method is a more reliable approach to access 
carbohydrate-derived DA cyclopropanes with stereochemistry complementary to those of 























Scheme 2.1: Reaction design 
2.2 SUBSTRATE PREPARATION 
The hallmarks of standard intramolecular diazo ester cyclopropanation are 
efficiency and a remarkable ability to rapidly increase molecular complexity.50,51,52 
Generally, excellent stereocontrol is observed in the intramolecular cyclopropanation of 
allylic alcohols. In pioneering investigations, Corey and Myers51 developed glyoxylic 
acid chloride p-toluenesulfonylhydrazone 2.253 as a versatile and practical reagent for 
efficient preparation of diazoacetic esters from allylic alcohols. However, despite ample 
precedence on various substrates, there were surprisingly no literature reports on 
intramolecular glycal cyclopropanation.  
As summarized in Scheme 2.2, the lactonized cyclopropanes 2.5a-c were 
prepared through intramolecular cyclopropanation of the corresponding diazo esters 2.3a-
c. The glycals 2.1a,54 2.1b,55 and 2.1c56 were accessible from tri-acetyl D-glucose 
according to literature procedures. In the first example attempted, the D-glycal was 
protected as the di-tert-butylsilylene ether 2.1a following Hoberg procedure54. The 
simple hydroxy manipulation together with the high stability of resulting silylene ether 
make this protecting protocol an excellent choice for this case, especially in consideration 
of strong Lewis acidic conditions that would be applied during the further exploration of 





As general examples (Scheme 2.2), the 4,6-O-protected glycals 2.1a-c were 
converted to their diazoacetates 2.3a-c in excellent yields using a slightly modified 
version of the Corey-Myers procedure. Treating the dichloromethane/N,N-
dimethylformamide (CH2Cl2-DMF) solution of the allylic alcohol and 2.257 sequentially 
with N,N-dimethylaniline (DMA) and triethylamine at 0 °C afforded the diazoacetates in 
excellent yields (88-92%). Specifically, small amounts (5-10%) of DMF as co-solvent 
proved critical for this transformation, and initial attempts using either pure CH2Cl2 or 
DMF solvent resulted in consistent decomposition of starting material and the  desired 
diazoester products were obtained in less than 5% yield.  
As a brief aside, in the preparation of glyoxylic acid chloride p-
toluenesulfonylhydrazone 2.2, we note that reaction of 2.7 with thionyl chloride 
occasionally proved fickle, frequently giving unstable oily product (Scheme 2.3). 
However, the acid chloride 2.2 could be reliably prepared if the intermediate carboxylic 
acid 2.7 was recrystallized from carbon tetrachloride-ethyl acetate (CCl4-EtOAc). 
Alternative diazoacetic esterification methods, such as Doyle’s diketene approach,58 were 























2.1a, R1, R2 = tBu2Si
2.1b, R1, R2 = Me2C

















1) p-TolSO2NHNCHCOCl (2.2) 
  CH2Cl2/DMF, Me2NPh, 0 °C
2) Et3N
































Scheme 2.3: Preparation of 2.2 
The cyclopropanation was achieved by slow addition of the diazoester 2.3a-c (8-
12 h via syringe pump) to a refluxing toluene solution of 5 mol % pre-catalyst bis(N-tert-
butylsalicylaldiminato)copper(II) [Cu(TBS)2] 2.4.59 The slow addition rate proved crucial 





and maleates. During this reaction, the C(3) stereochemistry of the starting glycal has 
demonstrated an absolute control on the facial selectivity of intermediate carbenoid 
species. On all the substrates investigated, the cis diastereomers proved to be the only 
products as detected both by TLC analysis and inspection of 1H NMR spectra of crude 
product mixtures. The examples in Scheme 2.2 also indicated that this intramolecular 
strategy is highly compatible with different protecting groups, including cyclic silylene 
ether (2.3a), acetonide (2.3b), as well as acyclic protecting groups such as benzyl and 
TBS (2.3c). It is noteworthy that the limited flexibility of cyclic 4,6-protection did not 
prevent effective formation of the highly strained cyclopropane products 
The intramolecular cyclopropanation process seemed to involve high activation 
energy, and lowered reaction temperatures led mainly to dimerization of the intermediate 
carbenoids. Among the solvents screened, toluene proved very efficient, but other 
common cyclopropanation solvents such as benzene or CH2Cl2 led mostly to substrate 
decomposition and/or dimerization. 
Besides the copper Shiff base Cu(TBS)2 complex 2.4, a wide variety of transition 
metal catalysts have been screened for this reaction and the results are briefly 
summarized in Table 2.1. The Cu(TBS)2 precatalyst 2.4 performed admirably on the 
cyclopropanation reaction under study; other common transition metal complexes 
however proved less than ideal after consistent attempts under different conditions. 
Among them, rhodium (II) acetate (Rh2(OAc4), the widely utilized cyclopropanation 
catalyst, provided less than 30% desired product.  Other catalysts including copper 
complexes CuPF6•(CH3CN)4, CuBF4•(CH3CN)2, Cu(OTf)2, CuClO4•(CH3CN)4, cobalt 
complexes (Co(acac)2) and zirconium chloride (ZrCl4) led to either dimerization of the 





that cyclopropanation was not accompanied by C-H insertion, even with rhodium(II) 
catalysts. It is likely that the limited conformational freedom of the intermediate 














Entry Catalyst Solvent Temperature Yield 
1 Cu(TBS)2 toluene 120 °C 92% 
2 Cu(TBS)2 CH2Cl2 39 °C Dimerization 
3 Rh2(OAc)4 CH2Cl2 39 °C 28% 
4 Rh2(OAc)4 toluene 120 °C < 25% 
5 CuPF6•(CH3CN)4 toluene 120 °C 8% 
6 CuBF4•(CH3CN)2 CH2Cl2 39 °C Dimerization 
7 CuClO4•(CH3CN)4 toluene 120 °C Dimerization 
8 Cu(OTf)2 CH2Cl2 39 °C Dimerization 
9 Co(acac)2 CH2Cl2 39 °C No Reaction 
10 ZrCl4 CH2Cl2 39 °C No Reaction 
Table 2.1: Screening on different transition metal catalysts  
In addition to the inherent complete facial selectivity, as expected, this 
intramolecular cyclopropanation strategy was not limited to carbohydrate-derived 
substrates, and the reaction of diazo ester 2.8 prepared from other readily available γ-
hydroxy dihydropyrans61 provided the pyran-derived cyclopropane 2.9 in 89% yield 
(Scheme 2.4). Moreover, besides the electron-rich olefins, the cyclopropanation of 






















5 mol %  2.4
 toluene, reflux
 
Scheme 2.4: Generality on different substrates   
While the intramolecular cyclopropanation has introduced considerable ring and 
bonding strains on the lactonized products, it does not prevent the cyclopropanes from 
possessing high stability. In fact, the product formation needs reaction temperature as 
high as refluxing toluene. In addition, the resultant cyclopropane products were found to 
be quite stable even under fairly harsh conditions including both strongly acidic (10% 
H2SO4, 10 hours) and basic conditions (saturated aqueous Na2CO3, 12 hours). 
The stereochemistry of cyclopropane 2.5a was unambiguously established by X-
ray crystallographic analysis of single crystals (mp 199.5-201.5 °C) obtained from 
EtOAc–hexanes solvent mixture (Figure 2.1). As anticipated, in the lactonized 
cyclopropane 2.5a, the bonds C(1)-C(2) and C(3)-O(8) are no longer in anti-parallel 
relationship but a torsion angle of 70.6°, which strongly disfavors the σ Ferrier 

















2.3 TRANSFORMATIONS UNDER MILD CONDITIONS 
Although DA cyclopropanes enjoy dual activation, reaction conditions to 
fragment these species are often quite harsh (Section 1.2.2). However, the lactonized 
substrates prepared through the aforementioned intramolecular strategy undergo certain 
useful transformations under milder conditions, thus opening the doors to new reaction 
pathways. 
 
2.3.1 Reactions attempted with organocopper reagents 
Acceptor substituted cyclopropanes 2.12 are opened by cuprates through what is 
generally perceived as a SN2 type reaction.63 One of the representative examples was 
demonstrated on Corey’s synthesis of prostaglandins,50 where the trans relationship 
required for the target prostaglandin E3 2.14 was established through SN2 like cuprate 






















In our glycal lactonized substrates, the analogous reaction did not happen. Upon 
treatment with a variety of alkyl organic copper reagents, the lactonized cyclopropanes 
such as 2.5a failed to react in an analogous fashion. Instead the nucleophilic addition to 
the lactone carbonyl was observed (Scheme 2.6). The ring strain appears to make this 
lactone more electrophilic than normal, and coupled with cyclopropane deactivation 
(toward nucleophiles) from the pyran oxygen, reaction at the cyclopropane under 
nucleophilic conditions has not been observed. When excess Grignard reagents were 
employed, the reaction generally provided enhanced yields of alcohol 2.15. Since the 
resultant product 2.15 possesses cis cyclopropane stereochemistry that are opposite to 
literature examples obtained through intermolecular cyclopropanations (Table 1.3),34,36 



















Scheme 2.6: Lactone breakage via cuprates or Grignard reagents 
2.3.2 Transition metal mediated cyclopropane ring opening 
2.3.2.1 Background 
Transition metal catalyzed rearrangements of DA cyclopropanes to give (or 
regenerate) enol ether products are well established and known as “Puddephatt” 





rhodium(I) ([Rh(CO)2Cl]2), ruthenium(II) ([Ru(CO)3Cl2]2), platinum(II) (PtCl2•2PhCN), 
copper bronze and CuCl were reported to be efficient catalysts for this transformation. 
The reaction proceeds by a regioselective oxidative addition to generate a 
metallacyclobutane intermediate.  A subsequent reductive β-hydride extraction and 
reductive elimination affords the vinyl ether products, which have shown little tendency 










2.16 2.17 2.18  
Scheme 2.7: Puddephatt rearrangement of DA cyclopropanes  
Using Ziese’s dimer in alcoholic solvent, Madsen recently extended this 
transformation to glycal-derived cyclopropane substrates as a means to access C(2) 
branched glycosides (Scheme 2.8).68 Interestingly, the platinacyclobutane intermediate 
gained sufficient lifetime for competitive C(1)-Pt bond dissociation before β-hydride 
elimination to the glycoside products.  Even when challenged with electronic effects from 
substrates bearing a carboxylate group 2.24, the C(1)-Pd bond dissociation still overrode 

































































Scheme 2.9: Ziese’s dimer mediated ring cleavage of 2.24 
 
2.3.2.2 Results and discussion 
In our situation, reaction of the lactonized cyclopropane 2.5a in the presence of 





provided the Puddephatt rearranged product 2.26 in 79% yield (Scheme 2.10).69 It is very 
likely that the conformational restriction of lactonized cyclopropane substantially offsets 
the stabilizing effect of the pyran oxygen, and the transient metallocyclic intermediate 





















Scheme 2.10: Puddephatt rearrangement of 2.5a 
2.4 APPLICATION IN QUASI FORMAL SYNTHESIS OF XYLOBOVIDE 
To demonstrate the potential synthetic utility of this methodology, the 
cyclopropane 2.5a was applied to a quasi formal synthesis of bislactone product 2.34a 
and its derivatives.  
The phytotoxic natural product xylobovide 2.34a,70 together with the fungicide 
canadensolide 2.34b,71 and antibacterial agent sporothriolide 2.34c are closely related 
natural products that differ simply in the length of their side chain (Scheme 2.11). These 
structures have received considerable attention as synthetic targets. Canadensolide 2.34b 
and sporothriolide 2.34c have been synthesized,72,73 but the total synthesis of xylobovide 
2.34a has not been reported. Inspection of 2.34a reveals that, excluding the exocyclic 
methylene,74 all of the carbons with the correct stereochemistry necessary for its 












2.34a, xylobovide, n = 1
2.34b, canadensolide n = 3
2.34c, sporothriolide, n = 5  
Scheme 2.11: Xylobovide and derivatives 
As illustrated in Scheme 2.12, cyclopropane 2.5a was converted into the 
advanced intermediate 2.32, which, on the basis of literature precedent,72g,h provides  
access to xylobovide 2.34a. The first synthetic task was the removal of the di-tert-butyl 
silylene ether. Complete desilylation with TBAF in THF afforded, as expected, the 
corresponding diol in 93% yield. However, the possibility of achieving a more interesting 
mono-desilylation of the di-tert-butylsilylene ether was explored with this substrate. 
After some experimentation, it was discovered that treatment of 2.5a with BF3•Et2O in 
toluene (85 °C, 30 min) in the presence an HF scavenger such as allyltrimethylsilane 
revealed exclusively the primary alcohol 2.27 in 95% yield.75,76 (The generality of this 
selective mono-deprotection protocol is described in Chapter 5.) Conversion of alcohol 
2.27 to iodide 2.29 (ca. 90%, two steps) following a Finkelstein transformation set the 
stage for a zinc-mediated reductive ring opening cascade.77 Addition of iodide 2.29 to a 
room-temperature suspension of zinc-copper couple78 in dry THF resulted in rapid 
reduction and cleavage of the pyran ether to zinc alkoxide, which spontaneously 
underwent further ring opening to aldehyde 2.30. Aldehyde 2.30 was converted without 
purification to the hemiacetal 2.31 by desilylation of the di-tert-butylfluorosilyl ether 





reaction sequence proved to be quite robust in the absence of fluoride ion and was labile 
only upon exposure for several hours to strongly basic conditions (5% aqueous NaOH). 
Reduction of olefin intermediate with hydrogen over palladium on carbon 
provided hemiacetal 2.32 (96%), which maps nicely onto an advanced intermediate in the 
Fraser-Reid total synthesis of canadensolide.72g,h Additionally, treatment of hemiacetal 
2.31 with catalytic H2SO4 in refluxing methanol afforded acetal 2.33 in 96% yield. The 
acetal 2.33 presents a convenient divergence point for the synthesis of canadensolide 

































































































Chapter 3: Lewis acid mediated reactions of DA cyclopropanes  
3.1 INTRODUCTION 
Lewis acid (LA) mediated ring opening reactions are among the most important 
synthetic transformations for DA cyclopropanes (Section 1.2.2.2).1 Lewis acid promoted 
reactions of DA-cyclopropanes prepared by intermolecular cyclopropanation offer an 
efficient route to oxapanes through ring expansion.17 While useful for accessing seven-
membered rings, the transformation fails to exploit the difficult-to-establish cyclopropane 
stereochemistry. 
In this regard, the unique bond angles of the lactonized DA cyclopropanes 
prepared through intramolecular cyclopropanation provided an excellent approach to 
circumvent the σ-Ferrier rearrangement. Single crystal X-ray crystallographic analysis of 
tricycle 2.5a revealed a twisted boat conformation of the pyran scaffold (instead of the 
chair-like intermolecular counterparts) and a C(1)-C(2)-C(3)-O(8) dihedral angle of 70.6° 
(Figure 2.1), which disfavors the C(3)-O(8) elimination pathway as observed on the 
intermolecular counterparts. Additionally, unlike the one in the chair like structure 1.58, 
the C(1)-C(7) bond alignment is distorted into a position reasonably anti-parallel to the 
lone pair electrons of the pyran ring oxygen, and therefore suitable for C(1)-C(7) bond 

























































3.1 3.2  
Scheme 3.1: Lewis acid mediated C(1) cleavage of lactonized DA cyclopropane 
The reactivity of cyclopropane 2.5a was studied with a variety of Lewis acids 
including SnCl4, Et2AlCl, Ti(iOpr)4, Cl2Ti(iOpr)2, ZnCl2, Sc(OTf)3, ZrCl4, Zr(OTf)4.  In 
most cases, Lewis acid treatment under various conditions resulted in either no reaction 
or substrate decomposition. However, three Lewis acids were identified to be effective 
for promoting C(1)-C(7) bond cleavage: BF3•OEt2 (Section 3.2), TMSOTF (Section 3.3), 
and TiCl4 (Section 3.4 and 3.5). This chapter summarizes the useful transformations we 





the newly discovered chemical reactivity of 2.5a has been expanded to encompass 
general non-carbohydrate derived DA cyclopropanes (Chapter 4). 
3.2 REACTIONS MEDIATED BY BORON TRIFLUORIDE ETHERATE 
Compared with TMSOTf and TiCl4, the use of BF3•OEt2 as an activator of DA 
cyclopropanes has received less attention. Generally, DA cyclopropanes are quite 
resilient to this promoter, and application of BF3•OEt2 has been mostly restricted to 
initiating cascade sequences consisting of pyran expansion and nucleophilic addition 
(Section 1.2.2.2).47,48,49 
The lactonized DA cyclopropane 2.5a was found to be essentially unreactive 
toward BF3•OEt2. Under conditions attempted for direct allylation, the cyclopropane 
refused to undergo either retro-aldol rearrangement or pyran ring expansion. Changing 
the solvent system to include CH2Cl2, chloroform, ether, or THF did not appear to have a 
positive effect. When forcing conditions were applied (e.g., 80 °C, toluene), the 
cyclopropane nucleus remained intact, but the di-tert-butylsilylene ether succumbed to 
ring cleavage (Scheme 3.2), giving the primary alcohol 2.27 in nearly quantitative 
yield.49 While there was no noticeable allylation side products observed during this 
reaction, the trimethyl allylsilane was found to be indispensable for maintaining high 
efficiency. Control experiments without this reagent normally led to incomplete reaction, 
poor regioselectivity, and over-deprotection. This apparent difference strongly suggested 



































Scheme 3.2: Regioselective desilylation of silylene ether 2.5a 
The general reactivity and selectivity of the deprotection, and the stability of the 
fluorosilane protective group have been systematically explored (Chapter 5).76 A useful 
observation from those studies is that the stability of the subject di-tert-butylsilylene ether 
falls in between that of the tert-butyl-dimethylsilyl ethers (TBDMS) and triisopropylsilyl 
(TIPS) ethers.  
The mono-desilylation of 2.5a requires relatively high temperatures (80 °C). For 
example, in refluxing CH2Cl2 solution, the reaction was still plagued with incompletion 
and over-deprotection, which strongly suggests the high stability of the subjective 
cyclopropane.  
The reactivity (or stability) of 2.5a afforded the opportunity for an important 
comparison between similar lactonized cyclopropanes and those prepared from 
intermolecular cyclopropanation. Specifically, the control cyclopropane 3.3 underwent 
rapid ring expansion at temperatures as low as –30 °C, giving oxacycloheptene products 





similar substrates in Scheme 3.2 and Scheme 3.3 appears to support the hypothesis that a 





























3.3 REACTIONS MEDIATED BY TRIMETHYLSILYL TRIFLUOROMETHANESULFONATE  
The use of trimethylsilyl trifluoromethanesulfonate (TMSOTf) to activate 
cyclopropanes has seen more frequent literature success, but the application on 
carbohydrate-derived DA cyclopropanes has been mainly restricted to pyran ring 
expansion (Section 1.2.2.2). For example, Hoberg showed that catalytic TMSOTf 
generated an oxocarbenium ion intermediate sufficiently long lived that it could be 
intercepted with a variety of nucleophiles, including allylsilanes, propargylsilanes, sily 
enol ethers and disulfides (Scheme 3.4).27b But the conformationally planar di-tert-butyl 





















Scheme 3.4: Pyran ring expansion of glycal derived DA cyclopropane  
In stark contrast, under similar conditions employing catalytic TMSOTf, the 
lactonized DA cyclopropane 2.5a remained intact even in refluxing CH2Cl2 (Scheme 
3.5). Cyclopropane cleavage at the C(1)-C(7) bond was eventually realized under forcing 
conditions including stoichiometric Lewis acid loading (1.5 equivalents) and extended 
reaction time (18 hours). But these conditions also led to destruction of the silylene ether, 





3.8 in up to 90% yield.  This anhydro-sugar 3.8 formation process appears to be very 












CH2Cl2, rt, 18 hr
3.8, R = Me3SiO(
tBu)2Si







Scheme 3.5: Anhydro-sugar 3.8 formation 
The amphibious chemical behavior of 2.5a has stimulated further investigation on 
lactonized DA cyclopropane reactivity. The unique ring strain and bonding angle of the 
quartcycle 2.5a seems to place the intermediate oxocarbenium ion in a self-stabilized 
conformation which is unmotivated for either C(2) deprotonation or neutralization with 
external nucleophiles. Further attempts to intercept the oxocarbenium generated from 
reaction of the lactonized DA cyclopropanes with TMSOTf using other nucleophiles 
eventually met success, and these results will be described in chapter 4.  
3.4 STEREOSELECTIVE ALLYLATION MEDIATED BY TITANIUM TETRACHLORIDE  
We have recently developed Lewis acid promoted direct allylation of glycal-
derived DA cyclopropane, and this methodology provided a convenient route toward 
glycosides with both C(1) and C(2) C-branches for future structural modifications.  
3.4.1 Brief literature survey 
The allylation of activated cyclopropanes is an attractive strategy for increasing 





activated cyclopropanes (Scheme 3.6).80 The allylation of 3.10 occurred regio-selectively 
at the substituted position, but in the case of 3.12 addition to the vinyl group was also 
observed. Hoberg reported the direct allylation of donor activated glycal-derived 
cyclopropane 3.6, but the flattened bicycle oxonium intermediate did not show 
























Scheme 3.6: Attempts on direct allylation of cyclopropanes 
Direct Lewis acid mediated allylation of DA cyclopropane might be anticipated to 
be a straightforward process, but throughout the literature there are few examples. 
Because allylsilanes can also function as both 1,2 and 1,3 dipoles, the  allylation of DA 
cyclopropanes 3.15 is often accompanied, or even dominated by [3+2] cycloaddition 





























Scheme 3.7: Allylation vs. [3+2] cycloaddition of 3.15 
Products derived from the formal allylation of DA cyclopropanes were recently 
reported by Reiser,82,83 but that process does not involve authentic allylation of the 
cyclopropane core (Scheme 3.8). Instead, reaction of cyclopropane 3.18 with 
allyltrimethylsilane in the presence of BF3•OEt2 resulted in Sakurai reaction with the 
pendant aldehyde. The alcohol 3.20 was converted into the lactone 3.12 through 
treatment with acid or base. Even with two electron withdrawing groups, the remarkable 
stability of the cyclopropane ring was further demonstrated by its noninvolvement during 





















2) Acid or base
(82%)
3.203.19  













Scheme 3.9: Mukaiyama transformation of 3.22 
3.4.2 Direct allylation of lactonized glucal-derived cyclopropanes 
A wealth of information is known about glycosyl donors,84 and this work 
prompted us to test whether activation of DA cyclopropane 2.5a with a suitable Lewis 
acid would generate an oxo-carbenium ion as a compatible glycosyl donor for direct 
allylation.85 Toward this end, treating the cyclopropane 2.5a with a stoichiometric (1.7 
equivalents) amount of TiCl4 for two hours at room temperature resulted in complete 
conversion to a more polar species (TLC), presumably the α-chloropyran intermediate 





of allyltrimethylsilane led to formation of 3.25 (Scheme 3.10) in 79% isolated yield, and 
the sterically favored α-diastereomer predominated (4:1) in the product mixture.86 While 
the similar 2-halopyrans/furanoses were reported isolatable,87 the 2-chloropyran 
intermediate 3.24 proved elusive for isolation after careful attempts, and it was finally 









1) TiCl4 (1.7 eq)
2) SiMe3















Scheme 3.10: Stereoselective allylation of 2.5a 
Lewis acid TiCl4 was found to be the only successful promoter for this reaction. 
Other Lewis acids (e.g., BF3·OEt2, SnCl4, Sc(OTf)3, ZrCl4 and Et2AlCl) under standard 
Sakura allylation conditions88 resulted in either substrate decomposition or no reaction. 
Reactions under TMSOTf condition furnished the anhydro-sugar product 3.8 after 
silylene ether cleavage (Section 3.3).  
A very curious aspect of this allylation had been the high dependence on reagent 
addition order, and the above stepwise addition sequence proved critical for success. 





as typically employed in Sakurai reactions,88 resulted exclusively substrate 
decomposition. 
As illustrated in Table 3.1, employing allyltributylstannanes improved both 
reaction yields and facial selectivity (entry 2), but due to high toxicity it was not the 
primary focus of the study. The subject allylation reaction was found to be quite general 
and efficient on this classic of lactonized DA cyclopropanes (entry 1-3), as well as the 
non-sugar-derived substrate 2.9 (entry 4). In entries 3 and 4 the conformationally 
restricted 4,6-cyclic protecting groups proved unnecessary. A variety of enantiomerically 
pure dihydropyrans are available from hetero-Diels-Alder cycloadditions,61 and entry 4 
confirms that cyclopropanes derived from these synthetically important substrates 
participate efficiently in the stereoselective allylation. The more hindered prenylsilane 
gave the addition product 3.29 in 78% yield with enhanced diastereoselectivity of 10:1 
(entry 5). Crotylation resulted in exclusive formation of the α-isomer 3.30, but no 























1 2.25a SiMe3 3.25 
79% 
(4:1) 


































































a CH2Cl2 solvent, isolated yields; b 1:1 mixture of diastereomers at the allylic position. 





To improve the diastereoselectivity of the allylation, steric hindrance was 
temporarily introduced onto the lactone tether to increase the nonbonding interactions 
between nucleophilic allylsilane and substrates (Table 3.2). In these reactions, premixing 
2.25a and electrophile compatible with strong base before enolate formation is absolutely 
necessary. Efforts to introduce different activating functionality through other 
















Entry Electrophile R Product Yield 
1 Me3SiCl Me3Si 3.31a 96% 
2 (C2H3)Me2SiCl C2H3Me2Si 3.31b 97% 
3 (C3H5)Me2SiCl (C3H5)Me2Si 3.31c 93% 
4 MeO2CCl - - decomposition 
Table 3.2: Temporary silylation of 2.5a 
With the temporary steric hindrance, the reaction diastereoselectivity increased to 
an 8:1 ratio (Table 3.3, entry 1). The stereochemical assignment of the major 
diastereomer 3.32a(α) (entry 1) was unambiguously confirmed by single-crystal X-ray 
analysis (Figure 3.1), and subsequent desilylation with KF in MeOH/MeCN provided a 
product identical to the major diastereomer 3.25(α) (Table 3.1, entry 1) obtained from 





















1. TiCl4 (1.7 eq)
 
  






































































 a CH2Cl2 solvent, isolated yields; b Structure assignment of 3.32a(α) by X-ray 
crystallography; c Inseparable mixture. 























3.31a(α) 3.25(α)  
Scheme 3.11: Selective desilylation of 3.32a(α) 
The internal lactone linkage proved to be a necessary structural feature for direct 
allylation, and control experiments attempted on flexible carbohydrate-derived substrate 
3.33 led to exclusive substrate decomposition (Table 3.3, entry 4). Application of similar 
conditions to general DA cyclopropane 3.34 resulted in formation of cyclopentene 
derivative 3.35 (entry 5).81  
In an attempt to access the β diastereomer as the major product, a possible 
intramolecular allylation was attempted on substrate 3.31c, which was prepared in 93% 
yield from allyl dimethyl chlorosilane following the similar procedure as described for 





from the β face of the intermediate oxonium ion (Table 3.3, entry 3; Scheme 3.12), but 
the change in the diastereomeric ratio was minimal (3:1 vs. 4:1); either in presence or 
absence of exogenous allylation reagents. Convincing evidence for the reactions 











































3.5 STEREOSELECTIVE GLYCOSYLATION MEDIATED BY TITANIUM TETRACHLORIDE 
In addition to direct DA cyclopropane allylation, Lewis acid TiCl4 also proved 
efficient in mediating alcohol solvolysis of lactonized glucal-derived DA cyclopropanes 
and provided C(2) branched glycoside products (Scheme 3.13).69 Alcohol has been 
reported to react with functionalized cyclopropane under various reaction conditions 
including neutral,89 acidic,90 electrochemical,91  photochemical,92 mercuration,93 and 
others as briefly summarized in Section 1.2.2.1. However, of these solvolysis reactions, 
few of the cyclopropanes were dihydropyran-derived, and a scant number of them were 
prepared from carbohydrates.94,95 It has been reported that closely related cyclopropanes 
preferentially undergo ring expansion to seven-membered oxacycles when treated with 
strong electrophiles (Section 1.2.2.2), but this mode of ring opening has not been 
























Scheme 3.13: Stereoselective glycosidation of 2.5a 
After activation of cyclopropane 2.5a with stoichiometric amounts of TiCl4, the 
resulting mixture was worked up with aqueous NaHCO3 solution to afford hemiacetal 





mixture with excess methanol led to the formation of acetal 3.36b, but the reaction was 
plagued with substrate decomposition and low conversion yield (<35%). Mercury or 
silver salts were added to promote reactivity in the Köenigs–Knoor glycosidation 
reaction, but both of these additives were less than ideal in the current case. In this 
regard, it was discovered that the addition of a catalytic amount of strong Brønsted acid, 
such as trifluoromethanesulfonic acid (TfOH), resulted in clean solvolysis. Under these 
conditions, a 6:1 mixture of α and β acetals 3.36b was obtained from the reaction with 
methanol (91%, Table 3.4, entry 2). Both the 13C and 1H NMRs consistently indicated α-
diastereomer as the major product. The observed facial selectivity is consistent with the 
anomeric effect as well as steric directing factor. Under the cooperation of increased 
alcohol steric hindrance, the reaction generally displayed elevated α-facial selectivity, 
with a ratio of 8:1 for benzyl alcohol (entry 3), and 15:1 (α:β) for allylic alcohol (entry 
4). Phenols worked equally well as glycosyl acceptors, and from the reaction in entry 5 












1) TiCl4 (1.7 eq)
2) aq NaHCO3
2.5a 3.36a (90%, α:β = 7:3)  

















1) TiCl4 (1.7 eq)
2) ROH (RSH)
    TfOH (cat)
2.5a 3.36a-e  












































3.36e 87% 12:1 
Table 3.4: Acetal formation from 2.5a 
Whereas CH2Cl2 has been the most efficient solvent for direct allylation (Section 





alcohol hydrolysis. Glycosidations in CH2Cl2 are normally accompanied with many 
uncharacterized by-products. 
A major disincentive for employing the acetal synthesis as outlined above for 
direct preparation of oligosaccharides is the requirement for excess alcohol to satisfy the 
electrophilic titanium chloride. However, practical glycosylation can be achieved by a 
two-step sequence that proceeds through traditional 2-sulfanyl pyran intermediates such 
as 3.36e,f. The S,O-acetals 3.36e,f were prepared through TiCl4 activation of 2.5a 
followed by thiol trapping (Table 3.4, entries 6 and 7).96,97,98 To demonstrate the 
glycosylation procedure, treatment of 3.36e with 2,3,4-tribenzyl methyl pyranoside 3.3799 
in the presence of N-iodosuccinamide and TfOH gave the disaccharide 3.38a (82%) as a 
3:1 mixture of diastereomers.100 As further structural confirmation, the 3.38a was 































3.38a, R = Bn (82%, α:β = 3:1)











   TfOH (cat)
2.5a RSH = PhSH
= 2-py-SH
3.36e (91%, α:β = 4:1)
3.36f (84%, α:β = 5:1)
 








Chapter 4: Formal [3+2] cycloaddition of DA cyclopropanes 
One of the most important synthetic applications of DA cyclopropanes has been 
in the area of (formal) [3+2] dipolar cycloadditions to generate five-membered 
carbocyclic and heterocyclic structures.1 Because of the dual electrostatic character of the 
intermediate 1,3-zwitterion (Scheme 1.1), the cyclization can begin with either an 
electrophilic or nucleophilic reaction with the intermediate 1,3-dipole. The unique 
chemical behavior of DA cyclopropane 2.5a prepared through intramolecular glucal 
cyclopropanation has led to the discovery of several new type of [3+2] dipolar 
cyclizations. 
4.1 INTRODUCTION 
A wide variety of π-electron systems are efficient dipolarophiles for cyclization 
with DA cyclopropanes, and aldehydes and ketones were among the first successful 
dipolarophiles to be identified. However, the majority of successful examples have 
employed cyclopropanes further activated by incorporation of additional electron donor 
or acceptor groups.  For example, reaction of 4.1 with aldehydes followed by an acidic 
workup provided γ-lactone products 4.2 (Scheme 4.1).101 The reaction was selective for 
the diastereomer with a cis relationship between the carboxylate and R2, but a subsequent 
basic epimerization provided access to the trans epimer 4.3. A similar reaction with a less 
substituted cyclopropane such as 4.4 resulted in the formation of four diastereomers 4.5 
(Scheme 4.2), but a single Diastereomer 4.6 was available by base catalyzed 
equilibration.102 Excellent stereocontrol was observed in the reaction with symmetric 





reported on 2,3-carboxylate substituted methanochromanone derived DA cyclopropane 





























































Scheme 4.3: DA cyclopropane-aldehyde/ketone cycloaddition 
Carbon-nitrogen double bonds in the form of imines,104  isocyanates,105 and 
isothiocyanates106 also react with DA cyclopropanes to provide lactams 4.10, 4.12 and 































































Scheme 4.5: DA cyclopropane-isocyanates cycloaddition 
DA cyclopropane 4.11 has also been reported to undergo thermal cyclization with 
azodicarbonyl compounds in 70–80% yields (Scheme 4.6),107 and the diastereoselectivity 
is highly dependent on the conformation of 4.11 as well as the polarity of the solvents. In 
other examples, the cyclization of 4.11 with electron deficient acetylene 4.15108 or alkene 





very good diastereoselectivity, but the former was accompanied by considerable 



















































Scheme 4.7: Cyclopentane/cyclopentene preparation from DA cyclopropanes 
Compared with the large diversity of electron deficient dipolarophiles, fewer 
electron rich dipolarophilic components have been reported to participate with DA 
cyclopropanes. The reaction with electron rich dipolarophiles normally requires catalytic 
Lewis acid activation. The reaction of cyclopropyl carboxylate or ketone 4.19 with silyl 
enol ethers under SnCl4 activation afforded the cyclopentane products 4.20 in good 




















Scheme 4.8: DA cyclopropane-silyl enol ether cycloaddition 
The reaction of cyclopropane 4.4 and silyl ketene acetals however did not stop at 
the cyclopentanes, and spontaneous elimination of MeOH gave the cyclopentenone 























Scheme 4.9: DA cyclopropane-silyl ketene acetals cycloaddition 
Recently, Yadav and coworkers have reported formal [3+2] cyclizations of 
acceptor cyclopropane 4.23 with aryl acetylenes 4.24 (Scheme 4.10),112 and 
allenylsilanes 4.27 (Scheme 4.11).113 These reactions demonstrated both high regio- and 









































Scheme 4.11: DA cyclopropane-allenylsilanes cycloaddition 
4.2 FORMAL [3+2] CYCLOADDITION OF GLYCAL-DERIVED DA CYCLOPROPANES  
Despite the above diverse examples on general DA cyclopropanes, the formal 
[3+2] dipolar cycloaddition has been unprecedented for carbohydrate-derived 
cyclopropanes. A likely reason behind the paucity of examples on this class of substrates 





cyclopropanes prepared by intramolecular cyclopropanation, in contrary, displayed many 
improved reactivities. Extension of the Lewis acid activation study on this class of 
substrates has led to discovery of several highly stereoselective formal [3+2] dipolar 
cycloadditions. This section summarizes those new cyclization reactions that we recently 
developed on lactonized cyclopropanes.114,115, 116 
4.2.1 Cyclization with sily enol ethers 
With the assistance of Lewis acid TiCl4 the lactonized cyclopropane 2.5a cyclizes 
with silyl enol ether 4.30 to provide the cycloadduct 4.31 as the only isolatable product in 
77% yield (Scheme 4.12). It is noteworthy that the cycloaddition reaction did not require 
cyclopropane pre-activation as previously employed for allylation86 and glycosidation.69 
Compared with substrates 1.58 and 1.62, the intramolecular lactone linkage seems to be 
responsible for the lack of ring expansion as previously observed on the flexible 




















Scheme 4.12: Cycloaddition with silyl enol ether 
The stereochemistry of the product 4.31 was determined by single crystal X-ray 
analysis (Figure 4.1). The stereochemistry of this reaction is consistent with a steric 
control process in which the nucleophilic silyl enol ether approaches the oxocarbenium 





intramolecular ring closure places the larger substituent (TBS) preferentially in a pseudo-
equatorial position.  
 
 
Figure 4.1: X-ray structure of 4.31 
This silyl enol ether cyclization displays high dependency on the reaction 
conditions and the reaction requires promotion by TiCl4. Efforts using Lewis acid 
promoters other than TiCl4 (e.g., ZrCl4, BF3•OEt2, TMSOTf) did not lead to successful 
transformation. Other reaction conditions such as lower temperatures (e.g., −78 °C), 
alternative solvents (including toluene, diethyl ether), or substrate pre-activation also led 
to less efficient reactions. Similar reaction conditions with silyl ketene acetals did not 



















































Scheme 4.13: Mechanistic hypothesis for silyl enol ether addition  
4.2.2 Cyclization with imines and carbonyl compounds 
In addition to electron rich π-electron systems, electron deficient dipolarophiles 
also participate in the cyclizations with lactonized DA cyclopropanes. The TMSOTf 





yield (Scheme 4.14). The reaction displayed excellent stereoselectivity and dependence 

































Scheme 4.14: Cycloaddition with imines 
Reactions with aldehydes required TiCl4 activation (Scheme 4.15). The acetal 
product 4.34 is highly susceptible to hydrolysis, which complicated isolation. Therefore, 






























    TfOH
1) PhCHO
    TiCl4
4.35(76%)
 





4.2.3 Cyclization with nitriles 
Acetonitrile is a common solvent for reactions involving charged intermediates, 
and often becomes incorporated into reaction products, as in the classic Ritter reaction.117 
It is generally a useful and unreactive solvent for ring opening reactions of DA 
cyclopropanes, even when highly electrophilic oxocarbenium ion intermediates are 
involved (e.g., Scheme 1.16, Scheme 3.4). In marked contrast, treating the lactonized DA 
cyclopropanes 2.5a under similar reaction conditions using TMSOTf as Lewis acid 
resulted in clean formation of 2H-3,4-dihydropyrrole product 4.36a in moderate to 
quantitative yields (Scheme 4.16). The same level of efficiency was also observed even 
in the presence of excess external nucleophilic allyltrimethylsilane,114 and possible side 
reactions such as pyran ring expansion were not observed.  
The efficient stereoselective assembly of densely functionalized amine-containing 
heterocycles is an active area of investigation due to the wide occurrence of these species 
in natural products and synthetic materials. Additionally, the 2H-3,4-dihydropyrrole 
products from the cycloaddition contain an aminal, a functional group that has classically 





















The stereochemistry of the reaction was unambiguously determined by X-ray 
crystallographic analysis of crystals of benzonitrile cyclization product 4.36b (Figure 
4.2).  
 
Figure 4.2: X-ray structure of 4.36b  
Curiously, the cis-like stereochemistry of this cyclization is opposite of that 
observed in the cycloaddition with silyl enol ethers (Scheme 4.12, Figure 4.1). A 
mechanistic hypothesis consistent with a Ritter-like transformation starts with 
nucleophilic nitrile addition onto an intermediate oxonium ion 4.37 (Scheme 4.17). 
Although steric approach control would favor attack at the α-face, but presumably the 
electrophilic linear nitrilium ion of 4.38 is too distant for enolate attack. In contrast, the 
sterically less favorable cis-like intermediate 4.39 can be trapped by the enolate giving 












































Scheme 4.17: Mechanistic hypothesis for cis cycloaddition  
This formal dipolar cycloaddition demonstrated excellent reagent compatibility as 
aliphatic, aromatic and α,β-unsaturated nitriles participated (Table 4.1). Aliphatic nitriles 
ranging from MeCN to the much larger tBuCN all gave the expected imine adducts in 
high efficiency. The nitrile could be used as solvent (entry 1), and where this was 
impractical, the use of MeNO2 or CH2Cl2 with 5 to 10 equivalents of nitrile also gave 
excellent yields (entry 2-9). The reaction with α,β-unsaturated nitriles in MeNO2 occurs 
exclusively on the nitrile functional group and no side reaction with C=C has been 
observed (entries 7-9).7a The nitrile components help to introduce diverse functionality 
such as halides, olefins onto the cyclization products and thus leaves a large window for 





introducing an aldehyde functional group (entry 9), and the vinylogous amide 4.36h was 
isolated in 78% yield. Among the nitriles screened for this reaction, electron rich nitriles 
generally provide high efficiency, electron deficient nitriles, however, failed to 
participate. The retarded reactivity of the latter is probably due to their poor 


















2.5a 4.36a-h  
Entry Nitrile Solvent Product Yield 
1 MeCN MeCN 4.36a, R = Me 96% 
2 MeCN CH2Cl2 4.36a, R = Me 84% 
3 PhCN CH2Cl2 4.36b, R = Ph 81% 
4 PrCN CH2Cl2 4.36c, R = Pr 95% 
5 tBuCN CH2Cl2 4.36d, R = tBu 79% 
6 Cl(CH2)3CN CH2Cl2 4.36e, R = (CH2)3Cl 87% 
7 Ph CN  MeNO2 4.36f, R = CHCHPh 60% 
8a Ar CN  MeNO2 4.36g, R = CHCHAr 75% 










 a Ar = m,p-(MeO)2C6H3-. 
Table 4.1: DA cyclopropane-nitrile [3+2] cycloaddition 
In addition to the diversity of suitable nitrile components, the cycloaddition 
tolerates reasonable diversity on cyclopropane substituents (Scheme 4.2). The di-tert-
butylsilylene protective group is not a necessary structural feature for successful [3 + 2] 





were equally effective substrates (entries 1 and 2). Moreover, cyclopropane 2.9, prepared 
from readily available γ-hydroxy dihydropyran also participates in the cycloaddition 
reaction (entries 3 and 4). This and related processes offer a new approach to the 
functionalization and utilization of the growing number of enantiomerically pure 
dihyropyrans available from hetero-Diels-Alder cycloadditions.61  
 



































































a CH2Cl2 solvent; b MeCN solvent;  





As illustrated on Table 4.2, the internal lactone linkage appears to have been an 
important advance necessary for accessing the 3,4-dihydro-2H-pyrrole cycloaddition 
products. Attempted [3 + 2] cycloaddition reactions between nitriles and various 
cyclopropane substrates (Table 4.6) prepared through intermolecular processes gave 
multiple products. The 1H NMR spectra of the crude reaction mixtures suggested imine 
formation, but decomposition occurred before purification was possible. Cyclopropanated 
furanose substrate 4.45120 in entry 5 however offered the imine addition product 4.46 in 
43% yield, but it has been the best results from intermolecular variants.  
 
4.3 A NEW POWERFUL PYRROLE SYNTHETIC METHODOLOGY  
Pyrroles are important heterocycles that occur in porphyrins,121 pigments,122 and 
natural alkaloids.123 They have found wide applications in materials science124 and are 
common components in molecular recognition and self-assembly ensembles.125 There are 
dozens of reported pyrrole syntheses, some of the most reliable of which date from the 
19th century, such as the Hantzsch126 and Paal-Knorr127 procedures. These classic 
condensation reactions between activated methylenes and amino ketones can be limited 
by their efficiency, functional group compatibility, regiospecificity, or the variety of 
substituents that can be introduced around the pyrrole. More recent pyrrole syntheses 
typically showcase special methodology or excel at accessing one substitution motif, but 
an universal strategy for efficiently preparing all combinations of substituted pyrroles 
from easily handled materials is lacking.  
The novelty and the synthetic potential of nitrile-DA cyclopropane cycloaddition 
prompted further study of the generality of this class of reactions. However, when 





reaction did not stop at the stage of the corresponding aminal cycloadduct 4.48 (Scheme 
4.18). Instead, the intermediate N,O-acetals were further driven to the aromatic pyrrole 
products 4.49 after an alcohol elimination and tautomerization. Based on this discovery, a 






















Scheme 4.18: Pyrrole formation through nitrile cycloaddition 
Initial studies of nitrile cyclizations with general DA cyclopropanes 4.47 in 
nonpoloar solvent as benzene, toluene or CH2Cl2 (Table 4.3) failed to incorporate the 
nitrile components. Instead, the intermediate 1,3-dipoles display reduced affinity toward 
the nitrile components and readily rearrange into enol ether 4.51 upon TMSOTf treatment 
(Scheme 4.19). While TMSOTf emerged as ideal Lewis acid for the cyclopropane 
activation, attempts with other Lewis acids have not met success. For further studies on 
the pyrrole synthesis the unsubstituted DA cyclopropane 4.52a (Table 4.4) was chosen as 
a model substrate. Reaction at room temperature with acetonitrile as solvent led to 
detectable cyclization, but enol ether formation kept plaguing the reaction and the target 
pyrrole was obtained in less than 9% isolated yield (entry 1). Employing reactant 





entry 2). Inclusion of other polar external solvents generally gave lower yields, but 
practical considerations required the use of solvent when most other nitriles were 
employed. In this regard, polar solvents such as nitromethane and nitroethane 
(CH3NO2/C2H5NO2, Table 4.3) that are capable of stabilizing the intermediate 
oxocarbenium ion tunneled the reaction back in to the cycloaddition manifold. After 
these condition modifications, the reaction was effectively directed into pyrrole products 
in good to excellent isolation yields (entry 3-8). In some difficult examples, reactions 
were conducted at a lower temperature of −50 °C. The standard conditions were to add 1 
to 1.5 equivalents of TMSOTf to a cold (−50 to −25 °C) solution of cyclopropane and 5 
to 10 equivalents of nitrile in either nitromethane or nitroethane solvent. 
 
Entry Solvent Dielectric Constant (25 °C) 
1 Benzene 2.28 
2 Toluene 2.36  
3 CH2Cl2 9.08 
4 CH3NO2 28.06  
5 C2H5NO2 35.87  
6 CH3CN 36.6 












 toluene or CH2Cl2
 
















Entry Nitrile Solvent Temperature Product Yield 






4.53a  <9% 















































a Ar = p-MeOC6H4-; b Ar’ = m,p-(MeO)2C6H3-. 





As clearly illustrated on Table 4.4, the nitrile components efficient for this 
pyrrole technology are consistent with those previously discovered in the formal [3+2] 
cyclization reaction on carbohydrate-derived DA cyclopropanes (Section 4.2.3). By using 
the right nitrile substitution, this synthetic approach allows for introduction of diverse 
C(2) pyrrole substituents (Table 4.4). Butyronitrile gives a yield similar to that obtained 
with acetonitrile (entry 4), and the aromatic nitriles provides reasonable reaction yields 
(entries 5, 6). When pressed with α,β-unsaturated nitriles, no product from reaction 
across the double bond of conjugated nitrile was detected (entry 7, 8).  
Because of the regiospecific nature of the cycloaddition reaction, product 
isolation for this preparative method has been very convenient, simply requiring a quick 
short column flash chromatography, as compared to the tedious separation processes 
typically involved in literature condensation methods.  
In addition to improved reaction efficiencies and simplified isolation, the 
regiospecificity of the pyrrole synthesis methodology permits an assortment of 
substitution patterns as summarized in Table 4.5. Synthesis of the required DA 
cyclopropanes by the established methods allows installation of alkyl groups selectively 
around the pyrrole product at either, both or neither the C(4) and C(5) positions without 
formation of constitutional diastereomers. Various nitriles are shown to react with pyran 
and furan derived cyclopropanes (entries 1−9), affording pyrroles with a hydroxy 
terminated C(4) side chain. Introduction of an alkyl group at C(5) resulted in lower yields 
for entries 8 and 9, but fortunately reaction efficiency was restored when unnecessary 
ring strain in the starting materials was avoided (entries 10-14). In entries 15 and 16, 
mono C(5) methyl pyrroles were obtained in 55-62% isolated yield. Placing the alkoxy 





4,5,6,7-tetrahydroindoles (entries 17 and 18), which are useful synthetic intermediates in 
natural product and pharmaceutical chemistry and can be readily oxidized to the 
indoles.129, 130  
 
Entry Substrate Nitrile Product Yield 
1 MeCN 4.54a 72% 
2 PrCN 4.54b 78% 













5 MeCN 4.54e 52% 





























10 MeCN 4.54j 93% 
































































The effectiveness of this methodology appeared unaffected by the  
stereochemistry of the starting cyclopropanes. As for all the examples examined in Table 
4.5, consistent yields were obtained from cyclopropane substrates with different 
diastereomeric ratios. Based on the above inherent merits, this methodology is of high 
potential as a new synthetic approach, especially to prepare pyrroles with substitution 
patterns less accessible by condensation methods. 
The nitrile cyclization attempted with more densely functionalized substrates 
prepared through intermolecular carbohydrate cyclopropanation provided multiple 
dihydropyrrole products. Subsequent aqueous acid treatment (e.g., 5% HCl) led to 
complete conversion to the pyrroles (Table 4.6). The substrate and functional group 
compatibility will be an important asset for preparing pyrroles of increased complexity. 
In this regard, the examples illustrated in Table 4.6 testify to the compatibility of the 
reaction with various functionalities including di-tert-butylsilylenes (entry 1, 4-6), benzyl 
ethers (entry 2) and acetates (entry 3). This reaction is also applicable to non-




















































4a tBuCN 4.55d 87% 






























a Acidic workup (1 M HCl); b ArCN = p-MeOC6H4CN. 
Table 4.6: Pyrrole from lactonized cyclopropanes 
In summary, the domino DA cyclopropane nitrile [3+2] cycloaddition, 
elimination, and tautomerization strategy is a powerful and efficient new method for 
pyrrole synthesis that allows precise control over the installation of substituents at three 





substrate generality, and mild reaction conditions. The material costs associated with this 
procedure are generally less than other modern strategies, and the ease of product 
purification simplifies large-scale reactions. Given the compatibility of this method with 
various nitrile classes and the great number of nitriles that are commercially available, it 
is likely that this work will find useful application in diversity-oriented synthesis. 
4.4 BIPYRROLE AND THIENYLPYRROLE SYNTHESIS 
Bipyrroles and thienylpyrrole have been synthetic building blocks for preparing 
medicinally interesting compounds including anti-tumor agents (e.g., prodigiosins,131 
sapphyrins132) and radiation sensitizers for photodynamic therapy.132 They have also 
found wide application in preparation of dyes133 and semi-conducting polymers.134 
Additionally, compounds prepared from bipyrroles have been used as anion binding 
agents as well as nuclear waste removal agents. 135,136  
Classic bipyrrole syntheses mostly employ oxidative,137 Ullman-type 
homocouplings138 or couplings of pyrrolinones with pyrroles.139 While these methods are 
widely employed, they are generally limited to symmetric bipyrrole product preparation. 
When pressed to create asymmetric products, the pyrrolinone pathway139 seems to be the 
favorable option, but still remains limited in substituent diversity. Recent years also 
brought new advances in Suzuki140 and Stille141 couplings, primarily focused on 
prodigiosin synthesis, for preparing asymmetric bipyrroles; however, a more practical 
and reliable synthetic method still remains desirable. 
The high efficiency of the pyrrole synthesis (Section 4.3) has inspired further 
extension of this technique to the synthesis of asymmetric bipyrroles and 
thienylpyrroles.116 During the course of these efforts, an efficient synthetic approach has 





a cyano group extending from a preexisting heterocycle.142 The required nitriles, 2-
cyanopyrroles 4.56a,b and 2-cyanothiophene 4.59, each possesses an electron rich 
aromatic ring and thus are very reactive substrates for the dipolar cyclization with DA 
cyclopropanes.  
The initial study was directed toward the synthesis of α,α'-bipyrroles from 2-
cyanopyrroles that are commercially available (4.56a, 1H-pyrrole-2-carbonitrile, Scheme 
4.20) or accessible through a literature procedure (3,4-diethyl-1H-pyrrole-2-carbonitrile, 
4.56b).143 When a cold (−25 to 0 °C) CH3NO2 or C2H5NO2 solution of DA cyclopropane 
4.52g and pyrrole-2-carbonitrile 4.56a was treated with a stoichiometric amount of 
TMSOTf, a cascade cycloaddition, elimination, and tautomerization reaction ensued and 
provided the targeted bipyrrole product 4.57a in isolated yield of 78%. The 2-carbonitrile 
with preexisting electron donating alkyl group (4.56b) led to slightly improved reaction 












4.57a, R = H (78%)
4.58a, R = Et (82%)
Me3SiOTf
CH3NO2 or C2H5NO2 
(–25 to 0°C)
4.56a, R = H





Scheme 4.20: Model reaction for bipyrrole synthesis  
Inspired by these results, the generality of the bipyrrole synthesis was further 





substitution patterns on the starting DA cyclopropanes, this methodology demonstrated 
complete regiochemical control. The first examples studied gave bipyrroles in excellent 
yield (78% and 82%) with an alkyl group at the alpha position (entries 1 and 2). The 
reactions in entries 3 and 4 show that the alpha substitution is unnecessary, but the 
reaction yields were considerably diminished (41% and 45% respectively). Entries 5 and 
6 provided bipyrroles with alkyl substitution at both the alpha and beta positions (82% 
and 85% respectively), and entry 7 completes the series by a bipyrrole with only beta 
substitution. The remaining entries explore reactivity with [4.1.0] and [3.1.0] cyclic DA 
cyclopropanes, including pyran and furan derivatives. These substrates afforded 
bipyrroles with different substitution patterns, and in entries 10−13, a hydroxy group 



















4.57a-f, R = H
4.58a-g, R = Et
4.56a, R = H
4.56b, R = Et  






Entry Substrate       Product Yield 






















































































HO (  )2 4.58g 42% 
 a R = H; b R = Et.  





Higher yields were generally obtained from reactions with DA cyclopropanes 
with alkoxy group attachment to a quaternary carbon (e.g., entries 1, 2, 5, 6, 8, 9 and 12). 
The gradual reactivity parallels the stability of the intermediate oxocarbenium ion 
generated from Lewis acid mediated cyclopropane ring opening, as observed in the 
previously discussed pyrrole synthesis (Section 4.4). A cursory inspection of the results 
summarized in Table 4.7 reveals that the yields for formation of bipyrroles starting from 
3,4-diethyl-1H-pyrrole-2-carbonitrile 4.56b were consistently higher than those obtained 
from the unsubstituted pyrrole 4.56a. This observation is consistent with the greater 
nucleophilicity expected to be endowed to the nitrile by the electron-donating ethyl 
groups at the pyrrole β-positions. 
Remarkably, the current bipyrrole preparation does not require prior protection of 
the starting pyrroles. The compatibility observed on the starting pyrrole under the strong 
Lewis acid conditions are likely attributed to the α-cyano group that significantly 
withdraws electron density from the pyrrole.  
With a bipyrrole synthesis established, identical reaction conditions were applied 
to the synthesis of thienylpyrroles by the combination of thiophene-2-carbonitrile 4.59 
and various DA cyclopropanes (Table 4.8). While the thienylpyrrole products are 
generally obtained in reduced yields, this method still remains attractive for its brevity in 


















4.59 4.60a-f  





















































HO (  )3
 
4.60f 73% 





For some prospective applications, electron rich variant of these bipyrroles and 
thienylpyrroles will be required. In this regard, the β-ethyl carboxylate can be removed 
by a convenient decarboxylation in hot alkaline ethylene glycol solution (Scheme 4.22). 
High reaction temperatures and short reaction times (e.g., 160 °C, 2 to 5 minutes) 










5 min; 160 °C
(92%)
NH S
as above NH S
HO (  )n
CO2Et
NH S





4.60e                                                       4.63, n = 2 (81%)
4.60f                                                        4.64, n = 3 (87%)  
Scheme 4.22: Decarboxylation  
Extension of the pyrrole construction method to electron deficient heterocyclic 
nitriles other than 4.56a,b and 4.59 did not result in formation of the corresponding 
bicyclic products. For example, 2-cyanofuran completely decomposed upon treatment 





4.5 CYCLIZATIONS WITH  PYRIDINES AND QUINOLINES 
4.5.1 Introduction 
Due to the unique chemical behavior of lactonized DA cyclopropanes they are 
well suited for highly stereoselective [3+2] dipolar cycloaddition with nitriles (Section 
4.2.3, 4.3 and 4.4).114 Extension of this reaction to general DA cyclopropane substrates 
has led to a synthetic pyrrole methodology with complete regiochemical control of the 
products.115,116 The high efficiency observed on the DA cyclopropane-nitrile cyclizations 
stimulated further exploration of diverse functionalized dipolarophiles for practical 
synthetic applications. This section summarizes the recently discovered cyclization 
reactions on heterocyclic dipolarophiles including pyridines and quinolines. 
Pyridines and quinolines are ubiquitous in natural compounds. They are also 
extensively employed in organic reactions.  Pyridines have been one of the most widely 
used chemical reagents, as catalysts and organic bases as well as solvents in both 
laboratory research and industrial production. Natural and artificial products containing 
pyridine and quinoline motifs have found wide applications in medicinal chemistry and 
material science (e.g., dyes, semi-conducting polymers). 
The effectiveness of formal [3+2] cycloadditions of DA cyclopropane proved 
highly dependent on the dipolarophile nucleophilicity. Among the nitrile dipolarophiles 
screened, the electron rich compounds provided higher affinity toward the 1,3-
zwitterionic intermediate (Table 4.4, entries 5 vs. 6 and entries 7 vs. 8). However, in the 
interest of investigating the scope of DA cyclopropane cyclizations, electron poor nitrile 
4.65 was also tested. Using conditions similar to the pyrrole methodology, nitrile 4.65 did 





observed occurring at N(1)=C(2) of the pyridine ring (Scheme 4.23). The cycloaddition 
was also followed subsequently with a elimination and tautomerization to provide 






















Scheme 4.23: Cycloaddition with 4-cyano pyridine 4.65 
Artificial and naturally occurring heterocycles indolizines 4.68, benzoindolizines 
4.69 (Figure 4.3), and derivatives are some of the most intriguing pyrrole derivatives that 
demonstrate high pharmacological properties in treating  inflammation,144 cardiovascular 
disease,145 as well as the physical problems associated with amplified Ca2+ channel.146 
Moreover, due to the high degree of conjugation throughout the systems, these 
compounds possess unique optical properties that can be translated into ideal materials 






4.68 4.69  





A wide variety of synthetic methods have been reported for the synthesis of 
indolizine and benzoindolizine products.149 Among these methods the 1,3-dipolar 
cycloaddition of pyridinium N-methylidine with π-electron systems such as 
acetylenedicarboxylate under hydrogenation conditions, or oxidative cyclization with 
ethylenes, have been well known.149,150 But, the requirement for prior formation of the 
pyridinium salt limits this method to electron rich pyridines. Further, due to poor 
regioselectivity, the reaction is typically applicable only when  R1 and R2 are equivalent.  
Cyclization employing pyridines as dipolarophile components has also been an efficient 
approach,151 and formal [3+2] dipolar cycloaddition of pyridines and quinolines have 
been recently reported on certain 1,3-dipoles such as nitrile ylides and nitrile imines.152,153  
But the poor regio-differentiation regarding R1 and R2 placement has also prevented these 
methods from accessing diverse substitution for the products.  
4.5.2 Cyclization with pyridines and quinolines 
In principle, one of the strengths of the subject DA cyclopropane-pyridine 
cyclization approach was its complete regiochemical control, which allowed for a wide 
variety of substituent patterns around the resultant indolizine derivatives. Having the first 
successful example in hand, attention was turned to the generality of this preparative 
method. For this, 4-cyano-pyridine 4.65 was screened as a model dipolarophile against a 
wide variety of DA cyclopropane substrates (Table 4.9), but the reaction yields remained 
poor to moderate even on highly reactive substrates with alkoxyl attachment to a 
quaternary carbon (entry 1-3). When applied to cyclopropanes without an R1 substituent 
(entry 4, 5), the reactions were unsuccessful, and only trace amounts of the desired 
products were obtained (<1%). Having explored scope in the context of the cyclopropane, 





several substituted pyridines were tested, showing that reaction efficiency is inversely 
related to the electron donating ability of the C(4) substituent. In entry 6, the unactivated 
pyridine provided product 4.67f in less than 3% isolated yield. When pressed with an 











Entry R1 R2 R3 R Product Yield 
1 Et Me Me CN 4.67a 52% 
2 -(CH2)4- Me CN 4.67b 41% 
3 Pr Et Me CN 4.67c 54% 
4 H Me Me CN 4.67d < 1% 
5 H H nBu CN 4.67e < 1% 
6 Et Me Me H 4.67f < 3% 
7 -(CH2)4- Me OMe - - 
Table 4.9: DA cyclopropane-pyridine cycloaddition 
The observed electronic effect of the current pyridine cycloaddition is opposite to 
those observed in nitrile cyclizations.114,115,116  A mechanistic hypothesis that accounts for 
this inverse relationship is depicted as in Scheme 4.24. Upon Lewis acid activation, DA 
cyclopropanes 4.47 undergo retro-aldol rearrangement forming the corresponding formal 
1,3-dipole intermediate 4.71. The subsequent nucleophilic addition from pyridine 





conjugated with C(4) substituent. When a C(4) EWG (e.g., X = CN) is present, it 
























































Scheme 4.24: Mechanistic hypothesis for pyridine cycloaddition 
intramolecular nucleophilic attack by the TMS enolate. This neutralization tendency 
remarkably overrides the price of aromaticity and leads to the formation of dihydro-
indolizine product 4.70 after R3OH elimination and tautomerization. Conversely, the 
electron donating C(4) substituent can sufficiently stabilize the pyridinium ion of 





closure step. In this case, the resulting formal 1,3-dipole 4.71 will be restricted in the 
equilibrium circle (4.71 ↔ 4.72 ↔ 4.75  ↔ 4.74 ↔ 4.71) before transforming into enol 
ether by product 4.76.154 This mechanistic hypothesis suggests that the RDS is the 
intramolecular ring closure. 
A similar electronic effect was observed on quinoline cyclizations. While 
unsubstituted quinoline refused to incorporate with LA activated DA cyclopropanes, 
electron deficient substrates such as 5-nitro quinoline 4.77 readily cyclize with various 






















4.78a-d 4.79a-d  
Scheme 4.25: Cycloaddition of DA cyclopropane and 5-nitroquinoline 4.77 
Compared with 4-cyano-pyridine 4.65, the reactions with 4.77 seemed to be quite 
effective even on less reactive cyclopropanes (Table 4.10, entry 1-3). But unlike in the 
pyridine cyclization, the aminal cyclization products 4.78a,b from this reaction have a 
reasonable lifetime and partially survived isolation (entry 1 and 2). Subsequent treatment 
of the crude mixture with aqueous acid (5% aqueous HCl) facilitated complete 
conversion into dihydro-benzoindolizine 4.79, which displayed high inclination for auto 





















































































Scheme 4.26: Oxidative aromatization of 4.79d 
As illustrated in Figure 4.4, the X-ray crystallographic analysis of 4.80 strongly 
suggests new double bond formation (C(1)−C(2) = 1.374 Å). The ease with which the 
cycloadducts undergo aromatization upon exposure to air made this reaction an attractive 
approach toward indolizine and benzoindolizine products with absolute regioselectivity. 
 
Figure 4.4: X-ray structure of 4.80 
In summary, the first formal [3+2] cycloaddition of DA cyclopropane with 
pyridines and quinolines was recently discovered. Electron poor dipolarophiles display 
enhanced efficiency for this reaction, and this methodology provided convenient access 





4.6 FORMAL [3+2] CYCLOADDITION WITH INDOLES  
As one of the classic heterocycles, indoles have played a large role in the history 
of organic chemistry. It is not only because of the frequent presence of this constructional 
motif in medicinally important and bioactive alkaloids, but also its unique and predictable 
reactivity. Indole-based synthetic methodologies have been well documented, among 
them transformations with indole as dienophiles for [4+2] cyclization155 is well 
established approaches toward complicated cyclic structures with high atom economy 
and diastereoselectivity. Recently Kerr and coworkers discovered a [3+2] cycloaddition 
of unprotected indole 4.81 with doubly activated acceptor cyclopropane 4.82 as a side 
reaction in C(3) indole alkylation studies (Scheme 4.27),156 and this transformation has 
been later developed as a general reaction of on different acceptor cyclopropanes.157  The 
reaction was believed to proceed through a tandem attack of the putative manolic enolate 



















Scheme 4.27: [3+2] cycloaddition of indole and acceptor cyclopropane  
Encouraged by the results from cycloadditions of DA cyclopropanes with 
pyridines and quinolines as described in previous sections, we sought to further extend 
the strategy to other useful heterocyclic dipolarophiles. During this course a general DA 





Our study began with a tentative cyclization between a reactive DA cyclopropane 
4.52h. Treating a CH3NO2 solution of 4.52h and indole 4.81 with stoichiometric amounts 
of TMSOTf (1.3 eq) led to rapid formation of cycloadduct 4.85a in 78% isolated yield 
(Scheme 4.28). Curiously, 1H NMR studies revealed a significant upfield shift of the 
auxiliary methoxy group (σ 2.75 ppm). This was good indication of  a shielding effect 
from the benzene ring. Finally single crystal X-ray structure analysis provided 
unambiguous determination of the stereochemistry of 4.85a, as well as a solid state 
explanation for this chemical shift. Figure 4.5 shows that the tetracyclic product 4.85a 
adapts trans conjunction between CD rings but a cis B-C ring relationship. This structural 
conformation helps force the methoxy group near to the π system of the benzene ring, 





























Figure 4.5: X-ray structure of 4.85a 
In addition to the high reaction yield, this single step cyclization is also featured 
with very high stereochemical control, with five relative stereocenters established around 
the middle C ring. After repeated attempts, the reaction provided 4.85a as the only 
isolatable diastereomeric product regardless of stereochemistry on starting cyclopropane 
4.52h. A tentative mechanistic hypothesis for this highly stereoselectivite process is 
illustrated in Scheme 4.29. After TMSOTf activation of the DA, the  nucleophilic indole 
approaches the formal 1,3-zwitterionic intermediate from the more sterically accessible 
face. This trans addition not only leads to the relative stereochemistry between the 1,2 
positions, but also places the resulting iminium ion below the enolate, allowing the latter 
to approach only from the top face leading to the relative configuration at positions 3, 4 
















































Scheme 4.29: Mechanistic hypothesis for indole cycloaddition 
With the model reaction established, efforts were focused on examining the 
generality of the reaction on DA cyclopropane components. For this purpose, indole 4.81 
was chosen as the model dipolarophile for screening on different DA cyclopropanes. As 
summarized in Table 4.11, this cyclization was highly effective with a variety of 
cyclopropanes, including those difficult for pyridines reactions (entry 3-5). A quick 
inspection of Table 4.11 reveals that that the preliminary D ring in the starting 
cyclopropanes is essential in achieving the relative stereochemistry (entries 1, 4, and 5). 
In entries 2 and 3, the conformationally flexibile substrates without D rings resulted in no 
strong facial selectivity during the indole nucleophilic addition, which makes possible 
formation of all the diastereomers. This observation is consistent with the mechanistic 




































































Table 4.11: Formal indole-DA cyclopropane [3+2] cycloaddition 
One of the key parameters examined for the subject reaction was substituent 
electronic effects on the indole dipolarophiles. In stark contrast to prior observations on 
pyridine cyclizations, introduction of strong EWG groups onto the indole significantly 
limited reactivity. As a comparison, the results from commercially available 5-iodo and 
5-methoxy indoles are summarized on Table 4.12. While the electron rich 5-methoxy 
















4.89a-d, R = OMe






4.87, R = OMe
4.88, R = I
 
Entry Cyclopropane R Product Yield 



















































Table 4.12: Substituent electronic effects  
The stereochemistry of cycloadduct 4.89b was determined by single crystal X-ray 
analysis as shown in Figure 4.6. Given the well-documented literature examples of 
transition metal catalyzed iodoarene transformations, the iodo-substituted products 4.90a-






Figure 4.6: X-ray structure of 4.89b 
The remainder of the study was centered on determining the scope of the reaction 
with respect to indole substitution pattern. In this regard, a matrix of reactions between 
DA cyclopropanes and commercially available methyl indoles was completed as shown 
in Table 4.13. From this table it is clear that the subject cyclization is relatively 










































































5 1-Me 4.91e 88%
6 2-Me 4.91f 89%















9 2-Me 4.91i 81%
10 5-Me 4.91j 81%

















While most of the mono-methyl substituted indoles successfully participated in 
the cycloaddition, it was interesting that 3-methyl indole 4.92 varied from the normal 
reaction pathway. Employing similar conditions on a mixture of 4.53b and 4.92 provided 
a clean mixture of two major products, which were later characterized to be 4.93a (76%) 
and 4.93b (8%) (Scheme 4.30). For the purpose of structure determination, the major 
product 4.93a was, after DIBAL-H reduction, converted into aminal 4.94, the structure 



























Scheme 4.30: Vinyl migration of 3-methyl indole 
 





It is noteworthy that this rearrangement was not observed on more sterically 
challenging indoles, specifically 2,3-dimethylindole (Table 4.13, entry 12), which 
provided cyclization product 4.91l in moderate yield (52%). A possible mechanistic 
rationale for this reactivity difference is provided in Scheme 4.31. It is very likely that 
increased steric interactions within the first addition intermediate A stimulates a prompt 
MeOH elimination. Therefore the resulting iminium ion B is aligned for a subsequent 
1,2-sigma shift (preferentially for a vinyl migration) and aromatization. While the 
bulkiness from 2,3-dimethylindole may encourage a stronger tendency for MeOH 
elimination, the preexisting 2-methyl makes subsequent aromatization impossible, thus 



























































Chapter 5: Mono-deprotection of Di-tert-butyl Silylene Ether 
5.1 INTRODUCTION 
 A frequently encountered challenge in organic synthesis is selective protection 
and deprotection of alcohols. The regioselectivity of 1,3-diol hydroxy protection is often 
governed by sterics, and the reactions normally favor the less hindered positions (Scheme 
5.1, pathway A). When protection of the more hindered hydroxy group is required, it is 
generally accomplished through multi-step transformations that involve temporary 
masking of the active hydroxy through labile protecting groups (P1). For example, the 
product 5.5 with secondary protection can be prepared from 1,3-diol 5.1 through 
transitory masking of the primary hydroxy group, protection of secondary hydroxy of the 


























5.3 5.4 5.5  





Among the numerous methods that have been developed for selective hydroxy 
protection, silyl ethers emerged as, undoubtedly, the most widely used protocols for 
selective alcohol protection.158 Standard silylation conditions normally result in 
preferential protection of the less hindered hydroxy group, whereas protection at the more 
hindered site of 1,3-diol is typically accomplished through a stepwise process. Since the 
increased reactivity at the more accessible position normally allows selective 
deprotection at the less hindered site of a persilylated substrate,159 a roundabout approach 
toward the “unfavorable” silylation could also be achieved through uniform full 
protection followed by discriminating desilylation at the less hindered sites. For example, 
by using BCl3, Lin and co-workers160 selectively cleaved the primary 6-tert-
butyldimethylsilyl ether (TBDMS) of 5.6 in the presence of secondary hydroxy group 















5.6 5.7  
Scheme 5.2: BCl3 mediated selective deprotection of TBDMS ether  
This strategy has also been reported for partial deprotection of cyclic 3,5-tetra-




















5.8 5.9  
Scheme 5.3 Selective cleavage of tetra-isopropyldisiloxane 
Cyclic protection of primary and secondary hydroxys employing di-tert-butylsilyl 
reagent gives the silylene ethers as five or six-membered ring. Since five-membered 
cyclic silyl ethers easily undergo hydrolysis and do not survive isolation, a recent one-pot 
protocol was developed for the selective silylation of 1,2-diol 5.10 (Scheme 5.4).162 The 
selective formation of primary alcohol was attributed to preferential complexation of 
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Scheme 5.4: Di-tert-butylsilylene ether protection of 1,2-diol 
In contrast to 5.10, the silylene ethers in six-membered rings are typically very 
stable and therefore more convenient for synthetic applications.163,164 However no general 
route to selective mono cleavage of this group exists. Very recently, Hoberg applied this 





silylene ether 2.1a in the presence of 3-hydroxy group (Scheme 5.5), but his attempt on 













5.13 2.1a  
Scheme 5.5: Di-tert-butylsilylene ether protection of Glucal 
We recently adapted this protection protocol to the preparation of lactonized 
glucal-derived DA cyclopropane 2.5a (Chapter 2). The 4,6-di-tert-butyl silylene ether 
2.5a turned out to be robust toward several Lewis acidic conditions. While probing the 
chemical behavior of this cyclopropane, a BF3•OEt2 mediated regioselective mono-
deprotection of the di-tert-butylsilylene ether 2.5a was discovered. Treating a toluene 
solution of 2.5a with BF3•OEt2 at 85 °C for 45 minutes resulted in exclusive formation of 
di-tert-butylfluorosilyl ether 2.27 in 95% isolated yield. Further investigation illustrated 
that small amounts (0.5 eq) of allyl trimethylsilane additive was crucial in inhibiting full 
deprotection and maintaining primary regioselectivity. The function of 
allyltrimethylsilane has not been exhaustively investigated, but presumably it serves as a 
acid scavenger to trap HF. This selective desilylation is consistent with a steric control 
process starting with regioselective boron coordination to the more accessible primary 
(C6) position followed by an internal fluoride delivery process (Scheme 5.6). The 
excellent regioselectivity and reaction yield have stimulated further investigation of this 

























































2.27, 95% Not observed
F
 







5.2 REGIOSELECTIVE MONO-DEPROTECTION OF DI-TERT-BUTYL SILYLENE ETHER 
5.2.1 Reaction condition optimization 
To simulate the chemical condition of 2.5a, a model substrate di-tert-butylsilylene 
ether 5.15163 was prepared via the conversion of the simple  1,3-diol 5.14.165 
Unfortunately, subjecting the model substrate 5.15 to reaction conditions (room 
temperature) similar to those applied on 2.5a resulted in formation of the desired 
fluorosilane 5.16a (21%) in a disappointing mixture of the unwanted regio-diastereomer 
5.16b (2%), silanols 5.17a (9%), 5.17b (3%), diol 5.14 (8%) and starting material 5.15 
(36%) (Scheme 5.7). This reaction proved to be extremely water sensitive, which 
induced formation of silanols 5.17a and 5.17b, and also plagued the products 5.16 with 
poor regioselectivity. Substantial reduction of the formation of silanols 5.17a and 5.17b 













































Scheme 5.7: Tentative deprotection of model substrate 5.15 
The screening of other commercially available BF3-Lewis base complexes, 
including BF3•THF, BF3•tBuOMe, and BF3•MeOH, revealed that BF3•SMe2 improved 
both the conversion and selectivity of the reaction. However, the formation of 
considerable amounts of diol 5.14 continued to plague the process. The varying reactivity 
displayed by different BF3 sources clearly demonstrated the importance of Lewis bases in 
the reaction, and a survey of assorted additives including esters, ethers, amines, and salts 
showed that the addition of excess anhydrous potassium acetate (KOAc) to the reaction 
greatly minimized complete desilylation to diol 5.14. The role of the KOAc is still 





PhCO2K, Na2CO3, and K2CO3. The more soluble salts such as potassium stearate 
(CH3(CH2)16COO- K+) and sodium 2-ethylhexanoate performed similarly to KOAc.  
Unlike the original reaction conditions utilized for substrate 2.5a, using toluene or 
benzene as solvent for 5.15 resulted in poor selectivity and incomplete conversion. 
Replacing toluene with oxygen-containing solvents such as THF, diethyl ether, EtOAc or 
CH3CN provided very slow reaction.  Surveying multi solvent systems demonstrated that 
polar solvents such as chloroform, CH2Cl2 were superior for this process, especially in 
minimizing diol 5.14 formation. With these modifications, the regioselective deprotection 
of 5.15 with BF3•SMe2 consistently yielded the fluorosilanes 5.16a:5.16b in over 15:1 











BF3•SMe2 (7.5 eq) 





Scheme 5.8: Regioselective deprotection of model substrate 5.15 
5.2.2 Stability of the resultant fluorosilane 
While results from the model substrate 5.15 were encouraging, to make the 
transformation valuable the fluorosilane products must be sufficiently robust to serve as 
viable protecting groups in subsequent reactions. In this regard, the fluorosilane 2.27 
survived several synthetic steps and flash chromatography.49 Likewise, the fluorosilane 





(THF, saturated NaHCO3) (Scheme 5.9), but strong basic conditions resulted in closure 
to the silylene ether 5.15 (THF, 10% aqueous NaOH, 15 min, 96%).  
 
Stable to:
• THF / aqueous 10% HCl, 15 h
• THF / saturated NaHCO3, 15 h
•  Flash Chromatography














Scheme 5.9: Stability of fluorosilane 5.16a 
Several transformations at the primary alcohol of the fluorosilane 5.16a have 
demonstrated the stability of the (F)tBu2Si group, including Jones oxidation to 5.18,166 
PCC oxidation to 5.19, and Finkelstein transformation to 5.20 (Scheme 5.10). A cursory 
inspection of the 1H NMR and IR spectra of these products proved the primary 
regiochemistry of mono-deprotection product 5.16a. The silanol 5.17a was also 
reasonably stable, as demonstrated by its conversion to 5.20b in 81% yield. As for full 
deprotection, the di-tert-butylfluorosilane 5.16a can be easily cleaved to the diol 5.14 





5.18, X = F (72%) 5.19, X = F (82%) 5.20a, X = F (85%)

























Jones PCC TsCl, py; NaI HF•py
 
Scheme 5.10: Chemical compatibility of fluorosilane 5.16a 
5.2.3 Compatibility with diverse functionality 
With the integrity of the di-tert-butylfluorosilane ether amply demonstrated, 
substrate compatibility and availability of orthogonal protective moieties was briefly 
surveyed. The model substrates shown in Table 5.1 were used to explore the functional 
group orthogonality between di-tert-butylsilylene ether and several common protective 
groups. Acetate and benzoate esters 5.21a-d are highly compatible with the deprotection 
conditions (entries 1-4), and no diminishment of regioselectivity at the silylene ether was 
observed, as might have occurred if complicated by neighboring group participation of 
the ester functionality. An allyl group easily survived the Lewis acid conditions (entry 5), 
as did benzyl 5.21f (entry 6), but the reaction with the latter failed to go to completion. 
The methyl ether substituted substrate 5.21g was poor (entry 7). The bulky 





BF3•SMe2 as depicted in entry 8, whereas cleavage of the tert-butyl dimethylsilyl ether 
5.21i demarcates silicon reactivity (entry 9). The gradient reactivity between these silyl 

























Entry n R Product Yield 
1 1 CH3CO 5.22a 91% 
2 2 CH3CO 5.22b 87% 
3 1 PhCO 5.22c 90% 
4 2 PhCO 5.22d 82% 
5 2 Allyl 5.22e 78% 
6 2 PhCH2 5.21f, 5.22f 57%, 35% 
7 2 CH3 5.22g 43% 
8 2 iPr3Si 5.22h 78% 
9 2 (tBu)Me2Si 5.21i 97% 
Table 5.1: Functional group compatibility 
While selective cleavage of silyl ethers with BCl3 is known,160 it is interesting to 
note that selective mono-desilylation of the di-tert-butylsilylene ether occurred cleanly 
with BCl3 (Scheme 5.11). Treatment of 5.15 and 5.21h with BCl3 (heptane solution) 
resulted in immediate formation of clean intermediate which after aqueous NaHCO3 





chlorosilane had to be characterized as their acetates 5.26 and 5.27, as the reactive free 
alcohols reverted back to starting material (with up to 15% silanol formation) under 
acidic, basic or even neutral conditions including simply standing in CHCl3 or methanol. 
The instability displayed by the chlorosilane discouraged further investigation on this 
















5.15, R = Ph
5.21h, R = OTIPS
5.24, R = Ph
5.25, R = OTIPS
5.26, R = Ph (81%, 2 steps)




Scheme 5.11: Regioselective desilylation via BCl3 
As anticipated, the Lewis acidic nature of the reaction media precluded the use of 
substrates with Lewis acid sensitive functionality. For example, at its current stage of 
development, silylene ethers prepared from tertiary or benzylic alcohols (Figure 5. 1) 






















5.2.4 Differentiation between secondary positions 
To ascertain whether deprotection could succeed selectively when challenged 
with substrates presenting less steric differentiation, silylene ethers derived from internal 
secondary 1,3-diol were examined (Table 5.2). In entries 1 and 2 methyl and tert-butyl 
groups are compared. In both cases, the Si-O cleavage occurred preferentially at the more 
accessible position, affording exclusively one diastereomeric fluorosilane products 5.32 
and 5.34. The syn diastereomer 5.33 required nearly three times as long (2.5 h) for 
complete consumption of starting material than did the anti diastereomer 5.31, and a third 
of the starting material was fully desilylated. Stopping the reaction in entry 2 prematurely 
before significant amounts of diol formation increased the yield to 79%, based on 
recovered starting material. Analogous results occurred with the anti and syn substrates 
shown in entries 3 and 4. Again, reaction with the syn diastereomer 5.37 gave nearly 30% 
of unwanted diol when allowed to proceed to complete consumption of the starting 
material. These experiments revealed that stereochemistry greatly influenced the 














KOAc, 3 Å MS
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4 5.37 5.38a         (6:1)        5.38b 43% 
Table 5.2: Selectivity between secondary positions 
In summary, parameters influencing the regioselective mono-desilylation of di-
tert-butylsilylene ethers using BF3•SMe2 have been elucidated. The reaction can be 
efficient, highly selective and provide access to 1,3-diols silylated at the sterically more 









The first intramolecular glycal cyclopropanation has been developed. The 
potential utility of this methodology has been demonstrated in the quasi formal synthesis 
of bislactone natural product xylobovide and derivatives. The unique chemical behavior 
of the resultant lactonized DA cyclopropane 2.5a under different Lewis acid promoters 
has led to the discovery of a wide variety of new reactions including regioselective 
deprotection of di-tert-butyl silylene ethers (BF3•OEt2), anhydro-sugar formation 
(TMSOTf), and stereoselective allylation and glycosidation (TiCl4). Under Lewis acid 
promotion, DA cyclopropane 2.5a also participated in formal [3+2] cycloadditions with 
various dipolarophiles including silyl enol enols, imines, aldehydes, nitriles, pyridines, 
quinolines and indoles. Extension of the nitrile cyclization reaction to general non-
carbohydrate-derived DA cyclopropanes has led to the discovery of a novel synthetic 





Chapter 6: Experimental Procedures 
General Procedures.  
All reactions were run under an atmosphere of argon unless otherwise indicated. 
Reaction vessels were oven or flame-dried and allowed to cool in a dry box or desiccator 
prior to use.  Solvents and reagents were purified by standard methods.168 Toluene, 
benzene, CHCl3, CH2Cl2, CH3NO2, C2H5NO2, CH3CN, THF, Et2O and pyridine were 
purified by distillation from CaH2 under an Ar atmosphere right before use. Powdered 
KOAc was flame dried as a melt under vacuum (0.1 mm Hg). Thin-layer chromatography 
(TLC) was performed on EM 250 Kieselgel 60 F254 silica gel plates. The plates were 
visualized by staining with I2 on silica, CAM,169 ninhydrin, or potassium permanganate. 
Column chromatography was performed with silica gel 60 according to the method of 
Still.170 
The 1H, 13C, 31F NMR data was obtained on a General Electric QE-300 
spectrometer, a Varian Unity Plus 300 or 400 spectrometer, or a Varian INOVA 500 
spectrometer.  For 1H NMR, chemical shifts are reported in parts per million (ppm) 
downfield from tetramethylsilane and are, in all cases, referenced to the residual proton 
resonance peaks: δ 7.24 for CHCl3, δ 7.15 for benzene-d6, δ 2.49 (hept) for DMSO-d6, 
and 2.09 (pent) for acetone-d6.   The 13C NMR chemical shifts were reported in ppm 
relative to the center peak of the multiplet for deuterated solvents: δ 77.0 (t) for CHCl3, 
39.5 (pent) for DMSO-d6, 29.8 (hept) for acetone-d6, and 28.0 (t) for benzene-d6. 13C and 
19F NMR spectra were routinely run with broadband 1H decoupling. Chemical shifts for 
19F NMR are reported in ppm downfield from CFCl3 as external standard.  Coupling 





NEXUS 470 FT-IR spectrometer as thin films on sodium bromide plates and are recorded 












naphthalen-8-yl ester (2.3a). To a solution of glycal 2.1a (288 mg, 1.0 mmol)54 and 
glyoxylic acid chloride p-toluenesulfonylhydrazone 2.2 (340 mg, 1.3 mmol)53 in CH2Cl2 
(8 mL) and DMF (2 mL) cooled to 0 °C was added N,N-dimethylaniline (294 µL, 2.9 
mmol) in one portion. The resulting solution was stirred 5 min and treated with Et3N (750 
µL, 5.4 mmol). The reaction mixture was stirred for an additional 10 min and H2O (30 
mL) and CH2Cl2 (10 mL) was added.  The organic layer was separated and washed with 
H2O (3 × 10 mL), saturated Na2CO3 solution (10 mL), and dried (Na2SO4). After 
filtration through a pad of celite, the solvent was removed under reduced pressure. 
Purification of the residue by flash chromatography on silica gel with 10:1 hexanes-
EtOAc for elution gave the title compound as a light yellow syrup (325 mg, 92%): Rf 
0.54 (15% EtOAc/hexanes); IR (thin film) ν 3150, 2105, 1692, 1643 cm-1; 1H NMR (300 
MHz, CHCl3): δ 6.27 (dd, J = 6.1, 1.2 Hz, 1H), 5.41 (dt, J = 6.1, 1.9 Hz, 1H), 4.76 (s, 
1H), 4.68 (dd, J = 6.1, 1.8 Hz, 1H), 4.15-4.00 (m, 2H), 3.93-3.78 (m, 2H), 1.01 (s, 9H), 
0.97 (s, 9H); 13C NMR (75 MHz, CHCl3): δ 166.8, 145.3, 101.0, 74.0, 73.2, 73.1, 66.1, 













Diazo-acetic acid 2,2-dimethyl-4,4a,8,8a-tetrahydro-pyrano[3,2-d]dioxin-8-yl ester 
(2.3b). The title compound was prepared from 2.1b (102 mg, 0.54 mmol)55 according to 
the general procedure described above for the preparation of 2.3a. Purification by flash 
chromatography on silica gel with 10:1 hexanes-EtOAc for elution gave the title 
compound as a colorless syrup (122 mg, 88%): Rf 0.45 (25% EtOAc/hexanes); IR (thin 
film) ν 3106, 2112, 1689, 1623 cm-1; 1H NMR (300 MHz, CHCl3): δ 6.32 (dd, J = 6.1, 
1.5 Hz, 1H), 5.41 (dd, J = 6.1, 1.8 Hz, 1 H), 4.79 (s, 1 H), 4.74 (dd, J = 6.0, 1.8 Hz, 1H), 
4.01-3.90 (m, 2H), 3.86-3.77 (m, 2H), 1.49 (s, 3H), 1.40 (s, 3H); 13C NMR (75 MHz, 
CHCl3): δ 166.6, 145.7, 101.2, 100.1, 70.2, 70.1, 70.0, 61.8, 46.6, 29.1, 19.2; HRMS: m/z 








2H-pyran-4-yl ester (2.3c). The title compound was prepared from 2.1c56 (110 mg, 0.31 
mmol) according to the general procedure described above for the preparation of 2.3a. 
Purification by flash chromatography on silica gel with 15:1 hexanes-EtOAc for elution 





= 1 : 5); IR (thin film) ν 3111, 2109, 1693, 1650 cm-1; 1H NMR (300 MHz, CHCl3): δ 
7.34-7.25 (m, 5H), 6.40 (dd, J = 6.1, 1.4 Hz, 1 H), 5.51-5.47 (m, 1 H), 4.74 (dd, J = 6.1, 
3.0 Hz, 1H), 4.69 (s, 2H), 4.67 (s, 1H), 3.95-3.81 (m, 4H), 0.89 (s, 9H), 0.06 (s, 6H); 13C 
NMR (75 MHz, CHCl3): δ 166.3, 145.9, 138.1, 128.4, 127.9, 127.7, 98.8, 78.1, 73.6, 
73.0, 71.0, 61.3, 46.3, 25.9, 18.3, -5.2, -5.4; HRMS: m/z calcd for C21H31N2O5Si (M+1+): 










one (2.5a). To a refluxing solution of Cu(TBS)2 complex 2.459 (7.5 mg, 5 mol %)  in 60 
mL of toluene was added 2.3a (1.20 g, 3.38 mmol) in 20 mL of toluene over a period of 
12 h via syringe pump. After the addition was complete, the reaction mixture was heated 
at reflux for additional 2 h, allowed to cool to rt, and the solvent was removed under 
reduced pressure. Purification of the residue by flash chromatography on silica gel with 
5:1 hexane-EtOAc to 100% EtOAc for gradient elution gave a pale yellow solid (1.01 g, 
92%): Recrystallization from EtOAc/hexane afforded the title compound as a colorless 
needles (81%): mp (ethyl acetate-hexanes) 199.5-201.0 °C; Rf 0.52 (33% 
EtOAc/hexanes); IR (KBr pellet) ν 3035, 1790, 1466 cm-1; 1H NMR (300 MHz, CHCl3): 
δ 4.91 (app d, J = 6.1 Hz, 1H), 4.34-4.29 (m, 2H), 3.92 (app d, J = 9.4 Hz, 1H), 3.79 (dd, 
J = 9.6, 10.8 Hz, 1H), 3.46 (ddd, J = 9.4, 5.3, 1.4 Hz, 1H), 2.57 (ddd, J = 12.1, 6.2, 6.0 





CHCl3): δ 171.1, 78.6, 76.3, 74.6, 67.2, 60.0, 28.9, 27.8, 27.5, 22.9, 22.8, 20.6; HRMS: 











The title compound was prepared from 2.3b according to the general procedure described 
above for the preparation of 2.5a. Purification by flash chromatography on silica gel with 
4:1 hexanes-EtOAc for elution gave the title compound as a pale yellow syrup (86 mg, 
89%): Rf 0.55 (33% EtOAc/hexanes); IR (thin film) ν 1792 cm-1; 1H NMR (300 MHz, d6-
benzene): δ 4.39 (app d, J = 6.4 Hz, 1H), 3.74 (ddd, J = 10.1, 4.7, 0.5 Hz, 1H), 3.60 (app 
d, J = 10.1 Hz, 1H), 3.43-3.34 (m, 2H), 3.00 (ddd, J = 10.3, 10.3, 4.7 Hz, 1H), 1.55 (dd, 
J = 6.7, 6.7 Hz, 1H), 1.40 (ddd, J =  13.0, 6.7, 6.7 Hz, 1H), 1.36 (d, J = 0.4 Hz, 3H), 1.03 
(d, J = 0.4 Hz, 3H); 13C NMR (75 MHz, d6-benzene): δ 169.9, 101.2, 76.2, 74.7, 73.1, 














cyclopropa[cd]inden-2-one one (2.5c). The title compound was prepared from 2.3c 
according to the general procedure described above for the preparation of 2.5a. 
Purification by flash chromatography on silica gel with 5:1 hexanes-EtOAc for elution 
gave the title compound as a yellow syrup (119 mg, 86%): Rf 0.35 (25% 
EtOAc/hexanes); IR (thin film) ν 3025, 1779 cm-1; 1H NMR (300 MHz, CHCl3): δ 7.38-
7.27 (m, 5H), 4.85 (dd, J = 6.2, 1.4 Hz, 1H), 4.58 ( ddd, J = 11.8,11.8, 11.8 Hz, 2H), 4.1 
(dd, J = 6.2, 6.2 Hz, 1H), 3.60-3.50(m, 4H), 2.51 (ddd, J = 6.2, 6.2, 6.2 Hz, 1H), 2.28 
(dd, J =  6.2, 6.2 Hz, 1H), 0.86 (s, 9H), 0.02 (s, 6H); 13C NMR (75 MHz, CHCl3): δ171.5, 
137.3, 128.6, 128.1, 127.9, 79.5, 73.4, 73.2, 72.4, 64.0, 54.3, 26.6, 25.9, 21.4, 18.3, -5.3; 







3-Diazenyl-acetaic acid 2-isopropyl-tetrahydro-pyran-4-yl-ester (2.8). The title 
compound was prepared from the corresponding allylic alcohol61 (136 mg, 0.36 mmol) 
according to the general procedure described above for the preparation of 2.3a. 
Purification by flash chromatography on silica gel with 3:1 hexanes-EtOAc for elution 
gave the title compound as a light yellow syrup (2.61 g, 83%): Rf 0.67 (25% 
EtOAc/hexanes); IR (thin film) ν 2110, 1690, 1644 cm-1; 1H NMR (400 MHz, CHCl3) δ 





2.0 Hz, 1H), 2.19  (dddd, J = 13.0, 6.5, 0.8, 0.8 Hz, 1H), 1.85 (dddd, J = 13.0, 6.5, 6.5, 
6.5 Hz, 1H), 1.69  (ddd, J = 11.3, 11.3, 9.6 Hz, 1H), 0.92  (d, J = 6.9 Hz, 3H), 0.90  (d, J 
= 6.9 Hz, 3H); 13C NMR (100 MHz, CHCl3) δ 166.6, 147.0, 100.8, 79.2, 66.8, 46.3, 31.6, 






4-Isopropyl-hexahydro-1,3-dioxa-cyclopropa[cd]inden-2-one (2.9). The title 
compound was prepared from 2.8 according to the general procedure described above for 
the preparation of 2.5a. Purification by flash chromatography on silica gel with 10:1 to 
3:1 hexanes-EtOAc for gradient elution gave the title compound as a pale yellow solid 
(1.99 g, 89%): Rf 0.28 (50% EtOAc/hexanes); IR (thin film) ν 1758 cm-1; 1H NMR (300 
MHz, CHCl3) δ 5.04 (ddd, J = 5.1, 5.1, 1.5 Hz, 1H), 4.03  (dd, J = 6.0, 6.0 Hz, 1H), 3.53 
(ddd, J = 7.5, 7.5, 7.5 Hz, 1H), 2.31 (ddd, J = 6.1, 6.1, 6.1 Hz, 1H), 2.23 (dd, J = 6.4, 6.4 
Hz, 1H), 1.87-1.81 (m, 2H), 1.65 (dddd, J = 13.3, 6.6, 6.6, 6.6 Hz, 1H), 0.89 (d, J = 6.7 
Hz, 3H), 0.84  (d, J = 6.7 Hz, 3H); 13C NMR (75 MHz, CHCl3) δ 172.4, 77.5, 72.7, 54.5, 
33.0, 29.6, 26.9, 22.4, 17.9, 17.4; HRMS m/z calcd for C10H15O3 [M+H]+ 183.1021, 











pyran-3-yl ester (2.10). The title compound was prepared from the corresponding allylic 
alcohol62 according to the general procedure described above for the preparation of 2.5a. 
Purification by flash chromatography on silica gel with 10:1 hexanes-EtOAc for elution 
gave title compound as a pale yellow syrup (144 mg, 86%): Rf 0.65 (40% 
EtOAc/hexanes); IR (thin film) v 3072, 2110, 1697, 1643 cm-1; 1H NMR (300 MHz, 
CHCl3): δ 5.92-5.76 (m, 3H), 5.18-5.13 (m, 2H), 5.11-5.04 (m, 1H), 4.75 (s, 1H), 4.25-
4.17 (m, 1H), 3.78 (ddd, J = 1.0, 5.3, 9.0 Hz, 1H), 3.72 (d, J = 5.3 Hz, 2H), 2.44-2.25 (m, 
2H), 0.87 (s, 9H), 0.03 (s, 6H); 13C NMR (75 MHz, CHCl3): δ 166.2, 134.2, 133.3, 123.6, 
117.3, 73.3, 70.9, 65.8, 62.8, 46.3, 38.2, 25.9, 18.3, -5.4; HRMS: m/z calcd for 








cyclopropa[cd]inden-2-one (2.11). The title compound was prepared from 2.10 
according to the general procedure described above for the preparation of 2.5a. 





gave the title compound as a pale yellow syrup (99 mg, 85%): Rf 0.35 (25% 
EtOAc/hexanes); IR (thin film) v 3073, 1763, 1643 cm-1; 1H NMR (300 MHz, CHCl3): δ 
5.89-5.75 (m, 1H), 5.19-5.05 (m, 2H), 4.72 (dd, J = 2.3, 4.4 Hz, 1H), 4.13 (dd, J = 6.7, 
6.7, 3.4 Hz, 1H), 3.96-3.75 (m, 3H), 2.62 (dd, J = 6.8, 6.8 Hz, 1H), 2.45-2.26 (m, 2H), 
2.14 (dd, J = 8.7, 6.7 Hz, 1H), 1.46 (ddd, J = 8.4, 8.4, 3.4 Hz, 1H), 0.88 (s, 9H), 0.06 (s, 
6H); 13C NMR (75 MHz, CHCl3): δ 174.0, 133.5, 117.9, 72.3, 71.1, 66.1, 60.1, 40.2, 










cyclopenta[a]naphthalene-2-one (2.26). To a mixture of cyclopropane 2.5a (75 mg, 
0.23 mmol) and ziese’s dimmer (14 mg, 0.02 mmol, 0.1 eq) in ClCH2CH2Cl (4 mL) was 
stirred at reflux temperature for 10 h.  To the cooled reaction mixture was added CH2Cl2 
(10 mL). The resulting mixture was washed sequentially with saturated aqueous Na2CO3 
(2 × 2 mL), H2O (2 × 2 mL), brine (4 mL) and dried (MgSO4). After filtration through a 
pad of celite, the solvent was removed under reduced pressure. Purification of the 
residual syrup by flash chromatography on silica gel with 5:1 hexanes-EtOAc for elution 
gave the title compound as a colorless syrup (59 mg, 79%): Rf 0.74 (50% 
EtOAc/hexanes); IR (thin film) ν 1785, 1725, 1698 cm-1; 1H NMR (400 MHz, CHCl3) δ 





9.9, 7.2 Hz, 1H), 4.00 (dd, J = 10.3, 10.3 Hz, 1H), 3.88 (ddd, J = 10.3, 10.3, 4.8 Hz, 1H), 
3.20 (ddd, J = 19.5, 2.2, 2.2 Hz, 1H), 3.05 (d, J = 19.5 Hz, 1H), 1.07 (s, 9H), 1.01 (s, 9H); 
13C NMR (100 MHz, CHCl3) δ 173.4, 138.0, 103.8, 81.1, 73.9, 71.4, 65.8, 31.2, 27.7, 










cyclopropa[cd]inden-2-one (2.27). To a rt solution of 2.5a (300 mg, 0.92 mmol) in 
toluene (11 mL) was added allyltrimethylsilane (306 µL, 1.92 mmol) and BF3•Et2O (207 
µL, 1.78 mmol) sequentially. The reaction vessel was placed into an 85 °C syrup bath 
and after 30 min TLC analysis of an aliquot indicated the reaction was complete. The 
reaction mixture was allowed to cool to rt and was treated with 5% aqueous Na2CO3 
solution (3 mL).  The organic layer was separated and washed with H2O (3 × 10 mL), 
brine (5 mL) and dried (MgSO4). After filtration through a small pad of celite, the solvent 
was removed under reduced pressure. Purification of the residue by flash chromatography 
on silica gel with 3:1 of hexanes-EtOAc for elution gave the title compound as a colorless 
syrup (302 mg, 95%): Rf 0.62 (66% EtOAc/hexanes); IR (thin film) ν 3200-3450 (br), 
3092, 1772 cm-1; 1H NMR (300 MHz, CHCl3): δ 4.86 (dd, J = 5.6, 1.6 Hz, 1H), 4.18 (dd, 
J = 6.1, 6.1 Hz, 1H), 4.13 (dd, J = 6.0, 1.5 Hz, 1H), 3.88-3.81 (m, 1H), 3.65-3.51 (m, 
2H), 2.54 (ddd, J = 5.8, 5.8, 5.8 Hz, 1H), 2.35 (dd, J = 6.4, 6.4 Hz, 1H), 2.1 (br s, 1H), 





(CH), 67.3 (CH), 63.0 (CH2), 54.1 (CH), 26.8 (CH3), 26.4 (CH), 20.8 (CH), 20.2 (d, J = 
14.6 Hz, C), 20.0 (d, J = 14.6 Hz, C); 19F NMR (470 MHz, CHCl3): -159.9; HRMS: m/z 










cyclopropa[cd]inden-4-ylmethyl ester (2.28). To a rt solution of 2.27 (270 mg, 0.78 
mmol) and p-toluene sulfonyl  chloride (186 mg, 0.98 mmol) in CH2Cl2 (6 mL) was 
added pyridine (2 mL, 24.7 mmol) in one portion. The resulting solution was stirred at rt 
for 20 h and then volatiles were removed in vacuo. The resulting residue was dissolved in 
EtOAc (30 mL) and the solution was washed with H2O (2 × 4 mL), brine (10 mL), and 
dried (MgSO4). After filtration through a pad of celite, the solvent was removed under 
reduced pressure. Purification of the residual syrup by flash chromatography on silica gel 
with 4:1 of hexanes-EtOAc for elution gave the title compound as white solid (344 mg, 
92%, the tosylate was used immediately in the next reaction): Rf 0.64 (50% 
EtOAc/hexanes); 1H NMR (300 MHz, CHCl3): 7.74 (dd, J = 6.8, 1.7 Hz, 2H), 7.30 (dd, J 
= 6.7, 1.7 Hz, 2H), 4.85 (dd, J = 5.7, 1.5 Hz, 1H), 4.27 (dd, J = 11.0, 2.5 Hz, 1H), 4.13 
(dd, J = 7.2, 1.5 Hz, 1H), 3.97-3.85 (m, 2H), 3.67 (ddd, J = 9.2, 6.8, 2.5 Hz, 1H), 2.54 
(ddd, J =  6.0, 6.0, 6.0 Hz, 1H), 2.46 (s, 3H), 2.34 (dd, J = 6.4, 6.4 Hz, 1H), 1.07 (s, 9H), 













cyclopropa[cd]inden-2-one (2.29). A mixture of the tosylate 2.28 (344 mg, 0.71 mmol) 
and NaI (700 mg, 4.35 mmol, 6.1 equiv) in acetone (3.5 mL) was stirred in the dark at 
reflux temperature for 30 h.  To the cooled reaction mixture solid NaHCO3 (15 mg, 0.21 
mmol) was added. After stirring for 10 min, the solvent was removed under reduced 
pressure.  Water (8 mL) and EtOAc (30 mL) were added to residue and the organic layer 
was separated, washed with H2O (8 mL) and dried (MgSO4). After filtration through a 
pad of celite, the solvent was removed under reduced pressure. Purification of the 
residual syrup by flash chromatography on silica gel with 6:1 of  hexanes-EtOAc for 
elution gave the title compound as a pale yellow syrup (300 mg, 92%): Rf 0.74 (50% 
EtOAc/hexanes); IR (thin film): ν 3115, 1779 cm-1; 1H NMR (300 MHz, CHCl3): δ 4.48 
(dd, J =  5.6, 1.3 Hz, 1H), 4.22 (dd, J = 6.0, 6.0 Hz, 1H), 4.00 (dd, J = 6.3, 1.1 Hz, 1H), 
3.49 (dd, J = 10.8, 2.7 Hz, 1H), 3.39 (ddd, J =  6.5, 6.5, 2.73 Hz, 1H), 3.13 (dd, J = 10.8, 
7.8 Hz, 1H), 2.55 (ddd, J = 6.0, 6.0, 6.0 Hz, 1H); 2.35 (dd, J = 6.4, 6.4 Hz, 1H), 1.09 (d, 
J = 0.9 Hz, 9H), 1.03 (d, J = 0.9 Hz, 9H); 13C NMR (75 MHz, CHCl3): δ 171.2 (C), 80.7 
(CH), 76.4 (CH), 71.5 (CH), 54.9 (CH), 26.8 (CH3), 26.7 (CH3), 26.6 (CH), 20.7(CH), 
20.2 (d, J = 14.5 Hz, C), 20.0 (d, J = 14.5 Hz, C), 4.9 (CH2); HRMS: m/z calcd for 













4-Hydroxy-6-vinyl-tetrahydro-furo[3,4-b]furan-2-one (2.31). A 10 mL round-
bottomed flask containing a suspension of Zn-Cu couple171 (400 mg, 6.2 mmol) in THF 
(1.2 mL) was placed in a 60 °C syrup bath.  The reaction mixture was treated sequentially 
with Me3SiCl (170 mL, 1.3 mmol) and BrCH2CH2Br (150 µL, 1.7 mmol).  After ethylene 
evolution ceased (about 5 min), the reaction mixture was allowed to cool to rt and a 
solution of iodide 2.29 (40 mg, 0.09 mmol) in 0.8 mL of THF was added.  After 20 min 
the reaction appeared complete as determined by TLC, and the cloudy solution was 
decanted from the remaining zinc metal and transferred with the aid of additional THF (2 
× 2 mL) into a plastic test tube containing HF•pyridine (20% HF, 0.5 mL) and THF (2 
mL).  After 2 min 10% aqueous H2SO4 (2 mL) was added, and the resulting mixture was 
extracted with EtOAc (4 × 1.5 mL).  The combined organic layers were washed with H2O 
(2 mL), saturated aqueous NaHCO3 solution (2 × 1 mL), brine (1 mL) and dried 
(MgSO4). Removal of volatile components under reduced pressure and purification of the 
resulting residue by flash chromatography on silica gel with 2:1 of hexanes-EtOAc for 
elution gave the title compound as a colorless syrup (11.4 mg, 76%): Rf 0.45 (25% 
EtOAc/hexanes); 1H NMR (300 MHz, CHCl3): δ 5.90 (ddd, J = 17.3, 10.4, 6.9 Hz, 1H), 
5.46-5.41 (m, 2H), 5.28 (app s, 1H), 5.00 (dd, J = 6.9, 4.0 Hz, 1H), 4.57-4.50 (m, 1H). 













6-Ethyl-4-hydroxyl-tetrahydro-furo[3,4-b]furan-2-one (2.32). To a solution of 2.31 
(25 mg, 0.145 mmol) in 2.5 mL of ethanol at rt was added 5% Pd-C (ca. 3 mg). The 
reaction mixture was stirred under hydrogen atmosphere (balloon) for 3 h and then 
filtrated through a pad of celite. Removal of the solvent under reduced pressure gave the 
title compound as a colorless oil (24 mg, 96%): The product was used immediately in the 
following reaction. Rf 0.45 (25% EtOAc/hexanes); 1H NMR (300 MHz, CHCl3): δ 5.32 
(s, 1H), 5.00 (dd, J = 4.9, 3.7 Hz, 1H), 4.15 (dt, J = 7.0, 4.9, Hz, 1H), 3.11-3.02 (m, 1 H), 
2.83 (app dd, J = 18.6, 11.2 Hz, 1H), 2.61 (br s, 1H), 2.48 (dd, 1 H, J = 18.6, 3.6 Hz, 









4-methoxy-6-vinyl-tetrahydro-furo[3,4-b]furan-2-one (2.33). To a solution of 
hemiacetal 2.31 (11.4 mg, 66 µmol) in 0.5 mL of MeOH was added 10% aqueous H2SO4 
(0.1 mL). The reaction mixture was stirred at rt for 6 h and subsequently concentrated 
under reduced pressure. The residue was dissolved in EtOAc (3 mL), which was then 
washed with aqueous Na2CO3 (2 × 0.5 mL), H2O (0.5 mL), brine (1 mL) and dried 





to afford 12.1 mg (96%) of the title compound as a mixture of diastereomers. Separation 
of the major diastereomer by flash chromatography on silica gel with 4: 1 hexanes-
EtOAc for elution gave the title compound as a colorless syrup (10 mg, 82%): Rf 0.75 
(50% EtOAc/hexanes); IR (thin film) v 1771, 1643 cm-1; 1H NMR (300 MHz, CHCl3): δ 
5.91 (ddd, J = 17.4, 10.4, 7.1 Hz, 1H), 5.55-5.35 (m, 2H), 4.95 (dd, J = 6.9, 3.9 Hz, 1H), 
4.85  (app s, 1H), 4.51-4.47 (m, 1H), 3.27 (s, 3H), 3.09-3.04 (m, 1H), 2.80 (dd, J = 18.6, 
11.2 Hz, 1H), 2.5 (dd, J = 18.5, 3.7 Hz, 1H); 13C NMR (75 MHz, CHCl3): δ 175.4, 131.2, 
119.7, 109.2, 84.0, 80.6, 54.8, 45.9, 31.9; HRMS: m/z calcd for C8H11O4 (M+1+): 










(3.8). To a solution of cyclopropane 2.5a (450 mg, 1.4 mmol) in CH2Cl2 (10 mL) at rt 
was added TMSOTf (400 µL, 2.1 mmol, 1.5 eq). After stirring at rt for 10 h saturated 
aqueous NaHCO3 (5 mL) was added to the reaction solution. The organic layer was 
separated and the aqueous layer was extracted with CH2Cl2 (2 × 8 mL). The combined 
organic layer was washed with H2O (2 × 8 mL), brine (3 mL) and dried (MgSO4). After 
filtration through a small pad of celite, volatiles were removed under reduced pressure. 
Purification of the residual syrup by flash chromatography on silica gel with 20:1 





90%): Rf 0.65 (33% EtOAc/hexanes); IR (thin film) ν 1790 cm-1; 1H NMR (400 MHz, 
CHCl3) δ 5.41 (s, 1 H), 4.57 (dd, J = 5.8, 1.3 Hz, 1H), 4.41 (ddd, J = 4.8, 1.3, 1.3 Hz, 
1H), 4.07 (s, 1H), 3.87 (dd, J = 7.5, 1.3 Hz, 1H), 3.68 (dd, J = 7.5, 5.8 Hz, 1H), 2.68  
(ddd, J = 8.5, 6.0, 2.5 Hz, 1H), 2.62 (dd, J = 17.0, 8.5 Hz, 1H), 2.45 (d, J = 17.0 Hz, 1H), 
1.00 (s, 9H), 0.97 (s, 9H), 0.16 (s, 9H); 13C NMR (75 MHz, CHCl3) δ 174.9, 100.7, 79.3, 
76.2, 67.5, 64.2, 36.3, 31.2, 27.4, 27.3, 20.6, 20.4, 2.1; HRMS m/z calcd for C19H37O6Si2 









naphthalene-2-one (3.9). To a solution of 3.8 (380 mg, 0.91 mmol) in THF (8 mL) at 0 
°C was added Bu4NF (4.0 mL × 1 M, 4.0 mmol, 4.5 eq). After stirring at rt for 3 h 
additional THF (10 mL) was added in to the reaction mixture and the resulting solution 
was washed with saturated aqueous NaHCO3 (2 × 5 mL), H2O (2 × 8 mL), brine (3 mL) 
and dried (MgSO4). After filtration through a small pad of celite, volatiles were removed 
under reduced pressure. Purification of the residual syrup by flash chromatography on 
silica gel with 3:1 hexanes-EtOAc for elution afforded the title compound as a colorless 
syrup (142 mg, 84%): Rf 0.32 (50% EtOAc/hexanes); IR (thin film) ν 3650-3250, 1779, 
1760 cm-1; 1H NMR (400 MHz, CHCl3) δ 5.40 (s, 1H), 4.61 (ddd, J = 4.4,1.5, 1.5 Hz, 





2.68-2.56 (m, 2H), 2.49-2.45 (m, 1H); 13C NMR (100 MHz, CHCl3) δ 174.5, 101.0, 78.3, 
















2-one (3.25(α) and 3.25(β)). To a solution of the cyclopropane 2.5a (250 mg, 0.76 
mmol) in CH2Cl2 (5 mL) at rt was added TiCl4 (82 µL, 1.7 eq). The mixture was stirred at 
rt for 1.0-1.5 h until TLC indicated complete consumption of starting material. To the 
dark brown solution was added allyltrimethylsilane (480 µL, 3.05 mmol, 4.0 eq). The 
resulting mixture was stirred for 2 h and then poured into saturated aqueous NaHCO3 (10 
mL). After stirring for 10 min the organic layer was separated and the aqueous layer was 
extracted with CH2Cl2 (2 × 8 mL). The combined organic solution was washed with H2O 
(2 × 4 mL), brine (5 mL) and dried (MgSO4). After filtration through a small pad of 
celite, volatiles were removed under reduced pressure. Purification of the residue by flash 
chromatography on silica gel with 30:1 hexanes-EtOAc for elution gave the title products 
as colorless syrups: 3.25(α)(232 mg, 63%): Rf 0.62 (25% EtOAc/hexanes); IR (thin film) 
ν 1783 cm-1; 1H NMR (300 MHz, CHCl3) δ 5.84-5.70 (m, 1H), 5.19-5.12 (m, 2H), 4.49 
(dd, J = 7.7, 7.7 Hz, 1H), 4.22 (ddd, J = 5.1, 5.1, 5.1 Hz, 1H), 3.90-3.76 (m, 3H), 3.32 





2.45-2.37 (m, 2H), 2.10 (ddd, J = 14.6, 7.4, 7.4 Hz, 1H), 1.06 (s, 9H), 1.02 (s, 9H); 13C 
NMR (75 MHz, CHCl3) δ 175.4, 133.1, 118.4, 81.4, 75.9, 72.5, 66.8, 66.6, 38.8, 37.1, 
32.0, 27.4, 27.0, 22.7, 19.9; HRMS m/z calcd for C19H33O5Si [M+H]+ 369.2097, found: 
369.2096; 3.25(β)(44 mg, 16 %): Rf 0.69 (25% EtOAc/hexanes); IR (thin film) ν 1779, 
1709, 1642 cm-1; 1H NMR (300 MHz, CHCl3) δ 5.84-5.70 (m, 1H), 5.19-5.12 (m, 2H), 
4.49 (dd, J = 7.7, 7.7 Hz, 1H), 4.22 (ddd, J = 5.1, 5.1, 5.1 Hz, 1H), 3.90-3.76 (m, 3H), 
3.32 (ddd, J = 10.2, 10.2, 5.1 Hz, 1H), 2.89-2.78 (m, H), 2.56 (dd, J = 16.9, 13.1 Hz, 1H), 
2.45-2.37 (m, 2H), 2.10 (ddd, J = 14.6, 7.4, 7.4 Hz, 1H), 1.06 (s, 9H), 1.02 (s, 9H); 13C 
NMR (75 MHz, CHCl3) δ 175.9, 133.1, 118.5, 82.9, 76.4, 75.7, 74.1, 66.5, 40.9, 37.9, 















2.5a 3.25  
The title compounds were prepared from 2.5a according to the general procedure 
described above for the preparation of 3.25, except that 1.5 equivalents of alltyltributyltin 














dioxa-cyclopropa[cd]inden-2-one (3.26). To a rt solution of the alcohol 2.27 (189 mg, 
0.54 mmol) in CH2Cl2 (3.0 mL) were added pyridine (0.25 mL, 3.1 mmol) and 
triisopropylsilyl chloride (115 µL, 0.82 mmol, 1.5 eq). The reaction mixture was stirred at 
rt for 20 h and then poured into saturated aqueous NH4Cl solution (4 mL) with vigorous 
stirring.  After 10 min the organic layer was separated and the aqueous layer was 
extracted with CH2Cl2 (2 × 5 mL). The combined organic layers were washed with H2O 
(2 × 3 mL), brine (3 mL) and dried (MgSO4). After filtration through celite, volatiles 
were removed under reduced pressure. Purification of the residual syrup by flash 
chromatography on silica gel using 20:1 hexanes-EtOAc for elution provided the title 
compound as a foamy solid (240 mg, 88%): Rf 0.75 (50% EtOAc/hexanes); IR (thin film) 
ν 1783 cm-1; 1H NMR (300 MHz, CHCl3) δ 4.84 (dd, J = 6.2, 2.0 Hz, 1H), 4.24 (dd, J = 
6.2, 2.0 Hz, 1H), 4.14 (dd, J = 6.0, 6.0 Hz, 1H), 3.90 (dd, J = 11.6, 2.4 Hz, 1H), 3.76 (dd, 
J = 11.6, 6.0 Hz, 1H), 3.44 (ddd, J = 6.0, 6.0, 2.4 Hz, 1H), 2.48 (ddd, J = 5.8, 5.8, 5.8 Hz, 
1H), 2.28 (dd, J = 6.2, 6.2 Hz, 1H), 1.04-1.00 (m, 39H); 13C NMR (75 MHz, CHCl3) δ 
171.4,81.8, 76.3, 67.1, 63.5, 54.5, 26.83, 26.80, 26.5, 20.9, 20.05 (d, J = 14.5 Hz), 20.02 
(d, J = 14.5 Hz), 17.8, 11.8; 19F NMR (300 MHz, CHCl3) δ -159.3; HRMS m/z calcd for 















furo[3,2-c] pyran-2-one (3.27). The title compounds were prepared from 3.26 according 
to the general procedure described above for the preparation of 3.25. Purification by flash 
chromatography on silica gel with 30:1 hexanes-EtOAc for elution gave the title 
compound as a colorless syrup (142 mg, 65%): Rf 0.74 (25% EtOAc/hexanes); IR (thin 
film) ν 1716 cm-1; 1H NMR (300 MHz, CHCl3) δ 5.87-5.73 (m, 1H), 5.15-5.03 (m, 2H), 
4.56 (dd, J = 8.8, 8.8 Hz, 1H), 4.38 (dd, J = 8.8, 8.8 Hz, 1H), 3.96 (dd, J = 14.0, 6.0 Hz, 
1H), 3.87 (dd, J = 14.4, 6.4 Hz, 1H), 3.75-3.62 (m, 2H), 2.65-2.44 (m, 2H), 2.44-2.23(m, 
3H), 1.07-1.02  (m, 39H); 13C NMR (100 MHz, CHCl3) δ 175.4, 133.5, 118.0, 81.3, 75.8, 
71.6, 68.0, 62.3, 37.9, 37.8, 32.5, 27.0, 26.9 (d, J = 15.3 Hz), 20.2 (d, J = 15.3 Hz), 18.0, 
17.9, 11.9; 19F NMR (300 MHz, CHCl3) δ -157.8; HRMS m/z calcd for C28H54O5FSi2 







4-Allyl-6-isopropyl-tetrahydro-furo[3,2-c]pyran-2-one (3.28). The title compounds 





preparation of 3.25. Purification by flash chromatography on silica gel with 20:1 
hexanes-EtOAc for elution gave the title compound as a colorless syrup (32 mg, 60%): Rf 
0.52 (33% EtOAc/hexanes); IR (thin film) ν 1759 cm-1; 1H NMR (400 MHz, CHCl3) δ 
5.85-5.75 (m, 1H), 5.11-5.07 (m, 2H), 4.73 (ddd, J = 9.4, 6.4, 6.4 Hz, 1H), 3.70 (ddd, J = 
8.2, 5.4, 5.4 Hz, 1H), 3.32 (ddd, J = 9.6, 7.8, 4.0 Hz, 1H), 2.56-2.42 (m, 2H), 2.38-2.30 
(m, 1H), 2.27-2.20 (m, 1H), 2.07 (ddd, J = 13.7, 5.8, 4.1 Hz, 1H), 1.78 (dddd, J = 6.8, 
6.8, 6.8, 6.8, 6.8 Hz, 1H), 1.67-1.51 (m, 2H), 0.86 (dd, J = 6.7, 6.7 Hz, 6H); 13C NMR 
(100 MHz, CHCl3) δ 176.2, 134.0, 117.7, 76.3, 74.1, 71.7, 38.0, 37.9, 31.8, 31.7, 29.7, 










cyclopenta[a] naphthalen-2-one (3.29). The title compounds were prepared from 2.5a 
according to the general procedure described above for the preparation of 3.25, except 
that 3.0 equivalents of prenyltrimethylsilane was used. Purification by flash 
chromatography on silica gel with 15:1 hexanes-EtOAc for elution gave the title 
compound as a colorless syrup (68 mg, 71%): Rf 0.65 (25% EtOAc/hexanes); IR (thin 
film) ν 1765 cm-1; 1H NMR (400 MHz, CHCl3) δ 5.86 (dd, J = 17.6, 10.4 Hz, 1H), 5.09-
5.05 (m, 2H), 4.52 (dd, J = 8.6, 8.6 Hz, 1H), 4.09-4.06 (m, 1H), 3.91 (dd, J = 8.9, 8.9 Hz, 





3H), 0.94 (s, 9H), 0.93 (s, 3H); 13C NMR (100 MHz, CHCl3) δ 175.4, 144.2, 113.9, 82.2, 
81.3, 75.1, 68.9, 66.6, 41.8, 35.7, 33.9, 27.3, 26.9, 26.0, 22.7, 22.6, 19.9;  HRMS m/z 










naphthalen-2-one (3.30). The title compounds were prepared from 2.5a according to the 
general procedure described above for the preparation of 3.25, except that 3.0 equivalents 
of crotyltrimethylsilane was used. Purification by flash chromatography on silica gel with 
15:1 hexanes-EtOAc for elution gave the title compounds as a colorless syrup: 
Diastereomer A (41 mg, 40%): Rf 0.60 (15% EtOAc/hexanes); IR (thin film) ν 1761 cm-
1; 1H NMR (400 MHz, CHCl3) δ 5.56 (ddddd, J = 10.1, 10.1, 10.1, 10.1, 1.4 Hz, 1H), 
5.15-5.08 (m, 2H), 4.45 (dd, J = 7.9, 7.9 Hz, 1H), 4.10 (ddd, J = 10.0, 5.0, 1.8 Hz, 1H), 
3.87-3.78 (m, 2H), 3.48 (dd, J = 10.0, 1.4 Hz, 1H), 3.44-3.37 (m, 1H), 3.01-2.94 (m, 1H), 
2.59-2.43 (m, 3H), 1.02 (d, J = 6.3 Hz, 3H), 1.01 (s, 9H), 0.98 (s, 9H); 13C NMR (100 
MHz, CHCl3) δ 175.5, 140.1, 117.1, 81.2, 76.8, 75.7, 66.7, 66.6, 40.0, 37.1, 32.4, 27.4, 
26.9, 22.7, 19.9, 16.6; Diastereomer B (39 mg, 39%): Rf 0.64 (15% EtOAc/hexanes); IR 
(thin film) ν 1768 cm-1; 1H NMR (400 MHz, CHCl3) δ 5.75-5.66 (m, 1H), 5.08-5.00 (m, 
2H), 4.52 (dd, J = 7.7, 7.7 Hz, 1H), 4.03 (dd, J = 10.0, 5.0 Hz, 1H), 3.96  (d, J = 10.4, 7.8 





9.2, 4.8 Hz, 1H), 2.57 (dd, J = 16.8, 8.8 Hz, 1H), 2.47 (d, J = 18.0, 10.0 Hz, 1H), 2.46-
2.37 (m, 1H), 1.05 (d, J = 6.5 Hz, 3H), 1.01 (s, 9H), 0.96 (s, 9H); 13C NMR (100 MHz, 
CHCl3) δ 175.5, 139.0, 115.8, 82.1, 76.5, 75.7, 67.0, 66.6, 40.4, 37.2, 30.9, 27.3, 27.0, 










cyclopropa[cd]inden-2-one (3.31a). To a solution of cyclopropane 2.5a (350 mg, 1.1 
mmol) in THF (6 mL) at –78 °C was added trimethyl chlorosilane (191 µL, 1.5 mmol, 1.4 
eq) followed by LDA (275 µL × 0.8 M, 2.2 mmol, 2.0 eq). After stirring at  –78 °C for 5 
min saturated aqueous NaHCO3 solution (5 mL) was added to the reaction solution. The 
resulting mixture was allowed to warm to room temperature and the organic layer was 
separated and the aqueous layer was extracted with Et2O (2 × 3 mL). The combined 
organic layers were washed with H2O (2 × 2 mL), brine (3 mL) and dried (MgSO4). After 
filtration through a small pad of celite, volatiles were removed under reduced pressure. 
Purification of the residual syrup by flash chromatography on silica gel with 50:1 
hexanes-EtOAc for elution afforded the title compound as a colorless needles (409 mg, 
96%): Rf 0.64 (20% EtOAc/hexanes); IR (thin film) ν 1759, 1713 cm-1; 1H NMR (300 
MHz, CHCl3) δ 4.85 (d, J = 6.1 Hz, 1H), 4.28 (dd, J = 9.5, 5.4 Hz, 1H), 4.17 (d, J = 5.4 
Hz, 1H), 3.97 (d, J = 9.5 Hz, 1H), 3.82 (dd, J = 10.8, 9.5 Hz, 1H), 3.51 (ddd, J = 9.5, 5.4, 





13C NMR (75 MHz, CHCl3) δ 173.2, 77.7, 76.3, 74.3, 66.9, 62.5, 28.3, 27.3, 27.1, 26.2, 










sila-benzo[g] cyclopropa[cd]inden-2-one (3.31b). The title compound was prepared 
from 2.5a according to the procedure described above for the preparation of 3.31a, except 
that 1.6 equivalents of vinyldimethylchlorosilane was used. Purification by flash 
chromatography on silica gel with 50:1 hexanes-EtOAc for elution gave the title 
compound as an syrup y solid (1.71 g, 97%): Rf 0.55 (25% EtOAc/hexanes); IR (thin 
film) ν 1761 cm-1; 1H NMR (300 MHz, CHCl3) δ 6.10-5.96 (m, 2H), 5.88 (dd, J = 18.4, 
5.6 Hz, 1H), 4.85 (d, J = 5.9 Hz, 1H), 4.28 (dd, J = 9.5, 5.4 Hz, 1H), 4.16 (d, J = 5.4 Hz, 
1H), 3.96 (d, J =  9.5 Hz, 1H), 3.81 (dd, J = 10.2, 10.2 Hz, 1H), 3.49 (ddd, J = 10.2, 10.2, 
5.4 Hz, 1H), 2.45 (dd, J = 5.6, 5.6 Hz, 1H), 1.04 (s, 9H), 1.00 (s, 9H), 0.27 (s, 3 H), 0.24 
(s, 3 H); 13C NMR (75 MHz, CHCl3) δ 173.4, 135.3, 134.5, 78.0, 76.5, 74.6, 67.2, 62.8, 
28.0, 27.6, 27.4, 26.5, 22.8, 20.4, -4.6, -4.7; HRMS m/z calcd for C20H35O5Si2 [M+H]+ 














benzo[g] cyclopropa[cd]inden-2-one (3.31c). The title compound was prepared from 
2.5a according to the procedure described above for the preparation of 3.31a, except that 
1.6 equivalents of allyldimethylchlorosilane was used. Purification by flash 
chromatography on silica gel with 50:1 hexanes-EtOAc for elution gave the title 
compound as a colorless syrup (178 mg, 93%): Rf 0.73 (25% EtOAc/hexanes); IR (thin 
film) ν 1759, 1627 cm-1; 1H NMR (300 MHz, CHCl3) δ 5.85-5.70 (m, 1H), 4.96-4.89 (m, 
2H), 4.28 (dd, J = 9.5, 5.4 Hz, 1H), 4.17 (d, J = 5.4 Hz, 1H), 3.96 (d, J = 9.5 Hz, 1H), 
3.81 (dd, J = 10.8, 9.9 Hz, 1H), 3.50 (ddd, J = 10.8, 9.5, 5.4 Hz, 1H), 2.45 (dd, J = 5.8, 
5.8 Hz, 1H), 1.73 (dd, J = 8.0, 1.0 Hz, 1H), 1.04 (s, 9H), 1.00 (s, 9H), 0.14 (s, 3H), 0.07 
(s, 3H); 13C NMR (75 MHz, CHCl3) δ 173.4, 133.6, 114.6, 78.0, 76.6, 74.6, 67.2, 62.6, 
27.8, 27.6, 27.4, 26.4, 22.7, 21.6, 20.4, -4.8, -4.9; HRMS m/z calcd for C21H37O5Si2 














cyclopenta[a] naphthalen-2-one (3.32a). The title compound was prepared from 3.31a 
according to the procedure described above for the preparation of 3.25. Purification by 
flash chromatography on silica gel with 50:1 hexanes-EtOAc for elution gave the title 
compound as a colorless syrup (68 mg, 72%): Rf 0.52 (25% EtOAc/hexanes); IR (thin 
film) ν 1751 cm-1;  1H NMR (300 MHz, CHCl3) δ 5.83-5.69 (m, 1H), 5.18 (s, 1H), 5.13 
(dd, J = 7.4, 1.5 Hz, 1H), 4.52 (dd, J = 8.3, 8.3 Hz, 1H), 4.18-4.08 (m, 2H), 3.88 (ddd, J = 
11.2, 11.2, 8.2 Hz, 1H), 3.55 (ddd, J = 10.2, 10.2, 5.1 Hz, 1H), 3.09 (dd, J = 11.0, 8.5 Hz, 
1H), 2.58 (ddd, J = 14.8, 7.4, 7.4 Hz, 1H), 2.37 (d, J = 11.0 Hz, 1H), 2.35 (ddd, J = 14.0, 
7.0, 7.0 Hz, 1H), 1.05 (s, 9H), 1.02 (s, 9H), 0.28 (s, 9 H); 13C NMR (75 MHz, CHCl3) δ 
178.5, 133.8, 118.4, 79.9, 75.8, 71.8, 67.0, 66.1, 42.3, 37.4, 35.7, 27.6, 27.2, 22.7, 20.2, 
















according to the procedure described above for the preparation of 3.25. Purification by 
flash chromatography on silica gel with 30:1 hexanes-EtOAc for elution gave the title 
compound as white solid (156 mg, 70%): Rf 0.50 (25% EtOAc/hexanes); IR (thin film) ν 
1758 cm-1; 1H NMR (300 MHz, CHCl3) δ 6.25 (dd, J = 20.0, 14.6 Hz, 1H), 6.07 (dd, J = 
14.6, 3.8 Hz, 1H), 5.82 (dd, J = 20.0, 3.8 Hz, 1H), 5.81-5.67 (m, 1H), 5.16 (s, 1H), 5.12 
(d, J = 8.2 Hz, 1H), 4.49 (dd, J = 8.2, 8.2 Hz, 1H), 4.16 (dd, J = 7.7, 7.7 Hz, 1H), 4.07 
(dd, J = 10.0, 5.1 Hz, 1H), 3.95 (dd, J = 9.1, 9.1 Hz, 1H), 3.84 (dd, J = 10.0, 10.0 Hz, 
1H), 3.52 (ddd, J = 10.0, 10.0, 5.1 Hz, 1H), 3.06 (dd, J = 10.7, 8.6 Hz, 1H), 2.55 (ddd, J 
= 14.7, 7.7, 7.7 Hz, 1H), 2.40 (d, J = 11.0 Hz, 1H), 2.31 (ddd, J = 14.3, 7.0, 7.0 Hz, 1H), 
1.04 (s, 9H), 1.00 (s, 9H), 0.37 (s, 3 H), 0.35 (s, 3 H); 13C NMR (75 MHz, CHCl3) δ 
178.2, 136.5, 135.0, 133.8, 118.4, 80.1, 75.6, 71.6, 66.9,  66.2, 42.2, 37.4, 35.5, 27.6, 
















To a solution of starting cyclopropane 3.31c (130 mg, 0.31 mmol) in CH2Cl2 (7 mL) at rt 
was added TiCl4 (27 µL, 0.25 mmol, 0.8 eq). The mixture was stirred at rt for 3.5 h until 
TLC indicated complete consumption of starting material. The reaction solution was then 
poured into saturated aqueous NaHCO3 (10 mL). After stirring for 10 min the organic 
layer was separated and the aqueous layer was extracted with CH2Cl2 (2 × 6 mL). The 





(MgSO4). After filtration through a small pad of celite, volatiles were removed under 
reduced pressure. Purification of the residue by flash chromatography on silica gel with 
30:1 hexanes-EtOAc for elution gave the title products as colorless syrups: 3.25(α)(65 

















To a solution of 3.32(α)(310 mg, 0.70 mmol) in CH3CN (4 mL) and MeOH (2 mL) was 
added KF (204 mg, 3.5 mmol, 5.0 eq). The mixture was stirred at rt for 30 min. The 
organic solvent was removed under reduced pressure and the residue was dissolved in 
EtOAc (10 mL). The resulting solution was washed with H2O (2 × 2 mL), brine (3 mL) 
and dried (MgSO4). After filtration through a small pad of celite, volatiles were removed 
under reduced pressure. Purification of the residual syrup by flash chromatography on 
silica gel with 30:1 hexanes-EtOAc for elution afforded the title compound as a colorless 













naphthalene-2-one (3.36a). To a solution of cyclopropane 2.5a (250 mg, 0.77 mmol) in 
Et2O (13 mL) at rt was added TiCl4 (138 µL, 1.27 mmol, 1.7 eq). The mixture was stirred 
at rt for 2.5-3.0 h until TLC indicated complete consumption of starting material. The 
dark brown solution was then quickly poured into saturated aqueous NaHCO3 (5 mL). 
After stirring for 20 min the organic layer was separated and the aqueous layer was 
extracted with Et2O (2 × 8 mL). The combined organic solution was washed with H2O (2 
× 8 mL), brine (6 mL) and dried (MgSO4). After filtration through a small pad of celite, 
volatiles were removed under reduced pressure. Flash chromatography on silica gel with 
5:1 hexanes-EtOAc for elution afforded the title compound as an inseparable mixture of 
two diastereomers (colorless syrup, 237 mg, 90%): Rf 0.51 (50% EtOAc/hexanes); IR 
(thin film) ν 3600-3250, 1763, 1709 cm-1; 1H NMR (400 MHz, CHCl3) δ 5.26 (d, J = 3.0 
Hz, 1H), 5.17 (dd, J = 3.8, 3.8 Hz, 0.44H), 4.64  (dd, J = 7.8, 7.8 Hz, 1H), 4.53 (dd, J = 
7.7, 7.7 Hz, 0.44H), 4.16 (dd, J = 10.2, 4.8 Hz, 0.44H), 4.15-4.09 (m, 2H), 4.07 (d, J = 
3.1 Hz, 0.44H), 4.01 (dd, J = 9.9, 4.8 Hz, 1H), 3.89-3.86 (m, 0.44H), 3.73 (d, J = 4.1 Hz, 
0.44H), 3.44 (ddd, J = 10.2, 10.2, 5.1 Hz, 0.44H), 3.24 (d, J = 3.1 Hz, 1H), 3.01 (m, 1H), 
2.96 (dd, J = 21.9, 8.5 Hz, 1H), 2.67-2.61 (m, 0.88H), 2.60-2.50 (m, 2H), 1.82 (s, 1 H), 
1.05 (s, 13.0 H), 1.01 (s, 13.0 H); 13C NMR (100 MHz, CHCl3) δ 175.3 (minor), 174.5, 





66.4, 64.0, 41.4, 40.7 (minor), 31.3, 28.9 (minor), 27.7, 26.7 (minor), 27.3, 23.1, 20.3; 










naphthalene-2-one (3.36b(α)). To a solution of cyclopropane 2.5a (199 mg, 0.61 mmol) 
in Et2O (10 mL) at rt was added TiCl4 (108 µL, 1.7 eq). The mixture was stirred at rt for 
about 2.5-3.0 h until TLC indicated complete consumption of starting material. To the 
dark brown solution was then added MeOH (250 µL, 6.1 mmol, 10 eq) immediately 
followed by triflic acid (100 µL × 3 M in Et2O, 0.5 eq). The resulting mixture was stirred 
for 30 min and then poured into saturated aqueous NaHCO3 (10 mL). After stirring for 10 
min the organic layer was separated and the aqueous layer was extracted with Et2O (2 × 8 
mL). The combined organic solution was washed with H2O (2 × 8 mL), brine (6 mL) and 
dried (MgSO4). After filtration through a small pad of celite, volatiles were removed 
under reduced pressure. Purification of the residue by flash chromatography on silica gel 
with 4:1 hexanes-EtOAc for elution gave the title compound as a colorless syrup (173 
mg, 78%): Rf 0.71 (50% EtOAc/hexanes); IR (thin film) ν 1783, 1713 cm-1; 1H NMR 
(400 MHz, CHCl3) δ 4.64 (d, J = 3.5 Hz, 1H), 4.50 (dd, J = 6.8, 6.8 Hz, 1H), 4.18 (dd, J 
= 10.2, 5.1 Hz, 1H), 4.13-4.07 (m, 1H), 3.87 (dd, J = 10.1, 10.1 Hz, 1H), 3.48-3.42 (m, 
1H), 3.43 (s, 3H), 2.99-2.92 (m, 1H), 2.53 (dd, J = 6.8, 3.5 Hz, 2H), 1.06 (s, 9H), 0.98 (s, 
















naphthalene-2-one (3.36c). The title compound was prepared from 2.5a according to the 
procedure described above for the preparation of 3.36b except that 10 equivalents of 
benzyl alcohol was used. Purification by flash chromatography on silica gel with 5:1 
hexanes-EtOAc for elution gave the title compound as a colorless syrup (187 mg, 75%): 
Rf 0.65 (50% EtOAc/hexanes); 1H NMR (400 MHz, CHCl3) δ 7.36-7.26 (m, 5H), 4.80-
4.77 (m, 2H), 4.54 (d, J = 12.3 Hz, 1H), 4.50 (dd, J = 7.5, 7.5 Hz, 1H), 4.18 (dd, J = 12.2, 
10.6 Hz, 1H), 4.17 (d, J = 10.3 Hz, 1H), 3.83 (dd, J = 10.3, 10.3 Hz, 1H), 3.43 (ddd, J = 
10.2, 10.2, 5.3 Hz, 1H), 2.94 (dddd, J = 8.6, 8.6, 8.6, 3.4 Hz, 1H), 2.55 (d, J = 8.9 Hz, 
2H), 1.02 (s, 9H), 0.96 (s, 9H); 13C NMR (100 MHz, CHCl3) δ 175.7, 136.9, 128.5, 
128.0, 127.8, 97.4, 82.2, 75.5, 70.0, 69.2, 66.6, 39.4, 29.1, 27.4, 26.9, 22.7, 19.8;  HRMS 















naphthalene-2-one (3.36d). The title compound was prepared from 2.5a according to the 
procedure described above for the preparation of 3.36b, except that 15 equivalents of 
allyl alcohol was used. Purification by flash chromatography on silica gel with 4:1 
hexanes-EtOAc for elution gave the title compound as white solid (310 mg, 84%): Rf 
0.61 (50% EtOAc/hexanes); IR (thin film) ν 1775, 1713 cm-1; 1H NMR (400 MHz, 
CHCl3) δ 5.92-5.82 (m, 1H), 5.29 (dddd, J = 17.1, 1.6, 1.6, 1.6 Hz, 1H), 5.22 (dddd, J = 
10.3, 1.3, 1.3, 1.3 Hz, 1H), 4.82 (s, 1H), 4.59 (dd, J = 7.8, 7.8 Hz, 1H), 4.14 (dddd, J = 
13.0, 5.3, 1.4, 1.4 Hz, 1H), 4.11 (dd, J = 9.9, 5.3 Hz, 1H), 3.97 (dddd, J = 12.9, 6.2, 1.3, 
1.3 Hz, 1H), 3.87 (dd, J = 9.9, 9.9 Hz, 1H), 3.80 (dd, J = 9.9, 7.8 Hz, 1H), 3.81-3.73 (m, 
1H), 2.94 (ddd, J = 13.4, 8.6, 8.6 Hz, 1H), 3.53 (dd, J = 17.1, 9.0 Hz, 1H), 2.47 (dd, J = 
17.1, 13.6 Hz, 1H), 1.07 (s, 9H), 1.00 (s, 9H); 13C NMR (100 MHz, CHCl3) δ 174.1, 
132.8, 117.8, 96.2, 80.9, 75.7, 68.2, 66.3, 64.0, 41.4, 31.3, 27.7, 27.3, 23.1, 20.3; HRMS 















naphthalene-2-one (3.36e(α)). The title compound was prepared from 2.5a according to 
the procedure described above for the preparation of 3.36b, except that 8.0 equivalents of 
phenol solution in 0.5 mL of Et2O was used. Purification by flash chromatography on 
silica gel with 5:1 hexanes-EtOAc for elution gave the title compound as a colorless 
syrup (180 mg, 80%): Rf 0.65 (50% EtOAc/hexanes); IR (thin film) ν 1779, 1713, 1661, 
1592 cm-1; 1H NMR (400 MHz, CHCl3) δ 7.30-7.26 (m, 2H), 7.04 (dd, J = 7.4, 7.4 Hz, 
1H), 6.98 (d, J = 7.4 Hz, 2H), 5.43 (d, J = 3.4 Hz, 1H), 4.66 (dd, J = 7.4, 7.4 Hz, 1H), 
4.38 (dd, J = 10.2, 6.8 Hz, 1H), 4.18 (dd, J = 10.2, 4.8 Hz, 1H), 3.84 (dd, J = 10.1. 10.1 
Hz, 1H), 3.66  (ddd, J = 10.2, 10.2, 4.8 Hz, 1H), 3.19-3.12 (m, 1H), 2.71(dddd, J = 17.0, 
17.0, 17.0, 8.5 Hz, 2H), 1.06 (s, 9H), 1.02 (s, 9H); 13C NMR (100 MHz, CHCl3) δ 174.7, 
155.7, 129.2, 122.6, 116.3, 96.9, 81.9, 75.3, 69.4, 66.7, 39.1, 29.9, 27.7, 27.3, 23.1, 20.3; 
















naphthalene-2-one (3.36e(α) and 3.36e(β)). To a solution of cyclopropane 2.5a (190 
mg, 0.58 mmol) in CH2Cl2 (6 mL) at rt was added TiCl4 (103 µL, 0.96 mmol, 1.7 eq). 
The mixture was stirred at rt for 2.0-2.5 h until TLC indicated complete consumption of 
starting material. To the dark brown solution was added benzenethiol (474 µL, 4.6 mmol, 





mixture was stirred for 2.0 h and then poured into saturated aqueous NaHCO3 (10 mL). 
After stirring for 10 min the organic layer was separated and the aqueous layer was 
extracted with CH2Cl2 (3 × 10 mL). The combined organic solution was washed with 
H2O (2 × 8 mL), brine (6 mL) and dried (MgSO4). After filtration through a small pad of 
celite, volatiles were removed under reduced pressure. Purification of the residue by flash 
chromatography on silica gel with 20:1 hexanes-EtOAc for elution gave the title products 
as colorless syrups: 3.36e(β) (184 mg, 73%): Rf 0.71 (25% EtOAc/hexanes); IR (thin 
film) ν 1779, 1732, 1580 cm-1; 1H NMR (400 MHz, CHCl3) δ 7.56-7.41 (m, 2H), 7.36-
7.29 (m, 3H), 5.06 (d, J = 3.4 Hz, 1H), 4.48 (dd, J = 7.8, 7.8, 1H), 4.20 (dd, J = 10.3, 5.1 
Hz, 1H), 3.95 (dd, J = 10.3, 10.3 Hz, 1H), 3.88 (dd, J = 9.9, 7.8 Hz, 1H), 3.34 (ddd, J = 
10.2, 5.1, 5.1 Hz, 1H), 3.24-3.16 (m, 1H), 2.76 (dd, J = 7.1, 3.0 Hz, 1H), 2.59 (dd, J = 
17.1, 8.2 Hz, 1H), 1.06 (s, 9H), 0.99 (s, 9H); 13C NMR (100 MHz, CHCl3) δ 174.0, 
132.6, 131.3, 128.8, 127.8, 84.2, 82.3, 75.5, 73.6, 65.9, 42.0, 29.0, 27.7, 27.3, 23.1, 20.3; 
HRMS m/z calcd for C22H33O5SiS [M+H]+ 437.1818, found: 437.1815; 3.36e(α) (46 mg, 
18%): Rf 0.60 (25% EtOAc/hexanes); IR (thin film) ν 1783, 1736 cm-1; 1H NMR (400 
MHz, CHCl3) δ 7.42-7.38 (m, 2H), 7.34-7.27 (m, 3H), 5.50 (s, 1H), 4.61 (dd, J = 7.9, 7.9 
Hz, 1 H), 4.33 (ddd, J = 10.2, 10.2, 5.1, 1H), 4.00 (dd, J = 10.2, 5.1 Hz, 1H), 3.90-3.81 
(m, 2H), 3.08 (ddd, J = 10.6, 7.9, 0.8 Hz, 1H), 2.63 (d, J = 10.6 Hz, 2H), 1.04 (s, 18H); 
13C NMR (100 MHz, CHCl3) δ 174.2, 132.8, 132.2, 129.3, 128.3, 84.1, 81.1, 76.5, 66.5, 
65.8, 42.2, 33.2, 28.2, 27.8, 23.6, 20.9; HRMS m/z calcd for C22H33O5SiS [M+H]+ 















naphthalene-2-one (3.36f(α)). The title compound was prepared from 2.5a according to 
the procedure described above for the preparation of 3.36e, except that 6.3 equivalents of 
2-mercaptopyridine was used. Purification by flash chromatography on silica gel with 
15:1 hexanes-EtOAc for elution gave the title compound as foamy solid (301 mg, 70%): 
Rf 0.66 (25% EtOAc/hexanes); IR (thin film) ν 1782, 1709, 1577, 1556 cm-1; 1H NMR 
(400 MHz, CHCl3) δ 8.47 (dd, J = 3.8, 1.0 Hz, 1H), 7.55 (ddd, J = 7.8, 7.8, 2.0 Hz, 1H), 
7.23 (d, J = 12.6 Hz, 1H), 7.08 (ddd, J = 5.3, 4.8, 1.0 Hz, 1H), 6.40  (s, 1H), 4.61 (dd, J = 
7.8, 7.8 Hz, 1H), 4.14-4.07 (m, 2H), 4.02 (dd, J = 10.2, 5.1 Hz, 1H), 3.94-3.83 (m, 2H), 
3.23-3.15 (m, 2H), 1.05 (s, 9H), 1.03 (s, 9H); 13C NMR (100 MHz, CHCl3) δ 173.8, 
154.8, 149.3, 136.4, 123.2, 120.7, 80.7, 80.2, 75.9, 67.0, 66.1, 42.3, 32.8, 27.6, 27.3, 23.1, 



















hexahydro-1,5,7,9-tetraoxa-8-sila-cyclopenta[a]naphthalene-2-one (3.38a(α)). To a 
10-mL round-bottomed flask containing 3.36e(α) (156 mg, 0.36 mmol) was added N-
iodosuccinimide (164 mg, 0.73 mmol, 1.5 eq) and freshly activated molecular sieves (3 
Å, 250 mg).  The flask was sealed with a rubber septum, flushed with argon and treated 
with Et2O (6 mL). After cooled to –35 °C the solution was sequentially treated with 
3.3799 (288 mg, 0.59 mmol, 1.2 eq, pre-dissolved in 2 mL of Et2O) and triflic acid (100 
µL × 1M in Et2O, 0.2 eq). After 50 min the glycosylation was complete (TLC) and Et3N 
(70 µL, 0.50 mmoL, 1.0 eq) was added. The resulting mixture was stirred for 5 min and 
poured into saturated aqueous NaHCO3 (5 mL). After 10 min the organic layer was 
separated and the aqueous layer was extracted with Et2O (2 × 8 mL). The combined 
organic solution was washed with H2O (2 × 8 mL), brine (6 mL) and dried (MgSO4). 
After filtration through a small pad of celite, volatiles were removed under reduced 
pressure. Flash chromatography on silica gel with 10:1 pentanes-Et2O for elution 
afforded the title compound as a colorless syrup (173 mg, 62%): Rf 0.41 (33% 
EtOAc/hexanes); 1H NMR (400 MHz, CHCl3) δ 7.36-7.23 (m, 15H), 4.97 (d, J = 10.8 
Hz, 1H), 4.88 (d, J = 10.8 Hz, 1H), 4.78 (d, J = 11.6 Hz, 2H), 4.63 (d, J = 12.0 Hz, 1H), 
4.55 (d, J = 10.8 Hz, 1H), 4.52-4.48 (m, 2H), 4.06 (dd, J = 11.6, 3.0 Hz, 1H), 3.98 (dd, J 
= 9.2, 9.2 Hz, 1H), 3.85-3.70 (m, 6H), 3.60 (dd, J = 16.0, 4.1 Hz, 1H), 3.48 (dd, J = 9.5, 
3.4 Hz, 1H), 3.40 (dd, J = 9.1, 9.1 Hz, 1H), 3.33 (s, 3H), 2.89 (ddd, J = 13.2, 8.3, 8.3 Hz, 
1H), 2.55-2.40 (m, 2H), 1.01 (s, 9H), 0.91 (s, 9H); HRMS m/z calcd for C44H57O11Si [M-































hexahydro-1,5,7,9-tetraoxa-8-sila-cyclopenta[a]naphthalene-2-one (3.38b(α) and 
3.38b(β)). To a solution of crude 3.38a (190 mg, 0.24 mmol) in ethanol (2.5 mL) at rt 
was added 5% Pd-C (ca. 6 mg). The reaction mixture was stirred under hydrogen 
atmosphere (balloon) for 2 h and then filtered though a pad of celite. Removal of the 
solvent under reduced pressure gave the debenzylated product as a colorless syrup . The 
crude product was immediately dissolved in CH2Cl2 (5 mL) and the solution was treated 
sequentially with pyridine (100 µL, 1.1 mmoL) and Ac2O (250 µL, 2.7 mmol). After 15 h 
at rt the mixture was poured into saturated aqueous NaHCO3 (20 mL).  After stirring for 
20 min the organic layer was separated and the aqueous layer was extracted with CH2Cl2 
(2 × 5 mL). The combined organic solution was washed with NH4Cl solution (4 mL), 
H2O (2 × 8 mL), brine (6 mL) and dried (MgSO4). After filtration through a small pad of 
celite, volatiles were removed under reduced pressure. Flash chromatography on silica 
gel with 5:1 pentanes-Et2O for elution afforded the title products as colorless syrups: 
3.38b(α) (95, 61%): Rf 0.36 (50% EtOAc/hexanes); IR (thin film) ν 1775, 1751,1709 cm-
1; 1H NMR (400 MHz, CHCl3) δ 5.46 (dd, J = 9.2, 9.2 Hz, 1H), 4.98 (dd, J = 9.8, 9.8 Hz, 
1H), 4.87-4.80 (m, 3H), 4.53 (dd, J = 7.8, 7.8 Hz, 1H), 4.10-4.07 (m, 1H), 3.92 (ddd, J = 





11.0, 2.0 Hz, 1H), 3.37 (s, 3H), 2.92 (ddd, J = 16.8, 8.7, 8.7 Hz, 1H), 2.61-2.42 (m, 2H), 
2.06 (s, 3H), 2.01 (s, 3H), 1.99 (s, 3H), 1.02 (s, 9H), 0.97 (s, 9H); 13C NMR (100 MHz, 
CHCl3) δ 174.7, 170.2, 170.1, 169.5, 97.7, 96.5, 80.8, 75.6, 70.8, 70.1, 69.1, 67.9, 66.3, 
65.6, 63.9, 55.3, 41.0, 30.9, 27.4, 26.9, 22.7, 20.73, 20.69, 20.65, 19.9; HRMS m/z calcd 
for C29H47O14Si [M+H]+ 647.2735, found: 647.2732; 3.38b(β) (20 mg, 14%): Rf 0.32 
(50% EtOAc/hexanes); 1H NMR (400 MHz, CHCl3) δ 5.45 (dd, J = 9.6, 9.6 Hz, 1H), 
4.99-4.87 (m, 2H), 4.80 (dd, J = 10.2, 3.8 Hz, 1H), 4.73 (d, J = 3.1 Hz, 1H), 4.51 (dd, J = 
7.8, 7.8 Hz, 1H), 4.17-4.11 (m, 2H), 3.90-3.82 (m, 3H), 3.47-3.34 (m, 2H), 3.37 (s, 3H), 
2.92 (dddd, J = 8.7, 8.7, 8.7, 3.1, Hz, 1H), 2.67-2.60 (m, 1H), 2.53 (dd, J = 17.8, 9.3 Hz, 
1H), 2.05 (s, 3H), 2.01 (s, 3H), 1.99 (s, 3H), 1.03 (s, 9H), 0.97 (s, 9H); 13C NMR (100 
MHz, CHCl3) δ 175.1, 170.1, 170.0, 169.8, 99.2, 96.5, 81.9, 75.4, 70.9, 69.9, 69.1, 69.0, 
68.2, 67.2, 66.5, 55.3, 39.4, 30.3, 29.7, 27.4, 27.0, 22.8, 20.69, 20.68, 19.8;  HRMS m/z 












tetraoxa-8-sila-pentaleno[1,6-ab]naphthalene-2-one (4.31). To a solution of 2.5a (92 
mg, 0.28 mmol) in CH2Cl2 (3.5 mL) at rt was added TiCl4 (45 µL, 0.40 mmol, 1.5 eq). 
The mixture was stirred at rt for 2.0-2.5 h until TLC indicated complete consumption of 
starting material. To the dark brown solution was added 1-phenyl-vinyl-tert-butyl-





stirred for 2 min and then poured into saturated aqueous NaHCO3 (2 mL). After stirring 
for 10 min the organic layer was separated and the aqueous layer was extracted with 
CH2Cl2 (3 × 4 mL). The combined organic solution was washed with H2O (2 × 3 mL), 
brine (3 mL) and dried (MgSO4). After filtration through a small pad of celite, volatiles 
were removed under reduced pressure. Purification of the residue by flash 
chromatography on silica gel with 100:1 hexanes-EtOAc for elution gave the title 
compound as a colorless syrup (123 mg, 77%): Rf 0.72 (20% EtOAc/hexanes); IR (thin 
film) ν 1775 cm-1; 1H NMR (400 MHz, CHCl3) δ 7.39-7.26 (m, 5H), 4.54-4.45 (m, 2H), 
4.20-4.17 (m, 1H), 3.99-3.91 (m, 3H), 3.33 (ddd, J = 13.7, 8.2, 5.5 Hz, 1H), 3.22 (d, J = 
8.2 Hz, 1H), 2.96 (dd, J = 12.0, 5.8 Hz, 1H), 2.20 (dd, J = 12.5, 12.5 Hz, 1H), 1.05 (s, 
9H), 1.00 (s, 9 H), 0.94 (s, 9H), -0.01 (s, 3H), -0.18 (s, 3H); 13C NMR (100 MHz, CHCl3) 
δ 172.0, 141.2, 127.6, 127.3, 125.8, 85.2, 80.6, 78.0, 73.4, 71.7, 67.0, 55.9, 47.0, 45.5, 
27.7, 27.3, 26.4, 23.1, 20.2, 18.6, -1.8, -2.2; HRMS m/z calcd for C30H49NO5Si2 [M+H]+ 














pentaleno[1,6-ab]naphthalen-2-one (4.33). To a solution of 2.5a (155 mg, 0.48 mmol) 
and the imine 4.32 (329 mg, 1.68 mmol, 3.5 eq) in CH2Cl2 (8.0 mL) at rt was added 





indicated complete consumption of starting material. The resulting dark solution was 
poured into a vigorously stirred saturated aqueous NaHCO3 (15 mL).  After 3 min the 
mixture was extracted with CH2Cl2 (3 × 10 mL).  The combined organic extracts were 
washed with H2O (2 × 5 mL), brine (5 mL) and dried (MgSO4). After filtration through a 
small pad of celite, volatiles were removed under reduced pressure. Purification of the 
residue by flash chromatography on silica gel with 8:1 hexanes-EtOAc for elution gave 
the title product as a pale yellow syrup (201 mg, 82%): Rf 0.53 (50% EtOAc/hexanes); 1H 
NMR (300 MHz, CHCl3) δ 7.25-7.23 (m, 4H), 7.14-7.12 (m, 2H), 6.99-6.96 (m, 4H), 
4.92 (d, J = 8.7 Hz, 1H), 4.78 (d, J = 3.6 Hz, 1H), 4.74 (d, J = 3.6 Hz, 1H), 4.67 (d, J = 
9.3 Hz, 1H), 4.64 (t, J = 3.9 Hz, 1H), 4.23 (dd, J = 6.9, 4.2 Hz, 1H), 4.16-4.07 (m, 2H), 
4.01 (t, J = 9.9 Hz, 1H), 3.79 (d, J = 14.1 Hz, 1H), 3.65 (d, J = 14.1 Hz, 1H), 3.40-3.29 
(m, 2H), 1.07 (s, 9H), 1.00 (s, 9H); 13C NMR (75 MHz, CHCl3) δ 194.0, 137.9, 135.4, 
129.0, 128.3, 127.9, 127.7, 126.7, 88.1, 81.4, 77.7, 72.7, 68.0, 67.0, 49.9, 44.9, 43.4, 27.4, 












cyclopenta[a]naphthalen-2-one (4.35). To a solution of cyclopropane 2.5a (226 mg, 0.69 
mmol) in Et2O (10 mL) at rt was added TiCl4 (121 µL, 1.7 eq). The mixture was stirred at 
rt for about 2.5-3.0 h until TLC indicated complete consumption of starting material. To 





immediately. The resulting mixture was stirred for 30 min and then poured into saturated 
aqueous NaHCO3 (10 mL). After stirring for 10 min the organic layer was separated and 
the aqueous layer was extracted with Et2O (2 × 15 mL). The combined organic solution 
was washed with H2O (2 × 8 mL), brine (8 mL) and dried (MgSO4). After filtration 
through a small pad of celite, volatiles were removed under reduced pressure. To the 
resulting residue was added MeOH (10 mL) followed with triflic acid (114 µL × 3 M in 
Et2O, 0.5 eq). After stirring at rt for 2.0 h, the resulting solution was poured into saturated 
aqueous NaHCO3 (8 mL). The mixture was extracted with Et2O (3× 12 mL) and the 
combined organic solution was washed with H2O (2 × 8 mL), brine (8 mL) and dried 
(MgSO4). After filtration through a small pad of celite, volatiles were removed under 
reduced pressure. Purification of the residue by flash chromatography on silica gel with 
4:1 hexanes-EtOAc for elution gave the title compound as a colorless syrup (173 mg, 
76%): Rf 0.62 (33% EtOAc/hexanes); 1H NMR (400 MHz, CHCl3) δ 7.36-7.30 (m, 4H), 
7.30-7.27 (m, 1H), 5.36 (dd, J = 5.5, 3.5 Hz, 1H), 4.46 (d, J = 7.2, 6.8 Hz, 1H), 4.37 (dd, 
J = 10.8, 7.2 Hz, 1H), 4.10 (t, J = 4.8 Hz, 1H), 4.09 (t, J = 7.2 Hz, 1H), 3.78 (t, J = 10.0 
Hz, 1H), 3.52 (ddd, J = 10.0, 10.0, 4.8 Hz, 1H), 3.23 (s, 3H), 3.01-2.95 (m, 2H), 2.81 
(ddd, J = 8.4, 5.2, 3.6 Hz, 1H), 1.03 (s, 9H), 0.96 (s, 9H); 13C NMR (100 MHz, CHCl3) δ 
177.6, 141.1, 129.0, 128.2, 125.7, 99.7, 82.1, 74.9, 72.7, 69.4, 67.4, 55.7, 50.0, 39.4, 27.7, 















sila-pentaleno[1,6-ab]naphthalen-2-one (4.36a). To a solution of 2.5a (184 mg, 0.57 
mmol) in CH2Cl2 (4 mL) at rt was added acetonitrile (370 µL, 3.7 mmol, 5.0 eq) and 
TMSOTf (110 µL, 0.74 mmol, 1.0 eq) sequentially. The resulting solution was stirred at 
rt for about 5 min and then poured into a vigorously stirred saturated aqueous NaHCO3 (8 
mL).  After 3 min the mixture was extracted with Et2O (3 × 5 mL).  The combined 
organic extracts were washed with H2O (2 × 3 mL), brine (3 mL) and dried (MgSO4). 
After filtration through a small pad of celite, volatiles were removed under reduced 
pressure. Purification by flash chromatography on silica gel with 1:1 hexanes-EtOAc for 
elution gave the title compound as a colorless syrup (174 mg, 84%): Rf 0.48 (67% 
EtOAc/hexanes); IR (thin film) ν 1767, 1654 cm-1; 1H NMR (400 MHz, CHCl3) δ 5.81 
(dd, J = 3.2, 1.0 Hz, 1H), 4.68 (dd, J = 9.9, 6.1 Hz, 1H), 4.19 (dd, J = 10.6, 5.2 Hz, 1H), 
3.92 (ddd, J = 10.2, 10.2, 6.2 Hz, 2H), 3.88-3.83 (m, 1H), 3.54 (ddd, J = 10.2, 10.2, 5.2 
Hz, 2H), 2.23 (d, J = 1.4 Hz, 3H), 1.02 (s, 9H), 0.97 (s, 9H); 13C NMR (100 MHz, 
CHCl3) δ 171.4, 169.8, 100.2, 82.3, 75.5, 69.8, 66.5, 59.4, 38.9, 27.7, 27.2, 23.0, 20.2, 











sila-pentalen-2-one (4.36b). The title compound was prepared from 2.5a according to 





equivalents of benzonitrile were used. Purification by flash chromatography on silica gel 
with 4:1 hexanes-EtOAc for elution gave the title compound as a pale yellow syrup (258 
mg, 81%): Rf 0.55 (50% EtOAc/hexanes); IR (thin film) ν 1763, 1705, 1612, 1577 cm-1; 
1H NMR (300 MHz, CHCl3) δ 8.15 (d, J = 7.2, 2H), 7.52-7.41 (m, 3H), 6.02 (d, J = 7.0 
Hz, 1H), 4.75 (dd, J = 10.1, 5.6 Hz, 1H), 4.53 (d, J = 10.2 Hz, 1H), 4.27 (dd, J = 10.2, 
5.0, 1H), 4.03 (dd J = 10.1, 5.6 Hz, 1H), 3.95 (dd, J = 10.1 Hz, 1H), 3.76-3.58 (m, 2H), 
1.00 (s, 9H), 0.98 (s, 9H); 13C NMR (100 MHz, CHCl3) δ 185.1, 171.0, 132.2, 129.9, 
128.5, 99.9, 81.8, 75.4, 70.4, 66.7, 55.9, 39.6, 27.3, 26.9, 22.6, 19.8; HRMS m/z calcd for 











sila-pentaleno[1,6-ab]naphthalene-2-one (4.36c). The title compound was prepared 
from 2.5a according to the general procedure described above for the preparation of 
4.36a, except that 10 equivalents of n-butyronitrile was used. Purification by flash 
chromatography on silica gel with 4:1 hexanes-EtOAc for elution gave the title 
compound as a colorless syrup (188 mg, 95%): Rf 0.45 (50% EtOAc/hexanes); IR (thin 
film) ν 1767, 1644 cm-1; 1H NMR (400 MHz, CHCl3) δ 5.81 (dd, J = 6.9, 0.7 Hz, 1H), 
4.65 (dd, J = 10.3, 6.4 Hz, 1H), 4.18 (dd, J = 10.3, 5.1 Hz, 1H), 3.93-3.84 (m, 3H), 3.57-
3.50 (m, 2H), 2.62-2.54 (m, 1H), 2.46-2.38 (m, 1H), 1.76-1.59 (m, 3H), 0.99 (s, 9H), 0.94 





100.2, 82.1, 75.4, 70.0, 66.6, 58.3, 38.5, 33.1, 27.3, 26.9, 22.6, 19.8, 19.2, 13.7; HRMS 











pentaleno[1,6-ab]naphthalene-2-one 4.36d). The title compound was prepared from 
2.5a according to the general procedure described above for the preparation of 4.36a, 
except that 5.0 equivalents of trimethylacetonitrile was used. Purification by flash 
chromatography on silica gel with 4:1 hexanes-EtOAc for elution gave the title 
compound as a pale yellow syrup (175 mg, 79%): Rf 0.48 (50% EtOAc/hexanes); IR (thin 
film) ν 1767, 1629 cm-1; 1H NMR (400 MHz, CHCl3) δ 5.76 (d, J = 3.5 Hz, 1H), 4.56 
(dd, J = 9.6, 7.2 Hz, 1H), 4.18 (dd, J = 10.2, 5.0 Hz, 1H), 4.00 (d, J = 9.6 Hz, 1H), 3.94-
3.85 (m, 2H), 3.64-3.56 (m, 2H), 1.28 (s, 9H), 0.99 (s, 9H), 0.95 (s, 9H); 13C NMR (100 
MHz, CHCl3) δ 178.6, 172.1, 98.9, 80.4, 74.9, 71.0, 67.0, 56.0, 40.1, 37.2, 28.4, 27.3, 















tetraoxa-4-aza-8-sila-pentaleno[1,6-ab]naphthalen-2-one (4.36e). The title compound 
was prepared from 2.5a according to the general procedure described above for the 
preparation of 4.36a, except that 7.0 equivalents of 4-chlorobutyronitrile was used. 
Purification by flash chromatography on silica gel with 1:1 hexanes-EtOAc for elution 
gave the title compound as a pale yellow syrup (137 mg, 87%): Rf 0.31 (50% 
EtOAc/hexanes); IR (thin film) ν 1770, 1649 cm-1; 1H NMR (400 MHz, CHCl3) δ 5.84 
(d, J = 7.2 Hz, 1H), 4.71 (dd, J = 10.3, 5.8 Hz, 1H), 4.20 (dd, J = 10.6, 5.1 Hz, 1H), 3.93 
(dd, J = 10.3, 5.8 Hz, 1H), 3.89 (dd, J = 16.0, 10.2 Hz, 2H), 3.66-3.50 (m, 4H), 2.83 (ddd, 
J = 17.5, 7.2, 7.2 Hz, 1H), 2.66-2.57 (m, 1H), 2.27-2.08 (m, 2H), 1.01 (s, 9H), 0.96 (s, 
9H); 13C NMR (100 MHz, CHCl3) δ 171.8, 171.4, 100.4, 82.5, 75.5, 70.0, 66.6, 58.8, 
44.1, 38.4, 28.4, 28.2, 27.3, 26.9, 22.6, 19.8; HRMS m/z calcd for C20H33NO5SiCl 










sila-pentaleno[1,6-ab]naphthalen-2-one (4.36f). The title compound was prepared from 
2.5a according to the general procedure described above for the preparation of 4.36a, 
except that nitromethane was used as solvent and 8.0 equivalents of cinnamonitrile was 





2:1 hexanes-EtOAc for elution gave the title product as a white solid (199 mg, 60%): Rf 
0.63(50% EtOAc/hexanes); IR (thin film) ν 1767, 1708, 1639 cm-1; 1H NMR (400 MHz, 
CHCl3) δ 7.77 (d, J = 16.8 Hz, 1H), 7.54 (d, J = 2.4 Hz, 1H), 7.53 (s, 1H), 7.39-7.32 (m, 
3H), 7.00 (d, J = 16.8 Hz, 1H), 5.92 (d, J = 7.2 Hz, 1H), 4.71 (dd, J = 10.0, 6.4 Hz, 1H), 
4.26 (d, J = 9.6 Hz, 1H), 4.23 (dd, J = 10.0, 5.0 Hz, 1H), 3.99 (dd, J = 10.4, 6.0 Hz, 1H), 
3.92 (dd, J = 10.0, 10.0 Hz, 1H), 3.69-3.58 (m, 2H), 1.00 (s, 9H), 0.97 (s, 9H); 13C NMR 
(100 MHz, CHCl3) δ 171.5, 166.6, 144.4, 135.1, 130.0, 128.9, 127.9, 120.1, 99.6, 81.8, 
75.4, 70.2, 66.7, 56.0, 39.1, 27.3, 26.9, 22.6, 19.8; HRMS m/z calcd for C25H34NO5Si 













2aH-1,5,7,9-tetraoxa-4-aza-8-sila-pentaleno[1,6-ab]naphthalen-2-one (4.36g). The 
title compound was prepared from 2.5a according to the general procedure described 
above for the preparation of 4.36a, except that nitromethane was used as solvent and 6.0 
equivalents of 3,4-dimethoxycinnamonitrile was employed. Purification by flash 
chromatography on silica gel with 3:1 hexanes-EtOAc for elution gave the title 
compound as a pale yellow syrup (141 mg, 75%): Rf 0.36(66% EtOAc/hexanes); IR (thin 
film) ν 1766, 1735, 1712, 1629 cm-1; 1H NMR (300 MHz, CHCl3) δ 7.71 (d, J = 16.5 Hz, 





8.1 Hz, 1H), 5.90 (d, J = 6.6 Hz, 1H), 4.70 (dd, J = 9.9, 6.6 Hz, 1H), 4.26-4.20 (m, 2H), 
4.10-3.91 (m, 2H), 3.89 (s, 6H), 3.70-3.56 (m, 2H), 1.00 (s, 9H), 0.97 (s, 9H); 13C NMR 
(75 MHz, CHCl3) δ 171.6, 150.9, 149.2, 144.3, 128.2, 122.3, 118.1, 111.0, 109.4, 99.5, 
81.8, 75.3, 70.3, 66.7, 55.94, 55.86, 39.2, 29.7, 29.2, 27.3, 26.9, 22.6, 19.8; HRMS m/z 












sila-pentaleno[1,6-ab]naphthalen-3-yl)-acetaldehyde (4.36h). The title compound was 
prepared from 2.5a according to the general procedure described above for the 
preparation of 4.36a, except that 9.0 equivalents of 3-methoxyacryloitrile was used. 
Purification by flash chromatography on silica gel with 2:1 to 1:1 hexanes-EtOAc for 
elution gave the title compound as a colorless syrup (151 mg, 78%): Rf 0.37 (50% 
EtOAc/hexanes); IR (thin film) ν 1774, 1711, 1649, 1618 cm-1; 1H NMR (300 MHz, 
CHCl3) δ 9.70 (s, br, 1H), 9.24 (d, J = 2.1 Hz, 1H), 5.63 (d, J = 6.6 Hz, 1H), 5.54 (s, 1H), 
4.78 (dd, J = 9.9, 5.6 Hz, 1H), 4.14 (ddd, J = 9.9, 9.9, 5.1 Hz, 2H), 3.85 (ddd, J = 10.2, 
10.2, 10.2 Hz, 2H), 3.59-3.47 (m, 2H), 1.01 (s, 9H), 0.96 (s, 9H); 13C NMR (75 MHz, 
CHCl3) δ 189.0, 171.4, 156.2, 93.2, 88.4, 82.1, 74.8, 70.0, 66.7, 49.2, 37.5, 27.3, 26.9, 











Acetic acid 5-(di-tert-butyl-fluoro-silanyloxy)-2-oxo-hexahydro-1,3-dioxa-cyclopropa 
[cd] inden-4-ylmethyl ester (4.40). To a solution of the 2.27 (2.70 g, 7.8 mmol) in 
CH2Cl2 (12 mL) was added pyridine (1.65 mL, 19.5 mmol) and Ac2O (2.97 mL, 31.5 
mmol). After 15 h at rt the mixture was poured into a vigorously stirred saturated 
NaHCO3 solution (10 mL).  The organic layer was separated and the aqueous solution 
was extracted with CH2Cl2 (2 × 8 mL). The combined organic solution was washed with 
saturated NH4Cl (15 mL), H2O (2 × 8 mL), brine (5 mL), dried (MgSO4) and filtered 
through celite. Volatile components were removed under reduced pressure, and the 
residual syrup was purified by flash chromatography on silica gel using 10:1 hexanes-
EtOAc for elution to provide the title compound as a pale yellow syrup (2.69 g, 89%): Rf 
0.38 (33% EtOAc/hexanes); IR (thin film) ν 1766, 1747 cm-1; 1H NMR (400 MHz, 
CHCl3) δ 4.86 (dd, J = 5.7, 1.5 Hz, 1H), 4.38 (dd, J = 12.3, 2.7 Hz, 1H), 4.18 (dd, J = 6.2, 
6.2 Hz, 1H), 4.13 (dd, J = 6.5, 1.4 Hz, 1H), 4.02 (dd, J = 12.3, 6.8 Hz, 1H), 3.64 (ddd, J = 
6.5, 6.5, 2.7 Hz, 1H), 2.53 (ddd, J = 6.0, 6.0, 6.0 Hz, 1H), 2.34 (dd, J = 6.2, 6.2 Hz, 1H), 
2.06 (s, 3H), 1.04 (s, 9H), 1.02 (s, 9H); 13C NMR (100 MHz, CHCl3) δ 171.8, 170.7, 
78.7, 75.8, 67.7, 63.8, 54.2, 26.8, 26.4, 20.8, 20.7, 20.1 (J = 16.8 Hz), 19.9 (J = 16.8 Hz); 
19F NMR (300 MHz, CHCl3) δ–159.8; HRMS m/z calcd for C18H30O6FSi [M+H]+ 















hexahydro-1,5-dioxa-4-aza-cyclopenta[cd]inden-6-ylmethyl ester (4.41). The title 
compound was prepared from 4.40 according to the general procedure described above 
for the preparation of 4.36a, except that 10.0 equivalents of acetonitrile was used and the 
reaction mixture was stirred for 10 h before quenched with saturated aqueous NaHCO3 
solution. Purification by flash chromatography on silica gel with 3:1 hexanes-EtOAc for 
elution gave the title compound as a pale yellow syrup (217 mg, 92%): Rf 0.42 (66% 
EtOAc/hexanes); IR (thin film) ν 1774, 1747, 1645 cm-1; 1H NMR (300 MHz, CHCl3) δ 
5.69 (dd, J = 5.6, 0.8 Hz, 1H), 4.84 (dd, J = 7.6, 2.8 Hz, 1H), 4.39 (dd, J = 5.4, 2.8 Hz, 
1H), 4.26 (dd, J = 12.1, 4.2 Hz, 1H), 4.18 (dd, J = 11.8, 5.9 Hz, 1H), 3.80 (dd, J = 9.4, 
4.7 Hz, 2H), 3.24 (ddd, J = 7.6, 7.2, 5.6 Hz, 1H), 2.32 (s, 3H), 2.05 (s, 3H), 1.04 (s, 18H); 
13C NMR (75 MHz, CHCl3) δ 175.8, 170.8, 170.7, 98.6, 79.2, 77.2, 66.9, 64.0, 57.6, 39.7, 
26.9, 26.8, 20.8, 20.2 (J = 14.2 Hz), 20.0 (J = 16.8 Hz), 19.0; 19F NMR (300 MHz, 














(4.42). To a rt solution of 2.5a  (1.85 g, 5.7 mmol) in THF (11 mL) was added 20% HF-
py (2.2 mL, 4.0 mmol). The resulting mixture was stirred for 10 min and the resulting 
solution was filtered through a small pad of silica gel and celite sequentially. Removal of 
the volatiles under reduced pressure afforded a pale yellow syrup. The crude product was 
dissolved in DMF (10 mL) and the solution was slowly added over 20 min to a mixture 
of NaH (680 mg, 17.1 mmol), tetrabutylammonium iodide (420 mg, 1.1 mmol) and 
benzyl bromide (2.05 mL, 17.1 mmol) in DMF (25 mL) maintained at 0 °C. The resulting 
mixture was allowed to warm to rt and after 30 min the reaction mixture was poured into 
a saturated aqueous NH4Cl solution (25 mL). The resulting mixture was extracted with 
Et2O (4 × 20 mL), the combined organic layer was washed with H2O (3 × 20 mL), brine 
(15 mL) and dried (MgSO4). After filtration through a small pad of celite, the solvent was 
removed under reduced pressure. Purification of the residue by flash chromatography on 
silica gel with 2:1 hexanes-EtOAc for elution gave the title compound as a colorless 
syrup (1.70 g, 82%): Rf 0.65 (33% EtOAc/hexanes); IR (thin film) ν 1774 cm-1; 1H NMR 
(400 MHz, CHCl3) δ 7.37-7.24 (m, 10H), 4.88 (dd, J = 5.4, 1.4 Hz, 1H), 4.62 (d, J = 12.0 
Hz, 1H), 4.52 (d, J = 12.0 Hz, 1H), 4.50 (dd, J = 11.8, 2.2 Hz, 2H), 4.17 (dd, J = 6.4, 6.4 
Hz, 1H), 3.71 (ddd, J = 6.4, 6.4, 4.4 Hz, 1H), 3.51 (dd, J = 7.0, 1.0 Hz, 1H), 3.46 (d, J = 
2.2 Hz, 1H), 3.44 (s, 1H), 2.54 (ddd, J = 6.0, 6.0, 6.0 Hz, 1H), 2.33 (dd, J = 6.4, 6.4 Hz, 
1H); 13C NMR (100 MHz, CHCl3) δ 171.5, 137.8, 137.0, 128.6, 128.4, 128.2, 128.0, 
127.8, 127.7, 78.1, 73.4, 73.3, 73.2, 72.4, 70.6, 54.5, 26.6, 21.3;  HRMS m/z calcd for 
















aza-cyclopenta[cd]inden-2-one (4.43). The title compound was prepared from 4.42 
according to the general procedure described above for the preparation of 4.36a, except 
that acetonitrile was used as solvent. Purification by flash chromatography on silica gel 
with 1:1 hexanes-EtOAc for elution gave the title product as a colorless syrup (225 mg, 
90%): Rf 0.24 (50% EtOAc/hexanes); IR (thin film) ν 1770, 1635 cm-1; 1H NMR (400 
MHz, CHCl3) δ 7.34-7.22 (m, 10H), 5.72 (d, J = 5.6 Hz, 1H), 4.86 (dd, J = 8.4, 2.4 Hz, 
1H), 4.62 (d, J = 11.6 Hz, 1H), 4.53-4.50 (m, 3H), 3.82-2.73 (m, 3H), 3.59 (d, J = 4.4 Hz, 
2H), 3.27 (ddd, J = 8.4, 8.4, 6.4 Hz, 1H), 2.30 (s, 3H); 13C NMR (75 MHz, CHCl3) δ 
174.4, 171.2, 138.0, 137.0, 128.5, 128.4, 128.1, 128.0, 127.8, 127.7, 99.4, 78.8, 76.1, 
73.5, 72.6, 72.2, 70.2, 58.1, 39.5, 18.7; HRMS m/z calcd for C24H26NO5 [M+H]+: 














according to the general procedure described above for the preparation of 4.36a, except 
that acetonitrile was used as solvent. Purification by flash chromatography on silica gel 
with 2:1 to 1:1 hexanes-EtOAc for elution gave the title compound as a pale yellow syrup 
(151 mg, 96%): Rf 0.25(66% EtOAc/hexanes); IR (thin film) ν 1758, 1649 cm-1; 1H 
NMR (300 MHz, CHCl3) δ 5.63 (dd, J = 6.1, 1.0 Hz, 1H), 4.89 (ddd, J = 8.1, 7.1, 5.5 Hz, 
1H), 3.77 (d, J = 9.0 Hz, 1H), 3.35 (ddd, J = 10.2, 6.1, 5.1 Hz, 1H), 3.13  (ddd, J = 8.6, 
8.6, 6.4 Hz, 1H), 2.25 (d, J = 0.8 Hz, 3H), 2.00 (ddd, J = 12.1, 6.9, 5.1 Hz, 1H), 1.80-1.68 
(m, 2H), 0.94 (d, J = 6.9 Hz, 3H), 0.87 (d, J = 6.9 Hz, 3H); 13C NMR (75 MHz, CHCl3) δ 
172.0, 171.9, 99.9, 76.7, 75.2, 58.6, 39.1, 33.5, 28.7, 18.5, 18.1, 17.7; HRMS m/z calcd 









cyclopenta[cd]inden-2-one (4.44b). The title compound was prepared from 2.9 
according to the general procedure described above for the preparation of 4.36a, except 
that 9.5 equivalents of benzonitrile was used. Purification by flash chromatography on 
silica gel with 2:1 hexanes-EtOAc for elution gave the title compound as white solid (180 
mg, 92%): Rf 0.59(50% EtOAc/hexanes); IR (thin film) ν 1743, 1610 cm-1; 1H NMR 
(300 MHz, CHCl3) δ 8.16-8.13 (m, 2H), 7.48-7.40 (m, 3H), 5.76 (d, J = 6.3 Hz, 1H), 4.95 





1H), 3.24  (ddd, J = 14.7, 7.5, 6.0 Hz, 1H), 2.01-1.86 (m, 2H), 1.79 (dddd, J = 12.6, 6.3, 
6.3, 6.3 Hz, 1H), 0.96 (d, J = 6.9 Hz, 3H), 0.91(d, J = 6.9 Hz, 3H); 13C NMR (75 MHz, 
CHCl3) δ 171.7, 170.5, 132.0, 131.4, 129.8, 128.4, 99.1, 77.0, 74.8, 55.1, 40.3, 33.5, 27.7, 











furo[2,3-b]pyrrole-4-carboxylic acid ethyl ester (4.46). The title compound was 
prepared from 4.45120 according to the general procedure described above for the 
preparation of 4.36a, except acetonitrile was used as solvent and the reaction mixture was 
stirred for 1 min before washing with saturated aqueous NaHCO3 solution. Purification 
by flash chromatography on silica gel with 1:15:100 Et3N-Et2O-hexanes for elution gave 
the title compound as a pale yellow syrup (191 mg, 43%): Rf 0.35 (20% EtOAc/hexanes); 
IR (thin film) ν 1735, 1665, 1599 cm-1;  1H NMR (400 MHz, CHCl3) δ 7.36-7.25 (m, 
5H), 5.74 (d, J = 7.6 Hz, 1H), 4.92 (s, 1H), 4.80 (d, J = 12.0 Hz, 1H), 4.62 (d, J = 12.0 
Hz, 1H), 4.39 (ddd, J = 6.0, 6.0, 6.0 Hz, 1H), 4.17-4.11 (m, 3H), 4.05 (dd, J = 8.4, 6.4 
Hz, 1H), 3.96 (dd, J = 8.0, 6.4 Hz, 1H), 3.85 (dd, J = 6.0, 3.2 Hz, 1H), 3.80 (dd, J = 7.2, 
0.8 Hz, 1H), 2.18 (d, J = 0.8 Hz, 3H), 1.40 (s, 3H), 1.34 (s, 3H), 1.26 (dd, J = 6.8, 6.8 Hz, 





90.9, 83.4, 80.8, 73.3, 71.2, 66.8, 58.9, 53.6, 26.6, 25.2, 14.6, 14.1; HRMS m/z calcd for 
C22H29NO6 M+ 403.1995, found: 403.1995. 
 
General Procedure for DA Cyclopropane Preparation (4.52a -i). To a solution of the 
corresponding enol ether (10 mmol) and bis(N-tert-butylsalicylaldiminato)copper(II) 
Cu(TBS)2 2.4 (0.5 mmol) in CH2Cl2 (10 mL) at reflux was slowly added a CH2Cl2 (20 
mL) solution of ethyl diazoacetate (1.5 g, 13 mmol) via syringe pump over 8 hours. After 
the addition the resulting mixture was stirred for 3 h and the volatiles were removed 
under reduced pressure. The crude products were purified by chromatography on silica 
using appropriate combination of hexanes-EtOAc for elution. 
 
General Procedure A for Pyrrole Synthesis (Nitrile as solvent) To a solution of the 
DA cyclopropane (1.0 mmol) in the nitrile (2.5 mL) at –40 °C was added TMSOTf (1.0 
mmol). The resulting solution was stirred at –40 °C for 10 h and then poured into a 
vigorously stirred solution of saturated aqueous NaHCO3 (10 mL). The heterogeneous 
mixture was extracted with Et2O (3 × 6 mL), and the combined organic extracts were 
washed with H2O (2 × 2 mL), brine (3 mL) and dried (MgSO4). After filtration through a 
small pad of celite, volatiles were removed under reduced pressure. The product was 
purified by chromatography on silica using appropriate combination hexanes-EtOAc for 
elution. 
 
General Procedure B for Pyrrole Synthesis. To a solution of the cyclopropane (1.0 
mmol) and the nitrile (10 mmol, 10 eq) in CH3NO2 or C2H5NO2  (2 mL) at –30 °C were 





into a vigorously stirred solution of saturated aqueous NaHCO3 (10 mL) and worked up 
as described in procedure A. 
 
General Procedure C for Pyrrole Synthesis. To a solution of the cyclopropane (1.0 
mmol) and the nitrile (10 mmol) in CH2Cl2 (2.0 mL) at rt was added TMSOTf (1.0 
mmol). The resulting mixture was stirred at rt for 5 h and then poured into a vigorously 
stirred solution of saturated aqueous NaHCO3 (10 mL). After 2 min the organic layer was 
separated and the aqueous layer was extracted with CH2Cl2 (2 × 6 mL). The combined 
organic solution was washed with H2O (2 × 3 mL) and the volatiles were removed under 
reduced pressure. The residue was dissolved in THF (6 mL) and treated with 5% aqueous 
HCl (1 mL) until complete consumption of the [3+2] cycloaddition intermediate (TLC). 
After extraction with CH2Cl2 (8 mL), the aqueous layer was treated with NaHCO3 (1 mL) 
and extracted with CH2Cl2 (2 × 4 mL). The combined organic extracts were washed with 
H2O (2 × 3 mL), brine (3 mL) and dried (MgSO4). After filtration through a small pad of 
celite, volatiles were removed under reduced pressure. Purification of the residue by flash 
chromatography on silica gel with appropriate combination of hexanes-EtOAc for elution 






2-Methyl-1H-pyrrole-3-carboxylic acid ethyl ester (4.53a). The title compound was 
prepared from 4.52a  and acetonitrile according to general procedure A for pyrrole 





hexanes-EtOAc for elution gave the title compound as a colorless syrup (245 mg, 
80%):173 Rf 0.47 (20% EtOAc/hexanes); IR (thin film) ν 3286, 1674 cm-1; 1H NMR (300 
MHz, CHCl3) δ 8.51 (s, br, 1H), 6.54 (s, 1H), 6.53 (s, 1H), 4.25 (q, J = 7.1 Hz, 2H), 2.50 
(s, 3H), 1.32 (t, J = 7.1 Hz, 3H); 13C NMR (75 MHz, CHCl3) δ 165.8, 135.2, 115.8, 







2-Propyl-1H-pyrrole-3-carboxylic acid ethyl ester (4.53b). The title compound was 
prepared from 4.52a  and n-butyronitrile (8.0 eq)  according to general procedure A for 
pyrrole synthesis  (–40 °C, 8 h). Purification by flash chromatography on silica gel with 
15:1 hexanes-EtOAc for elution gave the title compound as a colorless syrup (279 mg, 
77%):174 Rf 0.52 (20% EtOAc/hexanes); IR (thin film) ν 3310, 1674 cm-1; 1H NMR (400 
MHz, CHCl3) δ 8.57 (s, br, 1H), 6.55 (s, 1H), 6.54 (s, 1H), 4.24 (q, J = 7.2 Hz, 2H), 2.89 
(t, J = 7.6 Hz, 2H), 1.65 (qt, J = 7.6, 7.6 Hz, 2H), 1.32 (t, J = 7.6 Hz, 3H), 0.92 (t, J = 7.6 
Hz, 3H); 13C NMR (100 MHz, CHCl3) δ 165.7, 139.8, 115.8, 111.2, 110.4, 59.3, 29.2, 










2-Phenyl-1H-pyrrole-3-carboxylic acid ethyl ester (4.53c). The title compound was 
prepared from 4.52a  and benzonitrile (5.0 eq) in C2H5NO2 according to general 
procedure B  for pyrrole synthesis (–55 °C, 8 h). Purification by flash chromatography on 
silica gel with 15:1 hexanes-EtOAc for elution gave the title compound as a colorless 
solid (150 mg, 35%):175 Rf 0.35 (20% EtOAc/hexanes); IR (thin film) ν 3306, 1682 cm-1; 
1H NMR (400 MHz, CHCl3) δ 8.56 (s, br, 1H), 7.56-7.53 (m, 2H), 7.39-7.33 (m, 3H), 
6.72 (d, J = 2.8 Hz, 1H), 6.71 (d, J = 2.8 Hz, 1H), 4.17 (q, J = 7.2 Hz, 2H), 1.23 (t, J = 
7.2 Hz, 3H); 13C NMR (100 MHz, CHCl3) δ 165.0, 137.0, 132.1, 128.9, 128.2, 128.1, 








2-(4-methoxy-phenyl-1H-pyrrole-3-carboxylic acid ethyl ester (4.53d). The title 
compound was prepared from 4.52a  and 4-methoxybenzonitrile (5.0 eq) according to 
general procedure B  for pyrrole synthesis (–40 °C, 8 h). Purification by flash 
chromatography on silica gel with 5:1 hexanes-EtOAc for elution gave the title 
compound as a pale yellow syrup (271 mg, 55%): Rf 0.35 (20% EtOAc/hexanes); IR (thin 
film) ν 3309, 1682, 1615 cm-1; 1H NMR (300 MHz, CHCl3) δ 8.67 (s, br, 1H), 7.47 (d, J 
= 2.1 Hz, 1H), 7.45 (d, J = 2.1 Hz, 1H), 6.88 (d, J = 2.1 Hz, 1H), 6.85 (d, J = 2.1 Hz, 1H), 
6.68 (dd, J = 3.0, 3.0 Hz, 1H), 6.37 (dd, J =3.0, 3.0 Hz, 1H), 4.15 (q, J = 7.2 Hz, 2H), 





130.2, 124.5, 117.3, 113.4, 111.8, 111.4, 59.5, 55.2, 14.2; HRMS m/z calcd for 









2-[2-(3,4-Dimethoxy-phenyl)-vinyl]-1H-pyrrole-3-carboxylic acid ethyl ester (4.53e). 
The title compound was prepared from 4.52a  and 3,4-dimethoxycinnamonitrile (5.0 eq) 
according to general procedure B  for pyrrole synthesis (–40 °C, 8 h). Purification by 
flash chromatography on silica gel with 4:1 hexanes-EtOAc for elution gave the title 
compound as a colorless solid (512 mg, 85%): Rf 0.65 (50% EtOAc/hexanes); IR (thin 
film) ν 3340, 1693, 1670 cm-1; 1H NMR (400 MHz, CHCl3) δ 9.10 (s, br, 1H), 7.70 (d, J 
= 16.8 Hz, 1H), 6.99 (d, J = 1.6 Hz, 1H), 6.93 (dd, J = 8.0, 2.0 Hz, 1H), 6.77 (d, J = 8.8 
Hz, 1H), 6.74 (d, J = 14.4 Hz, 1H), 6.68 (dd, J = 2.8, 2.8 Hz, 1H), 6.63 (d, J = 2.8 Hz, 
1H), 4.30 (q, J = 7.2 Hz, 2H), 3.841 (s, 3H), 3.838 (s, 3H), 1.36 (t, J = 7.2 Hz, 3H); 13C 
NMR (100 MHz, CHCl3) δ 165.4, 149.03, 148.99, 135.1, 129.9, 127.3, 120.1, 118.4, 
116.0, 113.2, 111.6, 111.1, 108.3, 59.7, 55.8, 55.7, 14.4; HRMS m/z calcd for C17H20NO4 











2-Styryl-1H-pyrrole-3-carboxylic acid ethyl ester (4.53f). The title compound was 
prepared from 4.52a  and cinnamonitrile (5.0 eq) according to general procedure B  for 
pyrrole synthesis (–50 °C, 8 h). Purification by flash chromatography on silica gel with 
4:1 hexanes-EtOAc for elution gave the title compound as a pale yellow syrup (188 mg, 
39%): Rf 0.52 (50% EtOAc/hexanes); IR (thin film) ν 3324, 1670 cm-1; 1H NMR (400 
MHz, CHCl3) δ 8.89 (s, br, 1H), 7.87 (d, J = 17.2 Hz, 1H), 7.47 (d, J = 7.2 Hz, 2H), 7.33 
(ddd, J = 7.2, 7.2, 1.6 Hz, 2H), 7.25 (tdd, J = 7.2, 1.6, 1.6 Hz, 1H), 6.80 (d, J = 17.2 Hz, 
1H), 6.73 (dd, J = 2.8, 2.8 Hz, 1H), 6.67 (dd, J = 2.8, 2.8 Hz, 1H), 4.33 (q, J = 7.2 Hz, 
2H), 1.39 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CHCl3) δ 165.1, 136.8, 134.7, 128.7, 
127.8, 127.2, 126.4, 118.5, 118.0, 113.8, 111.8, 59.8, 14.5; HRMS m/z calcd for 









4-(2-Hydroxy-ethyl)-2-methyl-1H-pyrrole-3-carboxylic acid ethyl ester (4.54a). The 
title compound was prepared from 4.52b and acetonitrile according to general procedure 
A for pyrrole synthesis  (–40 °C, 12 h). Purification by flash chromatography on silica gel 
with 2:1 hexanes-EtOAc for elution gave the title compound as a colorless syrup (121 
mg, 72%): Rf 0.55 (66% EtOAc/hexanes); IR (thin film) ν 3450-3100, 1666 cm-1; 1H 
NMR (300 MHz, CHCl3) δ 8.60 (s, br, 1H), 6.35 (d, J = 2.1 Hz, 1H), 4.25 (q, J = 6.9 Hz, 
2H), 3.60 (t, J = 6.0 Hz, 2H), 2.76 (t, J = 7.2 Hz, 2H), 2.58 (s, br, 1H), 2.44 (s, 3H), 1.79 





136.2, 126.1, 114.5, 110.3, 62.2, 59.6, 34.3, 22.6, 14.7, 14.6; HRMS m/z calcd for 









4-(3-Hydroxy-propyl)-2-propyl-1H-pyrrole-3-carboxylic acid ethyl ester (4.54b). The 
title compound was prepared from 4.52b and n-butyronitrile (8.0 eq) according to general 
procedure B  for pyrrole synthesis (–40 °C, 8 h). Purification by flash chromatography on 
silica gel with 10:1 to 1:3 hexanes-EtOAc for elution gave the title compound as a 
colorless solid (272 mg, 78%): Rf 0.50 (66% EtOAc/hexanes); IR (thin film) ν 3380-
3100, 1670 cm-1; 1H NMR (400 MHz, CHCl3) δ 8.64 (s, br, 1H), 6.36 (d, J = 2.0 Hz, 1H), 
4.23 (q, J = 7.2 Hz, 2H), 3.60 (t, J = 6.0 Hz, 2H), 2.81 (t, J = 7.6 Hz, 2H), 2.77 (t, J = 7.2 
Hz, 2H), 2.67 (s, br, 1H), 1.80 (tt, J = 6.8, 6.8 Hz, 2H), 1.60 (qt, J = 7.6, 7.6 Hz, 2H), 
1.31 (t, J = 7.2 Hz, 3H), 0.90 (t, J = 7.6 Hz, 3H); 13C NMR (100 MHz, CHCl3) δ 166.5, 
140.4, 125.7, 114.3, 109.5, 61.8, 59.2, 33.9, 30.2, 22.8, 22.3, 14.3, 13.9; HRMS m/z calcd 








4-(3-Hydroxy-propyl)-2-phenyl-1H-pyrrole-3-carboxylic acid ethyl ester (4.54c). The 





procedure B  for pyrrole synthesis (–40 °C, 8 h). Purification by flash chromatography on 
silica gel with 2:1 hexanes-EtOAc for elution gave the title compound as a colorless 
syrup (207 mg, 58%): Rf 0.34 (50% EtOAc/hexanes); IR (thin film) ν 3305, 1678 cm-1; 
1H NMR (400 MHz, CHCl3) δ 8.50 (s, br, 1H), 7.46-7.44 (m, 2H), 7.39-7.33 (m, 3H), 
6.59 (d, J = 1.6 Hz, 1H), 4.13 (q, J = 7.2 Hz, 2H), 3.66 (t, J = 6.0 Hz, 2H), 2.84 (t, J = 7.2 
Hz, 2H), 2.44 (s, br, 1H), 1.86  (tt, J = 6.8, 6.8 Hz, 2H), 1.11 (t, J = 7.2 Hz, 3H); 13C 
NMR (100 MHz, CHCl3) δ 166.0, 137.5, 133.1, 129.1, 127.94, 127.89, 126.7, 116.4, 








2-(3-Chloro-propyl)-4-(3-hydroxy-propyl)-1H-pyrrole-3-carboxylic acid ethyl ester 
 (4.54d). The title compound was prepared from 4.52b and 4-chlorobutyronitrile (15 eq) 
according to general procedure B  for pyrrole synthesis (–40 °C, 8 h). Purification by 
flash chromatography on silica gel with 2:1 hexanes-EtOAc for elution gave the title 
compound as a colorless syrup (204 mg, 61%): Rf 0.31 (50% EtOAc/hexanes); IR (thin 
film) ν 3332, 1666 cm-1; 1H NMR (300 MHz, CHCl3) δ 8.28 (s, br, 1H), 6.41 (d, J = 2.4 
Hz, 1H), 4.26 (q, J = 7.2 Hz, 2H), 3.61 (t, J = 6.0 Hz, 2H), 3.48 (t, J = 6.3 Hz, 2H), 3.03 
(t, J = 7.2 Hz, 2H), 2.77 (t, J = 7.2 Hz, 2H), 2.08 (tt, J = 6.6, 6.6 Hz, 2H), 1.81 (tt, J = 6.6, 
6.6 Hz, 2H), 1.66 (s, br, 1H), 1.32 (t, J = 7.2 Hz, 3H); 13C NMR (75 MHz, CHCl3) δ 
166.0, 138.2, 126.1, 114.7, 110.1, 62.0, 59.4, 44.6, 33.9, 32.0, 25.3, 22.4, 14.4; HRMS 












4-(2-Hydroxy-ethyl)-2-methyl-1H-pyrrole-3-carboxylic acid ethyl ester (4.54e). The 
title compound was prepared from 4.52c and acetonitrile according to general procedure 
A (–40 °C, 10 h). Purification by flash chromatography on silica gel with 3:1 hexanes-
EtOAc for elution gave the title compound as a colorless syrup (167 mg, 52%): (167 mg, 
52%): Rf 0.41 (50% EtOAc/hexanes); IR (thin film) ν 3440-3200, 1670 cm-1; 1H NMR 
(400 MHz, CHCl3) δ 8.67 (s, br, 1H), 6.37 (d, J = 2.4 Hz, 1H), 4.26 (q, J = 7.2 Hz, 2H), 
3.79 (t, J = 6.1 Hz, 2H), 2.94 (t, J = 6.1 Hz, 2H), 2.45 (s, 3H), 2.32 (s, br, 1H), 1.33 (t, J = 
7.2 Hz, 3H); 13C NMR (100 MHz, CHCl3) δ 166.6, 136.4, 122.4, 115.3, 110.1, 63.6, 59.3, 









4-(2-Hydroxy-ethyl)-2-propyl-1H-pyrrole-3-carboxylic acid ethyl ester (4.54f). The 
title compound was prepared from 4.52c and n-butyronitrile (15 eq) in nitroethane 
according to general procedure B  for pyrrole synthesis (–40 °C, 10 h). Purification by 





compound as white solid (189 mg, 58%): Rf 0.55 (50% EtOAc/hexanes); IR (thin film) ν 
3380-3150, 1666 cm-1; 1H NMR (400 MHz, CHCl3) δ 8.47 (s, br, 1H), 6.42 (d, J = 2.4 
Hz, 1H), 4.24 (q, J = 7.2 Hz, 2H), 3.77 (t, J = 6.0 Hz, 2H), 2.93 (t, J = 5.6 Hz, 2H), 2.81 
(t, J = 7.6 Hz, 2H), 2.44 (s, br, 1H), 1.61 (tq, J = 7.6, 7.6 Hz, 2H), 1.31 (t, J = 7.2 Hz, 
3H), 0.92 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CHCl3) δ 166.4, 140.9, 122.5, 115.3, 
109.7, 63.6, 59.4, 30.2, 29.9, 22.7, 14.3, 13.9; HRMS m/z calcd for C12H20NO3 [M+H]+ 









4-(2-Hydroxy-ethyl)-2-(2-methoxy-vinyl)-1H-pyrrole-3-carboxylic acid ethyl ester 
(4.54g). The title compound was prepared from 4.52c and 3-methoxyacrylonitrile (5.0 eq) 
in nitroethane according to general procedure B  for pyrrole synthesis (–40 °C, 10 h). 
Purification by flash chromatography on silica gel with 4:1 hexanes-EtOAc for elution 
gave the title compound as a pale yellow syrup (482 mg, 81%): Rf 0.35 (50% 
EtOAc/hexanes); IR (thin film) ν 3420-3250, 1647 cm-1; 1H NMR (400 MHz, CHCl3) δ 
9.56 (s, br, 0.5H), 9.20 (s, br, 0.5H), 6.94 (d, J = 12.0 Hz, 0.5H), 6.52 (d, J = 2.4 Hz, 
0.5H), 6.41 (d, J = 13.2 Hz, 0.5H), 6.30 (d, J = 2.0 Hz, 0.5H), 6.19 (d, J = 6.8 Hz, 0.5H), 
6.12 (d, J = 6.8 Hz, 0.5H), 4.23 (q, J = 7.2 Hz, 1H), 4.22 (q, J = 7.2 Hz, 1H), 3.77 (s, 
1.5H), 3.74 (q, J = 7.2 Hz, 2H), 3.61 (s, 1.5H), 2.92 (t, J = 6.4 Hz, 1H), 2.88 (t, J = 6.4 
Hz, 1H), 2.56 (s, br, 1H), 1.31 (t, J = 7.2 Hz, 3H), 1.30 (t, J = 7.2 Hz, 1.5H);  NMR (100 





109.3, 109.2, 96.8, 63.4, 63.3, 60.8, 59.4, 59.5, 56.0, 29.94, 29.89, 14.3, 14.1; HRMS m/z 









4-(2-Hydroxy-ethyl)-2,5-dimethyl-1H-pyrrole-3-carboxylic acid ethyl ester (4.54h). 
The title compound was prepared from 4.52d and acetonitrile according to general 
procedure A for pyrrole synthesis  (–15 °C, 6 h). Purification by flash chromatography on 
silica gel with 2:1 hexanes-EtOAc for elution gave the title compound as a colorless solid 
(87 mg, 31%): Rf 0.22 (50% EtOAc/hexanes); IR (thin film) ν 3380-3240, 1654 cm-1; 1H 
NMR (300 MHz, CHCl3) δ 7.96 (s, br, 1H), 4.24 (q, J = 7.2 Hz, 2H), 3.74 (t, J = 6.3 Hz, 
2H), 2.87 (t, J = 6.3 Hz, 2H), 2.41 (s, 3H), 2.12 (s, 3H), 2.10 (s, br, 1H), 1.31 (t, J = 7.2 
Hz, 3H); 13C NMR (75 MHz, CHCl3) δ 166.9, 134.0, 123.5, 117.2, 110.5, 63.8, 59.4, 









4-(2-Hydroxy-ethyl)-5-methyl-2-propyl-1H-pyrrole-3-carboxylic acid ethyl ester 
(4.54i). The title compound was prepared from 4.52d and n-butylronitrile (5.0 eq)  in 





Purification by flash chromatography on silica gel with 2:1 hexanes-EtOAc for elution 
gave the title compound as a colorless solid (77 mg, 25%): Rf 0.25 (50% 
EtOAc/hexanes); IR (thin film) ν 3400-3280, 1666 cm-1; 1H NMR (400 MHz, CHCl3) δ 
7.98 (s, br, 1H), 4.24 (q, J = 7.2 Hz, 2H), 3.73 (t, J = 6.4 Hz, 2H), 2.87 (t, J = 6.4 Hz, 
2H), 2.78 (t, J = 7.6 Hz, 2H), 2.62 (s, br, 1H), 2.12 (s, 3H), 1.60 (qt, J = 7.6 Hz, 2H), 1.31 
(t, J = 7.6 Hz, 3H), 0.93 (dd, J = 7.6, 7.6 Hz, 3H); 13C NMR (100 MHz, CHCl3) δ 166.7, 
138.5, 123.5, 117.2, 110.0, 63.8, 59.3, 30.1, 28.3, 23.0, 14.3, 14.0, 10.7; HRMS m/z calcd 









4-Ethyl-2-methyl-5-propyl-1H-pyrrole-3-carboxylic acid ethyl ester (4.54j). The title 
compound was prepared from 4.52e and acetonitrile according to general procedure A for 
pyrrole synthesis  (rt, 10 min). Purification by flash chromatography on silica gel with 
30:1 hexanes-EtOAc for elution gave the title compound as a colorless solid (415 mg, 
93%): Rf 0.45 (25% EtOAc/hexanes); IR (thin film) ν 3320, 1666 cm-1; 1H NMR (400 
MHz, CHCl3) δ 7.79 (s, br, 1H), 4.24 (q, J = 7.2 Hz, 2H), 2.60 (ddd, J = 7.2, 7.2, 7.2 Hz, 
2H), 2.44 (s, 3H), 2.44 (t, J = 7.2 Hz, 2H), 1.53 (q, J = 7.2 Hz, 2H), 1.32 (t, J = 7.2 Hz, 
3H), 1.08 (t J = 7.2 Hz, 3H), 0.92 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CHCl3) δ 
166.2, 133.8, 126.4, 122.8, 109.8, 58.9, 27.2, 23.5, 18.5, 16.3, 14.4, 14.0, 13.8; HRMS 













4-Ethyl-2, 5-dipropyl-1H-pyrrole-3-carboxylic acid ethyl ester (4.54k). The title 
compound was prepared from 4.52e and n-butyronitrile (10 eq) in nitromethane 
according to general procedure B  for pyrrole synthesis (–10 °C, 10 h). ). Purification by 
flash chromatography on silica gel with 30:1 hexanes-EtOAc for elution gave the title 
compound as a colorless solid (411 mg, 82%): Rf 0.52 (25% EtOAc/hexanes); IR (thin 
film) ν 3327, 1662 cm-1; 1H NMR (400 MHz, CHCl3) δ 7.93 (s, br, 1H), 4.24 (q, J = 7.2 
Hz, 2H), 2.82 (t, J = 7.6 Hz, 2H), 2.61 (q, J = 7.2 Hz, 2H), 2.44 (t, J = 7.2 Hz, 2H), 1.61 
(qt, J = 7.6, 7.6 Hz, 2H), 1.53 (qt, J = 7.6, 7.6 Hz, 2H), 1.31 (t, J = 7.2 Hz, 3H), 1.08 (t, J 
= 7.6 Hz, 3H), 0.92 (t, J = 7.2 Hz, 3H), 0.90 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, 
CHCl3) δ 166.1, 138.4, 126.4, 122.7, 109.2, 58.8, 30.0, 27.2, 23.5, 22.9, 18.5, 16.5, 14.3, 









4-Ethyl-2-phenyl-5-propyl-1H-pyrrole-3-carboxylic acid ethyl ester (4.54l). The title 
compound was prepared from 4.52e and benzonitrile (10 eq) in nitromethane according 
to general procedure B  for pyrrole synthesis (–10 °C, 10 h). Purification by flash 





compound as a colorless solid (469 mg, 76%): Rf 0.45 (25% EtOAc/hexanes); IR (thin 
film) ν 3312, 1674, 1608 cm-1; 1H NMR (400 MHz, CHCl3) δ 8.22 (s, br, 1H), 7.47-7.45 
(m, 2H), 7.36-7.26 (m, 3H), 4.14 (q, J = 7.2 Hz, 2H), 2.71 (q, J = 7.2 Hz, 2H), 2.54 (t, J = 
7.2 Hz, 2H), 1.61 (qt, J = 7.2, 7.2 Hz, 2H), 1.18 (t, J = 7.2 Hz, 3H), 1.16 (t, J = 7.2 Hz, 
3H), 0.97 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CHCl3) δ 165.8, 135.2, 133.2, 129.0, 
128.8, 127.8, 127.4, 123.9, 110.5, 59.2, 27.2, 23.3, 18.4, 16.3, 13.9, 13.8; HRMS m/z 









5-Ethyl-2,4-dimethyl-1H-pyrrole-3-carboxylic acid ethyl ester (4.54m). The title 
compound was prepared from 4.52f and acetonitrile according to general procedure A for 
pyrrole synthesis  (rt, 2 h). Purification by flash chromatography on silica gel with 30:1 
hexanes-EtOAc for elution gave the title compound as a colorless solid (360 mg, 98%): 
Rf 0.48 (25% EtOAc/hexanes); IR (thin film) ν 3317, 1666 cm-1; 1H NMR (400 MHz, 
CHCl3) δ 8.52 (s, br, 1H), 4.26 (q, J = 7.2 Hz, 2H), 2.50 (q, J = 7.6 Hz, 2H), 2.45 (s, 3H), 
2.17 (s, 3H), 1.33 (t, J = 7.2 Hz, 3H), 1.13 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, 













5-Ethyl-4-methyl-2-propyl-1H-pyrrole-3-carboxylic acid ethyl ester (4.54n). The title 
compound was prepared from 4.52f and n-butyronitrile (10 eq) in nitromethane according 
to general procedure B  for pyrrole synthesis (–10 °C, 10 h). Purification by flash 
chromatography on silica gel with 30:1 hexanes-EtOAc for elution gave the title 
compound as a colorless solid  (436 mg, 85%): Rf 0.53 (25% EtOAc/hexanes); IR (thin 
film) ν 3328, 1662 cm-1; 1H NMR (400 MHz, CHCl3) δ 7.86 (s, br, 1H), 4.23 (q, J = 7.2 
Hz, 2H), 2.81 (t, J = 7.6 Hz, 2H), 2.49 (q, J = 7.6 Hz, 2H), 2.14 (s, 3H), 1.61 (q, J = 7.6 
Hz, 2H), 1.31 (t, J = 7.2 Hz, 3H), 1.12 (t, J = 7.6 Hz, 3H), 0.92 (t, J = 7.6 Hz, 3H); 13C 
NMR (100 MHz, CHCl3) δ 166.3, 138.1, 128.1, 115.2, 110.2, 58.9, 30.0, 23.0, 18.5, 14.4, 







2,5-Dimethyl-1H-pyrrole-3-carboxylic acid ethyl ester (4.54o). The title compound 
was prepared from 4.52g and acetonitrile (10 eq) in nitroethane according to general 
procedure B  for pyrrole synthesis (–10 °C, 9 h). Purification by flash chromatography on 
silica gel with 10:1 hexanes-EtOAc for elution gave the title compound as a colorless 
syrup (162 mg, 62%): Rf 0.71 (50% EtOAc/hexanes); IR (thin film) ν 3297, 1670 cm-1; 
1H NMR (400 MHz, CHCl3) δ 8.00 (s, br, 1H), 6.18 (dd, J = 1.2, 1.2 Hz, 1H), 4.22 (q, J = 
7.2 Hz, 2H), 2.45 (s, 3H), 2.17 (s, 3H), 1.30 (t, J =7.2 Hz, 3H); 13C NMR (100 MHz, 











5-Methyl-2-propyl-1H-pyrrole-3-carboxylic acid ethyl ester (4.54p). The title 
compound was prepared from 4.52g and n-butyronitrile (10 eq) in nitroethane according 
to general procedure B  for pyrrole synthesis (–10 °C, 9 h). Purification by flash 
chromatography on silica gel with 15:1 hexanes-EtOAc for elution gave the title 
compound as a colorless solid (171 mg, 55%): Rf 0.56 (30% EtOAc/hexanes); IR (thin 
film) ν 3309, 1674 cm-1; 1H NMR (400 MHz, CHCl3) δ 8.27 (s, br, 1H), 6.18 (dd, J = 1.0, 
1.0 Hz, 1H), 4.22 (q, J = 7.2 Hz, 2H), 2.84 (t, J = 7.2 Hz, 2H), 2.17 (s, 3H), 1.61 (dq, J = 
7.2, 7.2 Hz, 2H), 1.30 (t, J = 7.2 Hz, 3H), 0.92 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, 








2-Methyl-4,5,6,7-tetrahydro-1H-indole-3-carboxylic acid ethyl ester (4.54q). The title 
compound was prepared from 4.52h with acetonitrile according to general procedure A 
for pyrrole synthesis  (–40 °C, 10 h). Purification by flash chromatography on silica gel 
with 15:1 hexanes-EtOAc for elution gave the title compound as a colorless solid (166 
mg, 72%):176 Rf 0.60 (20% EtOAc/hexanes); IR (thin film) ν 3340, 1662 cm-1; 1H NMR 





2.46 (s, 3H), 2.46 (t, J = 6.0 Hz, 2H), 1.76-1.69 (m, 4H), 1.30 (t, J = 7.2 Hz, 3H); 13C 
NMR (100 MHz, CHCl3) δ 166.4, 134.1, 125.3, 118.6, 109.5, 58.9, 23.5, 23.3, 22.9, 22.4, 










2-Propyl-4,5,6,7-tetrahydro-1H-indole-3-carboxylic acid ethyl ester (4.54r). The title 
compound was prepared from 4.52h with n-butyronitrile according to general procedure 
A for pyrrole synthesis  (–40 °C, 10 h). Purification by flash chromatography on silica gel 
with 15:1 hexanes-EtOAc for elution gave the title compound as a colorless solid (98 mg, 
75%): Rf 0.65 (20% EtOAc/hexanes); IR (thin film) ν 3330, 1670 cm-1; 1H NMR (400 
MHz, CHCl3) δ 7.78 (s, br, 1H), 4.22 (q, J = 6.8 Hz, 2H), 2.84 (t, J = 7.8 Hz, 2H), 2.68 
(td, J = 6.0, 1.4 Hz, 2H), 2.47 (td, J = 6.0, 1.4 Hz, 2H), 1.79-1.68 (m, 4H), 1.61 (qt, J = 
7.5, 7.5 Hz, 2H), 1.30 (t, J = 7.2 Hz, 3H), 0.94 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, 
CHCl3) δ166.2, 138.8, 129.7, 125.4, 118.5, 58.8, 29.6, 23.4, 23.2, 23.0, 22.9, 22.4, 14.4, 











methyl-1H-pyrrole-3-carboxylic acid ethyl ester (4.55a). The title compound was 
prepared from the corresponding cyclopropane and acetonitrile according to general 





silica gel with 15:1 hexanes-EtOAc for elution gave the title compound as a colorless 
syrup (165 mg, 87%): Rf 0.53 (25% EtOAc/hexanes); IR (thin film) ν 3420-3260, 1666 
cm-1; 1H NMR (400 MHz, CHCl3) δ 8.25 (s, br, 1H), 7.31-7.25 (m, 5H), 6.75 (d, J = 2.4 
Hz, 1H), 5.57 (d, J = 3.6 Hz, 1H), 4.64 (d, J = 12.0 Hz, 1H), 4.40 (d, J = 11.6 Hz, 1H), 
4.19 (tt, J = 6.8, 6.8 Hz, 2H), 4.05 (ddd, J = 12.4, 8.8, 3.6 Hz, 1H), 3.95-3.89 (m, 1H), 
3.77 (dd, J = 10.0, 10.0 Hz, 1H), 3.09 (d, J = 3.2 Hz, 1H), 2.50 (s, 3H), 1.24 (t, J = 7.2 
Hz, 3H), 0.94 (s, 9H), 0.79 (s, 9H); 13C NMR (100 MHz, CHCl3) δ165.9, 138.5, 135.5, 
128.3, 127.7, 127.6, 122.1, 116.0, 111.4, 78.6, 75.3, 71.0, 68.2, 67.0, 59.3, 27.5, 26.6, 












 2-Methyl-4-(1,2,4-tris-benzyloxy-3-hydroxy-butyl)-1H-pyrrole-3-carboxylic acid 
ethyl ester (4.55b). The title compound was prepared from the corresponding 
cyclopropane and acetonitrile according to general procedure C for pyrrole synthesis (rt, 
3 h). Purification by flash chromatography on silica gel with 10:1 hexanes-EtOAc for 
elution gave the title compound as a colorless syrup (184 mg, 77%): Rf 0.53 (25% 
EtOAc/hexanes); IR (thin film) ν 3450-3180, 1662 cm-1; 1H NMR (300 MHz, CHCl3) δ 
8.25 (s, br, 1H), 7.24-7.02 (m, 15H), 6.73 (d, J = 2.4 Hz, 1H), 5.38 (d, J = 2.8 Hz, 1H), 





= 7.2 Hz, 2H), 4.02 (s, br, 1H), 3.90 (dd, J = 6.0, 2.8 Hz, 1H), 3.62 (dd, J = 7.2, 2.8 Hz, 
1H), 3.50 (dd, J = 7.2, 3.2 Hz, 1H), 2.68 (s, br, 1H), 2.49 (s, 3H), 1.22 (t, J = 7.2 Hz, 3H); 











2-Methyl-4-(1,2,4-triacetoxy-3-hydroxy-butyl)-1H-pyrrole-3-carboxylic acid ethyl 
ester (4.55c). The title compound was prepared from the corresponding cyclopropane 
and acetonitrile according to general procedure C for pyrrole synthesis (rt, 4 h). 
Purification by flash chromatography on silica gel with 2:1 hexanes-EtOAc for elution 
gave the title compound as a colorless solid (97 mg, 58%): Rf 0.45 (66% 
EtOAc/hexanes); IR (thin film) ν 3550-3180, 1740, 1715, 1705, 1673 cm-1; 1H NMR 
(400 MHz, CHCl3) δ 8.71 (s, br, 1H), 6.71 (d, J = 2.4 Hz, 1H), 6.52 (d, J = 1.6 Hz, 1H), 
5.37 (dd, J = 7.6, 3.2 Hz, 1H), 4.31-4.21 (m, 2H), 4.14-4.03 (m, 2H), 3.87 (s, br, 1H), 
3.49 (d, J = 6.0 Hz, 1H), 2.39 (s, 3H), 2.09 (s, 3H), 2.02 (s, 3H), 1.93 (s, 3H), 1.33 (t, J = 
7.2 Hz, 3H); 13C NMR (100 MHz, CHCl3) δ171.2, 171.0, 169.7, 165.3, 136.3, 121.2, 
115.1, 109.2, 73.4, 68.8, 68.5, 65.2, 59.7, 21.0, 20.8, 20.6, 14.4, 13.7; HRMS m/z calcd 

















furo[3,4-c]pyrrol-1-one (4.55d). The title compound was prepared from the 
corresponding cyclopropane and tert-butyronitrile (10 eq) in CH2Cl2 (3.0 mL) according 
to general procedure C for pyrrole synthesis (rt, 2 h). Purification by flash 
chromatography on silica gel with 4:1 hexanes-EtOAc for elution gave the title 
compound as a colorless syrup (96 mg, 87%): Rf 0.35 (50% EtOAc/hexanes); IR (thin 
film) ν 3650-3300, 1716 cm-1; 1H NMR (400 MHz, DMSO-D6) δ 11.17 (s, 1H), 6.50 (d, J 
= 2.1 Hz, 1H), 5.55-5.27 (m, 2H), 3.96 (dd, J = 9.9, 4.5 Hz, 1H), 3.86 (d, J = 9.2 Hz, 1H), 
3.77-3.70 (m, 1H), 3.64 (dd, J = 10.1, 10.1 Hz, 1H), 1.31 (s, 9H), 0.82 (s, 18 H); 13C 
NMR (100 MHz, DMSO-D6) δ 167.4, 141.2, 134.0, 111.3, 106.2, 79.8, 75.6, 69.2, 66.4, 


















The title compound was prepared from the corresponding cyclopropane and benzonitrile 
(10 eq) in CH2Cl2 (3.0 mL) according to general procedure C for pyrrole synthesis (rt, 2.5 
h). Purification by flash chromatography on silica gel with 3:1 hexanes-EtOAc for elution 
gave the title compound as a pale yellow syrup (119 mg, 85%): IR (thin film) ν 3550-
3080, 1717 cm-1; Rf 0.42 (50% EtOAc/hexanes); 1H NMR (400 MHz, CHCl3) δ 9.50 (s, 
br, 1H), 7.97 (d, J = 7.0, 2H), 7.41 (dd, J = 7.0, 7.0 Hz, 2H), 7.33-7.28 (m, 1H), 6.61 (s, 
1H), 5.82 (s, 1H), 4.18-4.09 (m, 3H), 3.91-3.78 (m, 2H), 0.94 (s, 9H), 0.90 (s, 9H); 














dihydro-furo[3,4-c]pyrrol-1-one (4.55f). The title compound was prepared from the 
corresponding cyclopropane and p-methoxybenzonitrile (5 eq) in CH2Cl2 (4.0 mL) 
according to general procedure C for pyrrole synthesis (rt, 2.5 h). Purification by flash 
chromatography on silica gel with 2:1 hexanes-EtOAc for elution gave the title 
compound as a pale yellow syrup (141 mg, 93%): Rf 0.24 (50% EtOAc/hexanes); IR (thin 
film) ν 3580-3200, 1619 cm-1; 1H NMR (400 MHz, CHCl3) δ 9.53 (s, br, 1H), 7.89 (dd, J 





(m, 4H), 3.85 (dd, J = 10.3, 10.3 Hz, 1H), 3.75 (s, 3H), 0.90 (s, 9H), 0.87 (s, 9H); 13C 
NMR (100 MHz, CHCl3) δ169.0, 159.5, 134.9, 130.9, 127.0, 122.7, 114.4, 111.8, 107.3, 
78.8, 68.7, 65.9, 55.3, 27.4, 27.3, 26.6, 22.7, 20.0; HRMS m/z calcd for C24H34NO6Si 









The title compound was prepared from 2.9 and benzonitrile (10 eq) in CH2Cl2 (3.0 mL) 
according to general procedure C for pyrrole synthesis (rt, 3 h). Purification by flash 
chromatography on silica gel with 1:1 hexanes-EtOAc for elution gave the title 
compound as a colorless solid (127 mg, 82%): Rf 0.35 (66% EtOAc/hexanes); IR (thin 
film) ν 3600-3220, 1713 cm-1; 1H NMR (400 MHz, acetone-d6) δ 11.4 (s, br, 1H), 8.18 
(dd, J = 6.8, 1.2 Hz, 2H), 7.43 (ddd, J = 8.0, 8.0, 2.0 Hz, 2H), 7.30 (tt, J = 7.2, 1.2 Hz, 
1H), 6.84 (dd, J = 1.2, 1.2 Hz, 1H), 5.62 (ddd, J = 9.6, 3.6, 1.2 Hz, 1H), 3.91 (d, J = 5.6 
Hz, 1H), 3.72 (qdd, J = 5.6, 5.6, 2.0 Hz, 1H), 1.90 (ddd, J = 14.0, 10.4, 4.8 Hz, 1H), 1.76 
(ddd, J = 14.0, 9.6, 2.4 Hz, 1H), 1.67 (ddqq, J = 1.6, 1.6, 6.8, 6.8 Hz, 1H), 0.93 (d, J = 1.2 
Hz, 3H), 0.92 (d, J = 1.2 Hz, 3H); 13C NMR (100 MHz, acetone-d6) δ167.4, 139.5, 131.4, 
130.5, 129.6, 128.5, 126.2, 113.1, 110.0, 76.2, 72.9, 42.1, 35.0, 30.5, 18.9, 17.6; HRMS 






Bipyrrole synthesis: General procedure A   
To a solution of cyclopropane (2.0 mmol) and 2-cyano-pyrrole (1.0 mmol) in CH3NO2 
(4.0 mL) at –25 0°C was added TMSOTf (1.5 mmol). The mixture was stirred at –25 °C 
for 0.5-4.0 h until TLC indicated complete consumption of starting 2-cyano-pyrrole. The 
resulting mixture was poured into saturated aqueous NaHCO3 (10 mL) with vigorous 
stirring. After 2 min the mixture was extracted with EtOAc (3 × 8 mL). The combined 
organic solution was washed with H2O (8 mL), brine (6 mL) and dried (MgSO4). After 
filtration through a small pad of celite, volatiles were removed under reduced pressure. 
The product was purified by chromatography on silica gel using appropriate combination 
of hexanes-EtOAc for elution. 
 
Thienylpyrrole synthesis: General procedure B 
To a solution of cyclopropane (2.0 mmol) and 2-thiophenecarbonitrile (1.0 mmol) in 
C2H5NO2 (4.0 mL) at –25 °C was added TMSOTf (1.5 mmol). The mixture was stirred at 
–25 °C for 0.5-1.5 h until TLC indicated complete consumption of starting 2-cyano-
thiophene and poured into a vigorously stirred solution of saturated aqueous NaHCO3 (10 






5-Methyl-1H,1’H-[2,2’]bipyrrolyl-3-caboxylic acid ethyl ester (4.57a). The title 





according to the general procedure A for bipyrrole synthesis (0 °C, CH3NO2, 25 min). 
Purification by flash chromatography on silica gel with 20:1 hexanes-EtOAc for elution 
gave the title compound as a colorless syrup (231 mg, 78%): Rf 0.61 (25% 
EtOAc/hexanes); IR (thin film) ν 3610-3130, 1670 cm-1; 1H NMR (400 MHz, CHCl3) δ 
12.11 (s, br, 1H), 8.39 (s, br, 1H), 6.85 (t, J = 2.0 Hz, 1H), 6.40 (td, J = 1.3, 1.3 Hz, 1H), 
6.29 (d, J = 2.0 Hz, 1H), 6.27-6.24 (m, 1H), 4.32 (q, J = 7.2 Hz, 2H), 2.22 (s, 3H), 1.38 
(t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CHCl3) δ 167.0, 130.6, 126.6, 124.1, 118.4, 
108.9, 108.6, 108.5, 104.2, 60.1, 14.3, 12.5; HRMS m/z calcd for C12H15N2O2 [M+H]+ 









3’,4’-Diethyl-5-methyl-1H,1’H-[2,2’]bipyrrolyl-3-caboxylic acid ethyl ester (4.58a). 
The title compound was prepared from cyclopropane 4.52g and 3,4-diethyl-1H-pyrrole-2-
carbonitrile 4.56b according to the general procedure A for bipyrrole synthesis (−10 °C, 
CH3NO2, 45 min). Purification by flash chromatography on silica gel with 20:1 hexanes-
EtOAc for elution gave the title compound as a colorless syrup (112 mg, 82%): Rf 0.56 
(15% EtOAc/hexanes); IR (thin film) ν 3450-3210, 1670 cm-1; 1H NMR (400 MHz, 
CHCl3) δ 11.83 (s, br, 1H), 8.28 (s, br, 1H), 6.63 (d, J = 2.7 Hz, 1H), 6.34 (dd, J = 1.0, 
1.0 Hz, 1H), 4.28 (q, J = 7.2 Hz, 2H), 2.71 (q, J = 7.5 Hz, 2H), 2.50 (q, J = 7.5 Hz, 2H), 
2.28 (s, 3H), 1.36 (t, J = 7.2 Hz, 3H), 1.26 (t, J = 7.5 Hz, 3H), 1.23 (t, J = 7.5 Hz, 3H); 





108.8, 60.0, 18.7, 18.1, 15.4, 14.9, 14.4, 12.8; HRMS m/z calcd for C16H23N2O2 [M+H]+ 






1H,1’H-[2,2’]Bipyrrolyl-3-caboxylic acid ethyl ester (4.57b). The title compound was 
prepared from cyclopropane 4.52a  and 1H-pyrrole-2-carbonitrile  4.56a according to the 
general procedure A for bipyrrole synthesis (−45 °C, C2H5NO2, 4.5 h). Purification by 
flash chromatography on silica gel with 20:1 hexanes-EtOAc for elution gave the title 
compound as a colorless syrup (130 mg, 41%): Rf 0.71 (25% EtOAc/hexanes); 1H NMR 
(400 MHz, CHCl3) δ 12.11 (s, br, 1H), 8.52 (s, br, 1H), 6.88-6.86 (m, 1H), 6.63 (t, J = 2.0 
Hz, 1H), 6.61 (t, J = 2.0 Hz, 1H), 6.42-6.41 (m, 1H), 6.26 (q, J = 2.0 Hz, 1H), 4.33 (q, J = 
7.2 Hz, 2H), 1.38 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CHCl3) δ 166.9, 131.5, 123.9, 
118.6, 116.6, 111.6, 109.1, 108.8, 104.7, 60.3, 14.4; HRMS m/z calcd for C11H13N2O2 








3’,4’-Diethyl-1H,1’H-[2,2’]bipyrrolyl-3-caboxylic acid ethyl ester (4.58b). The title 





carbonitrile 4.56b according to the general procedure A for bipyrrole synthesis (−40 °C, 
C2H5NO2, 3 h). Purification by flash chromatography on silica gel with 15:1 hexanes-
EtOAc for elution gave the title compound as a colorless syrup (147 mg, 45%): Rf 0.56 
(15% EtOAc/hexanes); IR (thin film) ν 3580-3050, 1670 cm-1; 1H NMR (400 MHz, 
CHCl3) δ 11.85 (s, br, 1H), 8.60 (s, br, 1H), 6.67 (d, J = 2.8 Hz, 2H), 6.63 (d, J = 2.4 Hz, 
1H), 4.30 (q, J = 7.5 Hz, 2H), 2.70 (q, J = 7.5 Hz, 2H), 2.49 (q, J = 7.5 Hz, 2H), 1.36 (t, J 
= 7.0 Hz, 3H), 1.24 (t, J = 7.5 Hz, 3H), 1.22 (t, J = 7.5 Hz, 3H); 13C NMR (100 MHz, 
CHCl3) δ 166.9, 132.4, 125.8, 121.3, 119.6, 116.2, 115.1, 111.7, 109.1, 60.2, 18.6, 18.1, 








5-Ethyl-4-methyl-1H,1’H-[2,2’]bipyrrolyl-3-caboxylic acid ethyl ester (4.57c). The 
title compound was prepared from cyclopropane 4.52f and 1H-pyrrole-2-carbonitrile  
4.56a according to the general procedure A for bipyrrole synthesis (−10 °C, CH3NO2, 45 
min). Purification by flash chromatography on silica gel with 20:1 hexanes-EtOAc for 
elution gave the title compound as a colorless syrup (231 mg, 82%): Rf 0.68 (25% 
EtOAc/hexanes); 1H NMR (400 MHz, CHCl3) δ 11.99 (s, br, 1H), 8.13 (s, br, 1H), 6.83 
(ddd, J = 5.6, 3.2, 3.2 Hz, 1H), 6.36-6.34 (m, 1H), 6.23 (dd, J = 6.2, 2.6 Hz, 1H), 4.31 (q, 
J = 7.2 Hz, 2H), 2.56 (q, J = 7.6 Hz, 2H), 2.16 (s, 3H), 1.37 (t, J = 7.2 Hz, 3H), 1.18 (t, J 





108.8, 108.6, 104.2, 60.0, 18.9, 14.4, 14.3, 11.6; HRMS m/z calcd for C14H19N2O2 









5,3’,4’-Triethyl-4-methyl-1H,1’H-[2,2’]bipyrrolyl-3-caboxylic acid ethyl ester 
(4.58c). The title compound was prepared from cyclopropane 4.52f and 3,4-diethyl-1H-
pyrrole-2-carbonitrile 4.56b according to the general procedure A for bipyrrole synthesis 
(0 °C, CH3NO2, 45 min). Purification by flash chromatography on silica gel with 20:1 
hexanes-EtOAc for elution gave the title compound as a colorless syrup (410 mg, 85%): 
Rf 0.51 (15% EtOAc/hexanes); 1H NMR (400 MHz, CHCl3) δ 11.19 (s, br, 1H), 8.18 (s, 
br, 1H), 6.59 (d, J = 2.4 Hz, 1H), 4.38 (q, J = 7.2 Hz, 2H), 2.66 (q, J = 7.5 Hz, 2H), 2.59 
(q, J = 7.5 Hz, 2H), 2.49 (q, J = 7.5 Hz, 2H), 2.17 (s, 3H), 1.35 (t, J = 7.2 Hz, 3H), 1.23 
(t, J = 7.2 Hz, 3H), 1.22 (t, J = 7.5 Hz, 3H), 1.20 (t, J = 7.5 Hz, 3H); 13C NMR (100 
MHz, CHCl3) δ 167.8, 130.3, 129.0, 125.5, 120.9, 120.1, 115.3, 114.4, 109.5, 59.9, 
18.63, 18.55, 18.2, 15.6, 14.8, 14.4, 13.8, 11.5; HRMS m/z calcd for C18H27N2O2 [M+H]+ 











4-Methyl-1H,1’H-[2,2’]bipyrrolyl-3-caboxylic acid ethyl ester (4.57d). The title 
compound was prepared from cyclopropane 4.52i and 1H-pyrrole-2-carbonitrile  4.56a 
according to the general procedure A for bipyrrole synthesis (−25 °C, CH3NO2, 45 min). 
Purification by flash chromatography on silica gel with 20:1 hexanes-EtOAc for elution 
gave the title compound as a colorless syrup (98 mg, 48%): Rf 0.52 (25% 
EtOAc/hexanes); 1H NMR (400 MHz, CHCl3) δ 12.06 (s, br, 1H), 8.34 (s, br, 1H), 6.85 
(dd, J = 4.0, 2.4 Hz, 1H), 6.42 (d, J = 1.2 Hz, 1H), 6.37 (dd, J = 3.2, 2.4 Hz, 1H), 6.25 
(dd, J = 6.0, 2.4 Hz, 1H), 4.33 (q, J = 7.2 Hz, 2H), 2.25 (s, 3H), 1.39 (t, J = 7.2 Hz, 3H); 
13C NMR (100 MHz, CHCl3) δ 167.9, 132.1, 124.3, 121.9, 118.3, 115.8, 108.9, 108.3, 







2-(1H-Pyrrol-2-yl)-4,5,6,7-tetrahydro-1H-indole-3-carboxylic acid ethyl ester 
(4.57e). The title compound was prepared from cyclopropane 4.52h and 1H-pyrrole-2-
carbonitrile  4.56a according to the general procedure A for bipyrrole synthesis (−10°C, 
CH3NO2, 45 min). Purification by flash chromatography on silica gel with 15:1 hexanes-
EtOAc for elution gave the title compound as a colorless syrup (162 mg, 62%): Rf 0.68 
(25% EtOAc/hexanes); IR (thin film) ν 3420-3180, 1660 cm-1; 1H NMR (400 MHz, 
CHCl3) δ 12.09 (s, br, 1H), 8.14 (s, br, 1H), 6.82 (dd, J = 2.0, 2.0 Hz, 1H), 6.33 (dd, J = 





Hz, 2H), 2.53 (t, J = 6.4 Hz, 2H), 1.81-1.71 (m, 4H), 1.36 (t, J = 7.2 Hz, 3H); 13C NMR 
(100 MHz, CHCl3) δ 168.0, 130.3, 126.8, 124.6, 119.2, 118.2, 108.8, 107.2, 104.2, 60.0, 









2-(3,4-Diethyl-1H-pyrrol-2-yl)-4,5,6,7-tetrahydro-1H-indole-3-carboxylic acid ethyl 
ester (4.58d). The title compound was prepared from cyclopropane 4.52h and 3,4-
diethyl-1H-pyrrole-2-carbonitrile 4.56b according to the general procedure A for 
bipyrrole synthesis (−35 °C, C2H5NO2, 45 min). Purification by flash chromatography on 
silica gel with 15:1 hexanes-EtOAc for elution gave the title compound as a colorless 
syrup (171 mg, 82%): Rf 0.68 (25% EtOAc/hexanes); IR (thin film) ν 3520-3180, 1665 
cm-1; 1H NMR (400 MHz, CHCl3) δ 11.56 (s, br, 1H), 8.13 (s, br, 1H), 6.60  (s, 1H), 4.27 
(q, J = 7.2 Hz, 2H), 2.75-2.69 (m, 2H), 2.68 (dq, J = 2.0, 7.6, Hz, 2H), 2.58-2.54 (m, 2H), 
2.49 (dq, J = 2.0, 7.6 Hz, 2H), 1.85-1.72 (m, 4H), 1.35 (td, J = 7.2, 2.0 Hz, 3H), 1.23 (t, J 
= 7.6 Hz, 6H); 13C NMR (100 MHz, CHCl3) δ 167.8, 130.9, 126.3, 125.5, 120.9, 120.0, 
118.9, 114.5, 107.9, 59.8, 23.9, 23.5, 22.7, 22.6, 18.6, 18.2, 15.6, 14.8, 14.4; HRMS m/z 











4-(3-Hydroxy-propyl)-1H-1’H-[2,2’]bipyrrolyl-3-carboxylic acid ethyl ester (4.57f). 
The title compound was prepared from cyclopropane 4.52b and 1H-pyrrole-2-carbonitrile  
4.56a according to the general procedure A for bipyrrole synthesis (−10 °C, CH3NO2, 25 
min). Purification by flash chromatography on silica gel with 5:1 hexanes-EtOAc for 
elution gave the title compound as a colorless syrup (231 mg, 46%): Rf 0.28 (50% 
EtOAc/hexanes); 1H NMR (400 MHz, CHCl3) δ 11.94 (s, br, 1H), 8.51 (s, br, 1H), 6.84 
(t, J = 1.2 Hz, 1H), 6.44 (s, 1H), 6.38 (d, J = 2.0 Hz, 1H), 6.25-6.23 (m, 1H), 4.32 (qd, J 
= 7.2, 2.0 Hz, 2H), 3.68 (td, J = 6.8, 2.0 Hz, 2H), 2.75 (t, J = 7.6 Hz, 2H), 1.84 (dq, J = 
6.8, 6.8 Hz, 2H), 1.53 (s, br, 1H), 1.37 (td, J = 7.2, 1.6 Hz, 3H); 13C NMR (100 MHz, 
CHCl3) δ 167.6, 132.4, 125.8, 124.2, 118.4, 115.6, 109.0, 107.6, 105.1, 62.6, 60.3, 33.4, 










3’,4’-Diethyl-4-(3-hydroxy-propyl)-1H-1’H-[2,2’]bipyrrolyl-3-carboxylic acid ethyl 
ester (4.58e). The title compound was prepared from cyclopropane 4.52b and 3,4-
diethyl-1H-pyrrole-2-carbonitrile 4.56b according to the general procedure A for 





silica gel with 3:1 hexanes-EtOAc for elution gave the title compound as a colorless 
syrup (76 mg, 54%): Rf 0.28 (50% EtOAc/hexanes); IR (thin film) ν 3580-3250, 1726 
cm-1; 1H NMR (400 MHz, CHCl3) δ 11.06 (s, br, 1H), 8.41 (s, br, 1H), 6.60 (d, J = 2.4 
Hz, 1H), 6.51 (d, J = 2.4 Hz, 1H), 4.27 (q, J = 7.2 Hz, 2H), 3.67 (q, J = 6.4 Hz, 2H), 2.77 
(q, J = 7.6 Hz, 2H), 2.63 (q, J = 7.6 Hz, 2H), 2.48 (q, J = 7.2 Hz, 2H), 1.88-1.81 (m, 3H), 
1.33 (t, J = 7.2 Hz, 3H), 1.21 (t, J = 7.6 Hz, 3H), 1.19 (t, J = 7.6 Hz, 3H); 13C NMR (100 
MHz, CHCl3) δ 167.4, 132.5, 125.64, 125.57, 121.7, 119.7, 115.3, 114.7, 108.8, 62.5, 
60.1, 33.5, 23.5, 18.4, 18.1, 15.8, 14.7, 14.2; HRMS m/z calcd for C18H27N2O3 [M+H]+ 












acid ethyl ester (4.58f). The title compound was prepared from cyclopropane 4.52d and 
3,4-diethyl-1H-pyrrole-2-carbonitrile 4.56b according to the general procedure A for 
bipyrrole synthesis (−25 °C, CH3NO2, 1.0 h). Purification by flash chromatography on 
silica gel with 3:1 hexanes-EtOAc for elution gave the title compound as a colorless 
syrup (151 mg, 84%): Rf 0.31 (50% EtOAc/hexanes); IR (thin film) ν 3500-3150, 1670 
cm-1; 1H NMR (400 MHz, CHCl3) δ 10.82 (s, br, 1H), 8.20 (s, br, 1H), 6.57 (d, J = 2.7 
Hz, 1H), 4.23 (q, J = 7.2 Hz, 2H), 3.74 (t, J = 6.4 Hz, 2H), 2.90 (t, J = 7.0 Hz, 2H), 2.61 
(t, J = 7.6 Hz, 2H), 2.47 (t, J = 7.6 Hz, 2H), 2.21 (s, 3H), 2.05 (s, br, 1H), 1.31 (t, J = 7.2 





167.1, 130.5, 125.5, 124.9, 121.5, 119.6, 116.6, 114.5, 109.3, 63.4, 60.0, 29.1, 18.4, 18.1, 











3’,4’-Diethyl-4-(2-hydroxy-ethyl)-1H-1’H-[2,2’]bipyrrolyl-3-carboxylic acid ethyl 
ester (4.58g). The title compound was prepared from cyclopropane 4.52c and 3,4-
diethyl-1H-pyrrole-2-carbonitrile 4.56b according to the general procedure A for 
bipyrrole synthesis (−40 °C, C2H5NO2, 1.0 h). Purification by flash chromatography on 
silica gel with 3:1 hexanes-EtOAc for elution gave the title compound as a colorless 
syrup (86 mg, 42%): Rf 0.45 (50% EtOAc/hexanes); 1H NMR (400 MHz, CHCl3) δ 11.13 
(s, br, 1H), 8.41 (s, br, 1H), 6.609 (s, 1H), 6.607 (s, 1H), 4.27 (dq, J = 2.0, 7.2 Hz, 2H), 
3.81 (t, J = 6.2 Hz, 2H), 2.97 (dt, J = 2.0, 6.2 Hz, 2H), 2.63 (tq, J = 2.0, 7.6 Hz, 2H), 2.47 
(dt, J = 2.0, 7.6 Hz, 2H), 1.33 (dt, J = 2.0, 7.6 Hz, 3H), 1.24-1.17 (m, 6H); 13C NMR (100 
MHz, CHCl3) δ 167.2, 133.1, 125.7, 122.0, 121.9, 119.5, 116.4, 114.9, 108.8, 63.0, 60.2, 









2-Thiophen-2-yl-1H-3-carboxylic acid ethyl ester (4.60a). The title compound was 
prepared from cyclopropane 4.52a  and 2-thiophenecarbonitrile 4.59 according to the 
general procedure B for thienylpyrrole synthesis (−30 °C, C2H5NO2, 3.5 h). Purification 
by flash chromatography on silica gel with 5:1 hexanes-EtOAc for elution gave the title 
compound as a colorless syrup (136 mg, 47%): Rf 0.51 (33% EtOAc/hexanes); 1H NMR 
(400 MHz, CHCl3) δ 8.56 (s, br, 1H), 7.50 (dd, J = 2.0, 1.2 Hz, 1H), 7.31 (dd, J = 5.0, 1.0 
Hz, 1H), 7.05 (dd, J = 5.2, 4.0 Hz, 1H), 6.72-6.70 (m, 2H), 4.25 (q, J = 7.2 Hz, 2H), 1.30 
(t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CHCl3) δ 164.7, 133.0, 130.1, 127.2, 127.1, 
125.9, 117.8, 112.6, 112.4, 59.8, 14.4; HRMS m/z calcd for C11H12NO2S [M+H]+ 







5-Methyl-2-thiophen-2-yl-1H-3-carboxylic acid ethyl ester (4.60b). The title 
compound was prepared from cyclopropane 4.52g and 2-thiophenecarbonitrile 4.59 
according to the general procedure B for thienylpyrrole synthesis (−15 °C, CH3NO2, 3.0 





elution gave the title compound as a colorless syrup (114 mg, 69%): Rf 0.46 (25% 
EtOAc/hexanes); IR (thin film) ν 3390-3240, 1675 cm-1; 1H NMR (400 MHz, CHCl3) δ 
8.39 (s, br, 1H), 7.46 (dd, J = 3.3, 1.0 Hz, 1H), 7.27 (dd, J = 4.8, 1.0 Hz, 1H), 7.02 (dd, J 
= 5.2, 4.0 Hz, 1H), 6.36 (dd, J = 1.0, 1.0 Hz, 1H), 4.23 (q, J = 7.2 Hz, 2H), 2.25 (s, 3H), 
1.29 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CHCl3) δ 164.8, 133.4, 129.0, 127.9, 
127.1, 126.7, 125.4, 112.5, 109.8, 59.7, 14.4, 12.7; HRMS m/z calcd for C12H14NO2S 







4-Methyl-2-thiophen-2-yl-1H-3-carboxylic acid ethyl ester (4.60c). The title 
compound was prepared from cyclopropane 4.52i and 2-thiophenecarbonitrile 4.59 
according to the general procedure B for thienylpyrrole synthesis (−25 °C, CH3NO2, 
3.0h). Purification by flash chromatography on silica gel with 10:1 hexanes-EtOAc for 
elution gave the title compound as a colorless syrup (119 mg, 63%): Rf 0.37 (25% 
EtOAc/hexanes); 1H NMR (400 MHz, CHCl3) δ 8.25 (s, br, 1H), 7.34 (d, J = 1.2 Hz, 
1H), 7.30 (d, J = 5.2, Hz, 1H), 7.03 (dd, J = 5.2, 4.0 Hz, 1H), 6.54 (dd, J = 1.6, 0.8 Hz, 
1H), 4.23 (q, J = 7.2 Hz, 2H), 2.27 (s, 3H), 1.27 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, 
CHCl3) δ 165.4, 133.8, 130.3, 127.1, 127.0, 126.8, 122.8, 116.9, 109.7, 59.6, 14.3, 12.7; 









2-Thiophen-2-yl-4,5,6,7-tetrahydro-1H-indole-3-carboxylic acid ethyl ester (4.60d). 
The title compound was prepared from cyclopropane 4.52h and 2-thiophenecarbonitrile 
4.59 according to the general procedure B for thienylpyrrole synthesis (−25 °C, CH3NO2, 
1.5 h). Purification by flash chromatography on silica gel with 10:1 hexanes-EtOAc for 
elution gave the title compound as a colorless syrup (83 mg, 37%): Rf 0.52 (25% 
EtOAc/hexanes); IR (thin film) ν 3650-3150, 1650 cm-1; 1H NMR (400 MHz, CHCl3) δ 
8.14 (s, br, 1H), 7.36 (dd, J = 3.6, 0.8 Hz, 1H), 7.25 (dt, J = 0.8, 5.2 Hz, 1H), 7.01 (dd, J 
= 5.2, 3.6 Hz, 1H), 4.23 (q, J = 7.2 H, 2H), 2.72 (t, J = 6.0 H, 2H), 2.53 (t, J = 6.0 H, 2H), 
1.80-1.73 (m, 4H), 1.27 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CHCl3) δ 165.4, 134.0, 
128.5, 128.1, 127.0, 126.7, 125.3, 120.4, 110.8, 59.4, 30.9, 23.4, 22.7, 22.5, 14.3; HRMS 





HO (  )2
 
4-(2-Hydroxyl-ethyl-2-thiophen-2-yl-1H-3-carboxylic acid ethyl ester (4.60e). The 
title compound was prepared from cyclopropane 4.52d and 2-thiophenecarbonitrile 4.59 
according to the general procedure B for thienylpyrrole synthesis (−40 °C, C2H5NO2, 4.0 





gave the title compound as a colorless syrup (114 mg, 41%): Rf 0.31 (50% 
EtOAc/hexanes); 1H NMR (400 MHz, CHCl3) δ 8.72 (s, br, 1H), 7.31 (d, J = 4.8 Hz, 
1H), 7.26 (d, J = 3.6 Hz, 1H), 7.02 (dd, J = 4.8, 3.6 Hz, 1H), 6.61 (d, J = 2.4 Hz, 1H), 
4.21 (q, J = 7.2 Hz, 2H), 3.81 (t, J = 6.0 Hz, 2H), 2.96 (t, J = 6.0 Hz, 2H), 2.45 (s, br, 
1H), 1.22 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CHCl3) δ 165.7, 133.6, 130.5, 127.4, 
126.8, 126.1, 123.7, 117.8, 111.7, 63.5, 59.9, 29.9, 14.1; HRMS m/z calcd for C13H16NO3 








4-(3-Hydroxyl-propyl-2-thiophen-2-yl-1H-3-carboxylic acid ethyl ester (4.60f). The 
title compound was prepared from cyclopropane 4.52b and 2-thiophenecarbonitrile 4.59 
according to the general procedure B for thienylpyrrole synthesis (−30 °C, C2H5NO2, 2.5 
h). Purification by flash chromatography on silica gel with 3:1 hexanes-EtOAc for elution 
gave the title compound as a colorless syrup (187 mg, 73%): Rf 0.25 (50% 
EtOAc/hexanes); IR (thin film) ν 3620-3175, 1665 cm-1; 1H NMR (400 MHz, CHCl3) δ 
8.92 (s, br, 1H), 7.31-7.25 (m, 2H), 7.03-7.01 (m, 2H), 6.55 (s, 1H), 4.20 (q, J = 7.2 Hz, 
2H), 3.65-3.63 (m, 2H), 2.79 (q, J = 7.6 Hz, 2H), 2.54 (s, br, 1H), 1.83-1.82 (m, 2H), 1.23 
(t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CHCl3) δ 165.7, 133.8, 130.1, 127.2, 126.8, 
126.7, 125.9, 116.9, 111.5, 61.8, 59.8, 33.7, 22.3, 14.1; HRMS m/z calcd for C14H18NO3S 








5-Methyl-1H,1'H-[2,2']bipyrrolyl (4.61). To a solution of 4.57a (143 mg, 0.65 mmol) in 
ethylene glycol (8.0 mL) was added powdered NaOH (260 mg, 6.5 mmol). After stirring 
at 160 °C for 5 min, the reaction mixture was treated with 10% aqueous NaCl (15 mL) 
and resulting solution was extracted with CH2Cl2 (3 × 10 mL). The combined organic 
solution was washed with H2O (8 mL), brine (6 mL) and dried (MgSO4). After filtration 
through a small pad of celite, volatiles were removed under reduced pressure. Purification 
by flash chromatography on silica gel with 20:1 hexanes-EtOAc for elution gave the title 
compound as white solid (88, 92%): Rf 0.52 (25% EtOAc/hexanes); 1H NMR (400 MHz, 
CHCl3) δ 8.12 (s, br, 1H), 7.88 (s, br, 1H), 6.72 (dd, J = 4.0, 2.8 Hz, 1H), 6.22 (dd, J = 
6.4, 2.4 Hz, 1H), 6.15 (dt, J = 4.4, 1.6 Hz, 1H), 6.06 (t, J = 2.8 Hz, 1H), 5.90-5.88 (m, 
1H), 2.28 (s, 3H); 13C NMR (100 MHz, CHCl3) δ 127.7, 126.2, 124.5, 117.2, 109.2, 






2-Thiophen-2-yl-1H-pyrrole (4.62). The title compound was prepared from 4.60a 
according to the decarboxylation procedure described above for preparation of 4.61. 
Purification by flash chromatography on silica gel with 15:1 hexanes-EtOAc for elution 





EtOAc/hexanes); 1H NMR (400 MHz, CHCl3) δ 8.28 (s, br, 1H), 7.13 (dt, J = 8.0, 3.2 Hz, 
1H), 7.02-6.99 (m, 2H), 6.79 (dt, J = 8.4, 1.6, 1H), 6.41-6.39 (m, 1H), 6.25 (dt, J = 6.0, 
2.8 Hz, 1H); 13C NMR (100 MHz, CHCl3) δ 136.2, 127.6, 122.7, 120.9, 118.5, 110.0, 




HO (  )2
 
2-(5-Thiophen-2-yl-1H-pyrrol-3-yl)-ethanol (4.63). The title compound was prepared 
from 4.60e according to the decarboxylation procedure described above for preparation 
of 4.61. Purification by flash chromatography on silica gel with 2:1 hexanes-EtOAc for 
elution gave the title compound as a colorless solid (62 mg, 81%): Rf 0.52 (66% 
EtOAc/hexanes); 1H NMR (400 MHz, CHCl3) δ 8.17 (s, br, 1H), 7.12 (dd, J = 3.6, 2.4 
Hz, 1H), 6.99 (s, 1H), 6.98(d, J = 0.8 Hz, 1H), 6.65 (dd, J = 2.4, 1.6 Hz, 1H), 6.62 (t, J = 
2.4 Hz, 1H), 3.79 (t, J = 6.4 Hz, 2H), 2.73 (t, J = 6.4 Hz, 2H), 1.57 (s, br, 1H); 13C NMR 
(100 MHz, CHCl3) δ 136.1, 127.6, 127.1, 122.7, 121.5, 120.8, 116.9, 107.1, 63.3,30.4; 




HO (  )3
 
3-(5-Thiophen-2-yl-1H-pyrrol-3-yl)-propan-1-ol (4.64). The title compound was 





preparation of 4.61. Purification by flash chromatography on silica gel with 2:1 hexanes-
EtOAc for elution gave the title compound as a colorless solid (86 mg, 87%): Rf 0.50 
(66% EtOAc/hexanes); 1H NMR (400 MHz, CHCl3) δ 8.16 (s, br, 1H), 7.10 (t, J = 3.2 
Hz, 1H), 6.98 (d, J = 0.4 Hz, 1H),6.97(s, 1H), 6.57 (s, 1H), 6.27 (t, J = 2.0 Hz, 1H), 3.70 
(t, J = 6.4 Hz, 2H), 2.56 (t, J = 7.6 Hz, 2H), 1.86 (tt, J = 6.4, 6.4 Hz, 2H), 1.40 (s, br, 1H); 
13C NMR (100 MHz, CHCl3) δ 136.3, 127.6, 126.7, 125.2, 122.5, 120.6, 115.9,106.9, 








7-Cyano-2,3-diethyl-2,3-dihydro-indolizine-1-carboxylic acid ethyl ester (4.67a) To a 
solution of the cyclopropane 4.52f (186 mg, 1.0 mmol) and 4.65 (520 mg, 5.0 mmol, 5.0 
eq) in CH3NO2 (2.0 mL) at −18 °C was added TMSOTf (1.0 mmol). The resulting 
mixture was allowed to warm to rt in 2.0 h and then poured into a vigorously stirred 
solution of saturated aqueous NaHCO3 (10 mL). After 2 min the resulting mixture was 
extracted with EtOAc (3 × 5 mL). The combined organic solution was washed with H2O 
(2 × 3 mL), brine (5 mL) and dried (MgSO4). After filtration through a small pad of 
celite, volatiles were removed under reduced pressure. Purification of the residue by flash 
chromatography on silica gel with 20:1 hexanes-EtOAc for elution gave the product as a 
solid (78 mg, 52%): Rf 0.38 (25% EtOAc/hexanes); 1H NMR (400 MHz, CHCl3) δ 7.55 





(dq, J = 4.0, 4.0 Hz, 1H), 2.88-2.82 (m, 1H), 1.71-1.54 (m, 2H), 1.24 (t, J = 6.8 Hz, 3H), 
1.12 (d, J = 6.8 Hz, 3H), 0.90 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CHCl3) δ 165.9, 
135.5, 125.4, 118.7, 116.9, 109.6, 103.3, 95.6, 72.6, 58.6, 39.5, 28.0, 21.4, 14.6, 8.4; 







8-Cyano-1,2,3,4,4a,10a-hexahydro-pyrido[1,2-a]indole-10-carboxylic acid ethyl ester 
(4.67b). The title compound was prepared from 4.52h according to the general procedure 
described above for the preparation of 4.67a. Purification by flash chromatography on 
silica gel with 10:1 hexanes-EtOAc for elution gave the title compound as a dark red 
solid (211 mg, 41%): Rf 0.34 (25% EtOAc/hexanes); 1H NMR (400 MHz, CHCl3) δ 7.61 
(s, 1H), 6.96 (d, J = 0.8 Hz, 1H), 5.70 (dd, J = 7.2, 1.6 Hz, 1H), 4.19-4.06 (m, 2H), 3.98 
(dt, J = 8.8, 4.0 Hz, 1H), 2.96-2.90 (m, 1H), 1.90-1.76 (m, 2H), 1.60-1.52 (m, 2H), 1.24 
(t, J = 7.2 Hz, 3H), 1.34-1.14 (m, 4H); 13C NMR (100 MHz, CHCl3) δ 165.9, 149.8, 
133.8, 125.5, 118.4, 117.0, 103.6, 96.8, 63.7, 58.6, 39.7, 26.8, 23.8, 21.5, 19.7, 14.7; 











7-Cyano-2-ethyl-3-propyl-2,3-dihydro-indolizine-1-carboxylic acid ethyl ester 
(4.67c). The title compound was prepared from 4.52e according to the general procedure 
described above for the preparation of 4.67a. Purification by flash chromatography on 
silica gel with 20:1 hexanes-EtOAc for elution gave the title compound as a dark red 
solid (177 mg, 54%): Rf 0.46 (15% EtOAc/hexanes); 1H NMR (400 MHz, CHCl3) δ 7.58 
(s, 1H), 6.87 (dd, J = 6.8, 0.4 Hz, 1H), 5.62 (dd, J = 6.8, 1.2 Hz, 1H), 4.25-4.15 (m, 2H), 
3.70 (dq, J = 4.0, 4.0 Hz, 1H), 2.75 (dd, J = 9.6, 4.0 Hz, 1H), 1.70-1.57 (m, 3H), 1.53-
1.30 (m, 3H), 1.26 (t, J = 7.2 Hz, 3H), 0.93 (t, J = 7.2 Hz, 3H), 0.83 (t, J = 7.2 Hz, 3H), 
13C NMR (100 MHz, CHCl3) δ 166.0, 135.5, 125.8, 118.7, 116.9, 103.3, 94.0, 68.6, 58.7, 















1-Butoxy-6-nitro-1,2,3,3a-tetrahydro-pyrrolo[1,2-a]quinoline-3-carboxylic acid ethyl 





ethyl ester (4.79a). The title compounds were prepared from 4.52a  and 4.77 according 
to the general procedure described above for the preparation of 4.67a. Purification by 
flash chromatography on silica gel with 5:1 hexanes-EtOAc for elution gave the title 
compounds: 4.78a: (81 mg, 31%, pale yellow syrup ): Rf 0.65 (50% EtOAc/hexanes); 1H 
NMR (400 MHz, CDCl3) δ 7.60 (q, J = 10.0 Hz, 2H), 7.48 (dd, J = 8.0, 1.2 Hz, 1H), 7.33 
(d, J = 8.0 Hz, 1H), 7.26 (d, J = 8.0 Hz, 1H), 5.90 (dd, J = 9.2, 2.4 Hz, 1H), 4.18 (q, J = 
7.2 Hz, 2H), 3.41 (dt, J = 12.8, 6.4 Hz, 1H), 3.25 (dt, J = 12.8, 6.4 Hz, 1H), 3.08 (dd, J = 
18.0, 9.2 Hz, 1H), 2.90 (dd, J = 18.0, 2.4 Hz, 1H), 1.46 (dq, J = 7.2, 7.2 Hz, 2H), 1.29 (t, 
J = 7.2 Hz, 3H), 1.24-1.22 (m, 4H), 0.80 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, 
CDCl3) δ 165.9, 165.1, 147.2, 139.8, 130.0, 127.9, 122.4, 117.5, 117.4, 116.0, 94.5, 88.1, 
62.7, 59.6, 33.3, 31.7, 19.5, 14.9, 13.9; HRMS m/z calcd for C19H23N2O5 [M-H]- 
359.1607, found: 359.1602; 4.79a: (108 mg, 52%, dark red solid): Rf 0.51 (50% 
EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 7.62 (d, J = 10.0 Hz, 1H), 7.59 (d, J = 
10.0 Hz, 1H), 7.43 (d, J = 8.0 Hz, 1H), 7.33 (t, J = 8.0 Hz, 1H), 6.83 (d, J = 8.0 Hz, 1H), 
4.18 (q, J = 7.2 Hz, 2H), 4.01 (t, J = 10.0 Hz, 2H), 3.00 (t, J = 10.0 Hz, 2H), 1.28 (t, J = 
7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 186.0, 148.7, 146.8, 140.7, 130.0, 127.5, 
122.4, 116.1, 115.8, 115.6, 95.7, 59.1, 48.2, 27.0, 14.7; HRMS m/z calcd for C15H15N2O4 




















carboxylic acid ethyl ester (4.78b) and 2-(3-Hydroxy-propyl)-6-nitro-1,2-dihydro-
pyrrolo[1,2-a]quinoline-3-carboxylic acid ethyl ester (4.79b). The title compounds 
were prepared from 4.52b and 4.77 according to the general procedure described above 
for the preparation of 4.67a. Purification by flash chromatography on silica gel with 10:1 
to 2:1 hexanes-EtOAc for elution gave the title compounds: 4.78b (115 mg, 41%, pale 
yellow syrup): Rf 0.61 (33% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 7.47-7.38 
(m, 2H), 7.26 (d, J = 8.4 Hz, 1H), 7.00 (dd, J = 10.0, 2.4 Hz, 1H), 5.93 (dd, J = 10.0, 2.4 
Hz, 1H), 4.43-4.31 (m, 4H), 4.28-4.22 (m, 1H), 3.81 (dd, J = 11.6, 3.6 Hz, 1H), 2.97 (dd, 
J = 12.0, 10.0 Hz, 1H), 2.30-2.14 (m, 2H), 1.88-1.80 (m, 2H), 1.63 (dq, J = 3.2, 12.0 Hz, 
1H), 1.43 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 171.1, 146.7, 142.8 127.4, 
125.1, 122.2, 119.0, 117.4, 114.3, 91.3, 67.3, 61.0, 55.1, 46.5, 45.3, 25.9, 25.4, 14.1; 
HRMS m/z calcd for C18H21N2O5 [M+H]+ 345.1450, found: 345.1443; 4.79b (106.6 mg, 
38%): Rf 0.38 (66% EtOAc/hexanes, dark red solid); 1H NMR (400 MHz, CDCl3) δ 7.62 
(d, J = 10.4 Hz, 1H), 7.56 (d, J = 10.4 Hz, 1H), 7.41 (d, J = 8.0 Hz, 1H), 7.32 (t, J = 8.0 
Hz, 1H), 6.89 (d, J = 8.0 Hz, 1H), 4.22-4.09 (m, 2H), 4.04 (t, J = 11.2 Hz, 1H), 3.71 (dd, 
J = 11.2, 4.8 Hz, 1H), 3.62 (t, J = 6.0 Hz, 1H), 3.37-3.31 (m, 1H), 2.35 (s, br, 1H), 1.89-
1.81 (m, 1H), 1.64-1.48 (m, 3H), 1.26 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 
166.0, 148.5, 146.6, 140.3, 129.9, 127.8, 122.4, 116.3, 116.1, 115.5, 99.4, 62.4, 59.0, 














ethyl ester (4.79c). The title compound was prepared from 4.52c and 4.77 according to 
the general procedure described above for the preparation of 4.6a. Purification by flash 
chromatography on silica gel with 2:1 hexanes-EtOAc for elution gave the title 
compound as a colorless syrup (117 mg, 42%): Rf 0.35 (66% EtOAc/hexanes); 1H NMR 
(400 MHz, CHCl3) δ 7.72 (d, J = 10.4 Hz, 1H), 7.61 (d, J = 10.4 Hz, 1H), 7.48 (d, J = 8.0 
Hz, 1H), 7.37 (t, J = 8.0 Hz, 1H), 6.96 (d, J = 8.4 Hz, 1H), 4.20 (dq, J = 1.6, 7.2 Hz, 1H), 
4.13 (t, J = 11.2 Hz, 1H), 3.84 (dd, J = 11.2, 4.4 Hz, 1H), 3.73-3.68 (m, 2H), 3.52-3.45 
(m, 1H), 2.88 (s, br, 1H), 1.95-1.87 (m, 1H), 1.79 (dq, J = 7.2, 7.2 Hz, 1H), 1.30 (t, J = 
7.2 Hz, 3H); 13C NMR (100 MHz, CHCl3) δ 166.7, 148.8, 146.8, 140.4, 130.0, 128.2, 
122.5, 116.6, 116.4, 115.6, 99.0, 60.1, 59.4, 55.3, 38.7, 36.4, 14.6; HRMS m/z calcd for 










4-Nitro-8,9,10,11-tetrahydro-indolo[1,2-a]quinoline-7-carboxylic acid ethyl ester 
(4.80). To a solution of the cyclopropane 4.52h (198 mg, 1.0 mmol) and 4.77 (610 mg, 
3.5 mmol, 3.5 eq) in CH3NO2 (4.0 mL) at −18 °C was added TMSOTf (1.0 mmol). The 
resulting mixture was allowed to warm to rt in 45 min and then poured into a vigorously 
stirred solution of saturated aqueous NaHCO3 (12 mL). After 2 min the resulting mixture 
was extracted with EtOAc (3 × 5 mL). The combined organic solution was washed with 
H2O (2 × 3 mL), brine (5 mL) and dried (MgSO4). After filtration through a small pad of 
celite, volatiles were removed under reduced pressure and the residue was dissolved in 
EtOAc (15 mL). The resulting solution was stirred in air for 48 h and the solvent was 
removed under reduced pressure. Purification of the residue by flash chromatography on 
silica gel with 5:1 hexanes-EtOAc for elution gave the product as a dark red solid (277 
mg, 83%): Rf 0.34 (33% EtOAc/hexanes); 1H NMR (400 MHz, CHCl3) δ 8.39 (d, J = 7.6 
Hz, 1H), 8.27 (dd, J = 10.0, 2.8 Hz, 1H), 7.85 (dd, J = 7.6, 2.8 Hz, 1H), 7.65 (dd, J = 
10.0, 2.8 Hz, 1H), 7.45 (td, J = 7.6, 2.8 Hz, 1H), 4.35 (q, J = 7.6 Hz, 2H), 3.17 (s, 2H), 
2.95 (s, 2H), 1.91-1.90 (m, 2H), 1.84-1.83 (m, 2H), 1.41 (td, J = 7.6, 2.8 Hz, 3H); 13C 





119.9, 118.8, 114.9, 106.0, 59.6, 28.5, 24.3, 23.7, 22.1, 14.5; HRMS m/z calcd for 












acid ethyl ester (4.85a). To a solution of the cyclopropane 4.52h (198 mg, 1.0 mmol) 
and 4.81 (351 mg, 3.0 mmol, 3.0 eq) in CH3NO2 (2.5 mL) at −18 °C was added TMSOTf 
(1.0 mmol). The resulting mixture was stirred for 45 min and then poured into a 
vigorously stirred solution of saturated aqueous NaHCO3 (10 mL). After 2 min the 
resulting mixture was extracted with EtOAc (3 × 6 mL). The combined organic solution 
was washed with H2O (2 × 3 mL), brine (5 mL) and dried (MgSO4). After filtration 
through a small pad of celite, volatiles were removed under reduced pressure. Purification 
of the residue by flash chromatography on silica gel with 10:1 hexanes-EtOAc for elution 
gave the product as white solid (301 mg, 78%): Rf 0.31 (20% EtOAc/hexanes); 1H NMR 
(400 MHz, CHCl3) δ 7.15 (d, J = 7.2 Hz, 1H), 7.03 (t, J = 7.2 Hz, 1H), 6.64 (t, J = 7.2 
Hz, 1H), 6.59 (d, J = 7.6 Hz, 1H), 4.53 (dd, J = 10.0, 5.2 Hz, 1H), 4.20-4.11 (m, 3H), 
3.45 (d, J = 10.8 Hz, 1H), 2.99 (dd, J = 12.4, 5.6 Hz, 1H), 2.68 (s, 3H), 2.52 (d, J = 14.0 
Hz, 1H), 1.80-1.69 (m, 2H), 1.62-1.54 (m, 3H), 1.38-1.17 (m, 3H), 1.25 (t, J = 7.2 Hz, 





83.6, 67.0, 60.3, 58.0, 55.3, 50.5, 30.5, 25.2, 24.1, 21.4, 14.3; HRMS m/z calcd for 











ethyl ester (4.85b). The title compound was prepared from 4.52gand 4.81 at −18 °C 
according to the general procedure described above for the preparation of 4.85a. 
Purification by flash chromatography on silica gel with 10:1 hexanes-EtOAc for elution 
gave the title compound in form of three diastereomers as colorless syrups. 
Diastereomer A  (35 mg, 14%): Rf 0.62 (33% EtOAc/hexanes); 1H NMR (400 MHz, 
CHCl3) δ 7.04 (d, J = 7.2 Hz, 1H), 6.99 (t, J = 7.2 Hz, 1H), 6.50 (d, J = 7.6 Hz, 1H), 
6.23 (td, J = 7.2, 1.0 Hz, 1H), 4.77-4.71 (m, 1H), 4.19 (q, J = 7.2 Hz, 2H), 4.04 (s, br, 
1H), 3.64 (d, J = 8.4 Hz, 1H), 3.27-3.21 (m, 1H), 3.22 (s, 3H), 2.18 (dd, J = 13.6, 6.0 
Hz, 1H), 1.73 (t, J = 13.6 Hz, 1H), 1.27 (t, J = 7.2 Hz, 3H), 1.17 (s, 3H); 13C NMR (100 
MHz, CHCl3) δ 173.3, 151.7, 128.0, 127.8, 1276.3, 117.9, 108.7, 86.3, 64.7, 60.4, 56.8, 
49.4, 48.5, 36.1, 19.3, 14.3; HRMS m/z calcd for C16H22NO3 [M+H]+ 276.1600, found: 
276.1601; Diastereomer B (20 mg, 8%): Rf 0.58 (33% EtOAc/hexanes); 1H NMR (400 
MHz, CHCl3) δ 7.09 (d, J = 7.2 Hz, 1H), 7.02 (t, J = 7.2 Hz, 1H), 6.66 (td, J = 7.2, 1.0 
Hz, 1H), 6.54 (d, J = 8.0 Hz, 1H), 4.81(dd, J = 10.0, 3.6 Hz, 1H), 4.22-4.08 (m, 3H), 





1H), 1.82 (dd, J = 13.2, 8.0 Hz, 1H), 1.27 (t, J = 7.2 Hz, 3H), 1.17 (s, 3H); 13C NMR 
(100 MHz, CHCl3) δ 173.8, 151.4, 128.0, 127.6, 126.2, 118.1, 109.1, 86.4, 65.0, 60.5, 
56.5, 51.9, 50.1, 38.7, 19.3, 14.2; HRMS m/z calcd for C16H22NO3 [M+H]+ 276.1600, 
found: 276.1605; Diastereomer C (106 mg, 42%): Rf 0.52 (33% EtOAc/hexanes); 1H 
NMR (400 MHz, CHCl3) δ 7.13 (d, J = 7.2 Hz, 1H), 7.04 (t, J = 7.2 Hz, 1H), 6.71 (td, J 
= 7.2, 1.0 Hz, 1H), 6.59 (d, J = 7.2 Hz, 1H), 4.50 (dd, J = 13.2, 6.0 Hz, 1H), 4.25 (s, br, 
1H), 4.18 (q, J = 7.2 Hz, 2H), 3.67 (d, J = 10.0 Hz, 1H), 3.09 (s, 3H), 3.02 (dt, J = 12.0, 
6.4 Hz, 1H), 2.32 (dd, J = 13.2, 6.8 Hz, 1H), 1.72 (dd, J = 13.2, 12.0 Hz, 1H), 1.45 (s, 
3H), 1.29 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CHCl3) δ 175.1, 151.6, 127.8, 127.3, 
125.3, 118.4, 109.5, 83.9, 66.3, 60.6, 59.0, 51.8, 49.8, 38.7, 21.7, 14.2; HRMS m/z calcd 










1-Butoxy-1,2,3,3a,4,8b-hexahydro-cyclopenta[b]indole-3-carboxylic acid ethyl ester 
(4.85c). The title compound was prepared from 4.52a and 4.81 at −18 °C according to 
the general procedure described above for the preparation of 4.85a. Purification by flash 
chromatography on silica gel with 15:1 hexanes-EtOAc for elution gave the title 
compound as a colorless syrup (132 mg, 62%): Rf 0.63 (25% EtOAc/hexanes); 1H NMR 





Hz, 1H), 6.49 (d, J = 7.6 Hz, 1H), 5.67 (dd, J = 8.0, 5.6 Hz, 1H), 4.18 (q, J = 7.2 Hz, 
2H), 4.12 (s, br, 1H), 3.79-3.76 (m, 2H), 3.46 (qdd, J = 7.2, 9.2, 6.4 Hz, 2H), 3.25 (qd, J 
= 6.0, 12.0 Hz, 1H), 2.10 (dd, J = 13.6, 6.0 Hz, 1H), 1.86 (qd, J = 9.6, 4.4 Hz, 1H), 1.55 
(tt, J = 12.8, 6.4, Hz, 2H), 1.39 (qt, J = 6.4, 12.8 Hz, 2H), 1.28 (t, J = 7.2 Hz, 3H), 0.93 
(t, J = 7.6 Hz, 3H); 13C NMR (100 MHz, CHCl3) δ 173.2, 151.1, 128.7, 128.0, 124.5, 
118.1, 108.5, 86.8, 68.4, 63.1, 60.4, 54.3, 49.4, 31.9, 31.6, 19.4, 14.3, 13.9; HRMS m/z 












acid ethyl ester (4.85d). The title compound was prepared from 4.52b and 4.81 at −18 
°C according to the general procedure described above for the preparation of 4.85a. 
Purification by flash chromatography on silica gel with 10:1 hexanes-EtOAc for elution 
gave the title compound as inseparatable mixture of two diastereomers as colorless syrups 
(179 mg, 74%): Rf 0.47 (33% EtOAc/hexanes); 1H NMR (400 MHz, CHCl3) δ 7.22 (d, J 
= 7.2 Hz, 0.55H), 7.14 (d, J = 7.6 Hz, 0.45H), 7.05 (t, J = 7.6 Hz, 0.55H), 6.99 (t, J = 7.6 
Hz, 0.45H), 6.71 (t, J = 7.2 Hz, 0.55H), 6.65 (t, J = 7.2 Hz, 0.45H), 6.58 (d, J = 7.6 Hz, 
0.55H), 6.50 (d, J = 7.6 Hz, 0.45H), 4.59-4.50 (m, 1H), 4.29-4.13 (m, 3H), 4.07-4.00 (m, 
1.45H), 3.63 (t, J = 8.0 Hz, 0.55H), 3.52-3.40 (m, 1H), 3.35 (dd, J = 10.4, 7.6 Hz, 0.45 





6.4 Hz, 0.55 H), 2.25-2.21 (m, 0.45H), 2.12-2.08 (m, 0.55H), 1.84-1.72 (M, 1H), 1.66-
1.56 (m, 1H), 1.53-1.48 (m, 1H), 1.34-1.21 (m, 4H); 13C NMR (100 MHz, CHCl3) δ 
173.8, 171.9, 151.7, 150.0, 129.8, 128.1, 127.8, 126.8, 126.7, 124.5, 118.7, 118.0, 109.4, 
108.4, 89.0, 84.4, 69.2, 69.0, 63.8, 61.0, 60.6, 60.3, 55.6, 52.7, 50.8, 47.7, 45.3, 39.2, 













acid ethyl ester (4.85e). The title compound was prepared from 4.52c and 4.81 at −18 °C 
according to the general procedure described above for the preparation of 4.85a. 
Purification by flash chromatography on silica gel with 15:1 hexanes-EtOAc for elution 
gave the title compound in form of two diastereomers as colorless syrups. Diastereomer 
A (53 mg, 25%): Rf 0.55 (33% EtOAc/hexanes); 1H NMR (400 MHz, CHCl3) δ 7.11 (d, J 
= 7.2 Hz, 1H), 7.00 (t, J = 7.6 Hz, 1H), 6.64 (td, J = 7.6, 0.8 Hz, 1H), 6.52 (d, J = 8.0 Hz, 
1H), 4.98-4.92 (m, 1H), 4.34 (td, J = 8.0, 1.0 Hz, 1H), 4.26 (dd, J = 9.6, 7.2 Hz, 1H), 
4.22-4.14 (m, 3H), 3.97-3.92 (m, 2H), 2.65 (dd, J = 12.8, 6.0 Hz, 1H), 2.38-2.28 (m, 1H), 
1.98-1.92 (m, 1H), 1.70-1.60 (m, 1H); 13C NMR (100 MHz, CHCl3) δ 171.9, 152.2, 
127.9, 126.3, 125.7, 118.1, 108.4, 89.8, 75.6, 69.7, 60.4, 49.1, 46.0, 45.1, 26.4, 14.3; 





(70 mg, 33%): Rf 0.61 (33% EtOAc/hexanes); 1H NMR (400 MHz, CHCl3) δ 7.20 (d, J = 
7.6 Hz, 1H), 7.04 (td, J = 7.6, 1.0 Hz, 1H), 6.70 (td, J = 7.6, 0.8 Hz, 1H), 6.57 (d, J = 7.6 
Hz, 1H), 4.96 (dd, J = 10.4, 6.0 Hz, 1H), 4.42-5.29 (m, 2H), 4.30 (s, br, 1H), 4.23-4.15 
(M, 2H), 3.75 (t, J = 10.2 Hz, 1H), 3.65 (t, J = 10.2 Hz, 1H), 2.57 (dd, J = 12.4, 5.6 Hz, 
1H), 2.38-2.28 (m, 1H), 1.97 (tdd, J = 6.4, 11.2, 2.4 Hz, 1H), 1.76-1.65 (m, 1H), 1.29 (t, J 
= 6.8 Hz, 3H); 13C NMR (100 MHz, CHCl3) δ 173.9, 150.4, 128.9, 128.2, 124.7, 118.9, 
109.6, 93.9, 75.5, 72.9, 60.8, 51.6, 51.4, 47.6, 26.4, 14.3; HRMS m/z calcd for 












ethyl ester (4.89a). The title compound was prepared from 4.52a  and 4.87 at −18 °C 
according to the general procedure described above for the preparation of 4.85a. 
Purification by flash chromatography on silica gel with 15:1 hexanes-EtOAc for elution 
gave the title compound in form of two diastereomer s as a colorless syrup. 
Diastereomer A (89 mg, 31%): Rf 0.42 (20% EtOAc/hexanes); 1H NMR (400 MHz, 
CHCl3) δ 6.68 (d, J = 2.0 Hz, 1H), 6.56 (dd, J = 8.4, 2.4 Hz, 1H), 6.43 (d, J = 8.8 Hz, 
1H), 4.66 (dd, J = 8.4, 5.6 Hz, 1H), 4.17 (q, J = 7.2 Hz, 2H), 3.85 (s, br, 1H), 3.77-3.74 
(m, 2H), 3.71 (s, 3H), 3.47-3.42 (m, 2H), 3.23 (td, J = 6.4, 7.2 Hz, 1H), 2.08 (dd, J = 





J = 7.2, 7.2 Hz, 2H), 1.26 (t, J = 7.2 Hz, 3H), 0.92 (t, J = 7.2 Hz, 3H); 13C NMR (100 
MHz, CHCl3) δ 173.2, 153.2, 145.2, 130.5, 113.0, 111.3, 109.3, 86.6, 68.4, 63.8, 60.3, 
56.0, 54.9, 49.5, 32.0, 31.6, 19.4, 14.3, 13.9; HRMS m/z calcd for C19H28NO4 [M+H]+ 
334.2018, found: 334.2021. Diastereomer B (123 mg, 43%): Rf 0.38 (20% 
EtOAc/hexanes); 1H NMR (400 MHz, CHCl3) δ 6.74 (d, J = 2.4 Hz, 1H), 6.58 (dd, J = 
8.0, 2.0 Hz, 1H), 6.44 (d, J = 8.4 Hz, 1H), 4.57 (dd, J = 8.0, 6.0 Hz, 1H), 4.17 (q, J = 7.2 
Hz, 2H), 3.99-3.95 (m, 2H), 3.88 (s, br, 1H), 3.71 (s, 3H), 3.51 (t, J = 6.4 Hz, 2H), 2.78 
(td, J = 5.6, 13.2 Hz, 1H), 2.20-2.14 (m, 1H), 1.82-1.73 (m, 1H), 1.56 (dq, J = 7.2, 7.2 
Hz, 2H), 1.37 (tq, J = 7.6, 7.6 Hz, 2H), 1.26 (t, J = 7.2 Hz, 3H), 0.89 (t, J = 7.2 Hz, 3H); 
13C NMR (100 MHz, CHCl3) δ 172.3, 152.8, 146.0, 128.6, 113.7, 113.4, 109.1, 81.3, 
70.1, 62.8, 60.4, 55.9, 49.2, 47.7, 31.9, 30.5, 19.4, 14.3, 13.9; HRMS m/z calcd for 














carboxylic acid ethyl ester (4.89b). The title compound was prepared from 4.52b and 
4.87 at −18 °C according to the general procedure described above for the preparation of 
4.85a. Purification by flash chromatography on silica gel with 10:1 hexanes-EtOAc for 
elution gave the title compound as inseparatable mixture of two diastereomers as 





CHCl3) δ 6.83 (d, J = 2.4 Hz, 0.55H), 6.77 (d, J = 2.4 Hz, 0.45H), 6.63 (dd, J = 8.4, 2.8 
Hz, 0.55H), 6.56 (dd, J = 8.4, 2.8 Hz, 0.45H), 6.52 (d J = 8.0 Hz, 0.55H), 6.43 (d, J = 8.0 
Hz, 0.45H), 4.56-4.49 (m, 1H), 4.20-3.96 (m, 5H), 3.72 (s, 1.65H), 3.70 (s, 1.35H), 3.49-
3.39 (m, 1H), 3.32 (dd, J = 10.0, 8.0 Hz, 0.55H), 3.16 (t, J = 10.0 Hz, 0.45 H), 2.43-2.35 
(m, 1H), 2.22-2.05 (m, 1H), 1.81-1.70 (m, 1H), 1.64-1.45 (m, 3H), 1.28-1.21 (m, 3H); 
13C NMR (100 MHz, CHCl3) δ 173.8, 171.9, 153.6, 152.8, 145.7, 143.8, 131.6, 128.6, 
113.7, 113.2, 113.1, 110.6, 110.5, 109.2, 89.0, 84.2, 69.2, 69.0, 64.4, 61.6, 60.6, 60.2, 
55.9, 55.8, 55.6, 52.7, 51.3, 48.3, 45.4, 39.3, 28.4, 28.1, 25.5, 25.2, 14.3; HRMS m/z 













carboxylic acid ethyl ester (4.89c). The title compound was prepared from 4.52h and 
4.87 at −18 °C according to the general procedure described above for the preparation of 
4.85a. Purification by flash chromatography on silica gel with 15:1 hexanes-EtOAc for 
elution gave the title compound as a pale yellow solid (142 mg, 72%): Rf 0.54 (33% 
EtOAc/hexanes); 1H NMR (400 MHz, CHCl3) δ 6.77 (d, J = 2.4 Hz, 1H), 6.61 (dd, J = 
8.4, 4.2 Hz, 1H), 6.52 (d, J = 8.4 Hz, 1H), 4.51 (dd, J = 10.4, 5.6 Hz, 1H), 4.18-4.09 (m, 
2H), 3.70 (s, 3H), 3.39 (d, J = 10.0 Hz, 1H), 2.96 (dd, J = 7.6, 4.8 Hz, 1H), 2.69 (s, 3H), 





(t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CHCl3) δ 175.8, 152.9, 146.6, 129.0, 113.2, 
112.2, 110.7, 83.5, 67.5, 60.3, 58.5, 55.9, 55.4, 53.6, 50.5, 30.4, 25.1, 24.0, 21.3, 14.3; 












ethyl ester (4.90a). The title compound was prepared from 4.52a  and 4.88 at −18 °C 
according to the general procedure described above for the preparation of 4.85a. 
Purification by flash chromatography on silica gel with 10:1 hexanes-EtOAc for elution 
gave the title compound as a yellow solid (93 mg, 51%): Rf 0.41 (25% EtOAc/hexanes); 
1H NMR (400 MHz, CHCl3) δ 7.30 (s, 1H), 7.22 (dd, J = 8.4, 1.6 Hz, 1H), 6.26 (d, J = 
8.0 Hz, 1H), 4.69-4.63 (m, 1H), 4.17 (t, J = 7.2 Hz, 2H), 4.14-4.09 (m, 1H), 3.73 (d, J = 
4.8 Hz, 2H), 3.48-3.39 (m, 2H), 3.23 (td, J = 5.6, 12.8 Hz, 1H), 2.11(dd, J = 13.6, 5.6 Hz, 
1H), 1.80 (td, J = 13.6, 4.0 Hz, 1H), 1.58-1.50 (m, 3H), 1.38 (dt, J = 7.2, 7.2 Hz, 2H), 
1.30-1.23 (m, 4H), 0.92 (s, 3H); 13C NMR (100 MHz, CHCl3) δ 173.0, 150.8, 136.6, 
133.2, 131.7, 112.5, 110.4, 86.6, 68.5, 63.3, 60.4, 53.9, 49.2, 31.9, 31.7, 19.4, 14.3, 13.9; 

















carboxylic acid ethyl ester (4.90). The title compound was prepared from 4.52b and 
4.88 at −18 °C according to the general procedure described above for the preparation of 
4.85a. Purification by flash chromatography on silica gel with 15:1 hexanes-EtOAc for 
elution gave the title compound as a colorless solid (218 mg, 61%): Rf 0.61 (25% 
EtOAc/hexanes); 1H NMR (400 MHz, CHCl3) δ 7.46 (s, 1H), 7.30 (dd, J = 8.0, 2.0 Hz, 
1H), 6.34 (d, J = 8.0 Hz, 1H), 4.51 (dd, J = 11.2, 6.8 Hz, 1H), 4.26 (s, br, 1H), 4.24-4.14 
(m, 2H), 4.06-4.03 (m, 1H), 3.57 (t, J = 8.8 Hz, 1H), 3.43 (td, J = 11.2, 4.0 Hz, 1H),  3.14 
(t, J = 9.6 Hz, 1H), 2.36 (dd, J = 12.0, 6.4 Hz, 1H), 2.10 (dd, J = 12.0, 2.8 Hz, 1H), 1.73 
(dq, J = 3.2, 12.0 Hz, 1H), 1.63-1.57 (m, 2H), 1.36-1.24 (m, 1H), 1.27 (t, J = 7.2 Hz, 3H); 
13C NMR (100 MHz, CHCl3) δ 173.6, 149.7, 136.8, 133.2, 132.6, 111.3, 88.8, 79.2, 69.1, 
64.0, 60.8, 55.5, 50.4, 45.2, 28.2, 25.5, 14.3; HRMS m/z calcd for C17H21INO3 [M+H]+ 

















carboxylic acid ethyl ester (4.90c). The title compound was prepared from 4.52h and 
4.88 at −18 °C according to the general procedure described above for the preparation of 
4.85a. Purification by flash chromatography on silica gel with 15:1 hexanes-EtOAc for 
elution gave the title compound colorless solid (171 mg, 54%): Rf 0.65 (25% 
EtOAc/hexanes); 1H NMR (400 MHz, CHCl3) δ 7.40 (s, 1H), 7.28 (dd, J = 8.4, 1.2 Hz, 
1H), 6.36 (d, J = 8.4 Hz, 1H), 4.52 (dd, J = 10.0, 5.6 Hz, 1H), 4.26 (s, br, 1H), 4.20-4.07 
(m, 2H), 3.38 (d, J = 10.0 Hz, 1H), 2.95 (dd, J = 12.0, 4.8 Hz, 1H), 2.74 (s, 3H), 2.49 (d, 
J = 13.2 Hz, 1H), 1.76-1.69 (m, 2H), 1.58-1.52 (m, 3H), 1.32-1.19 (m, 3H), 1.24 (t, J = 
7.2 Hz, 3H); 13C NMR (100 MHz, CHCl3) δ 175.5, 152.2, 136.8, 133.9, 130.3, 111.7, 
83.8, 78.2, 67.1, 60.4, 57.7, 55.2, 53.4, 50.8, 30.5, 25.1, 24.0 21.4, 14.3; HRMS m/z calcd 













carboxylic acid ethyl ester (4.91a). The title compound was prepared from 4.52 and 2-
methyl indole at −18 °C according to the general procedure described above for the 
preparation of 4.85a. Purification by flash chromatography on silica gel with 20:1 
hexanes-EtOAc for elution gave the title compound as a colorless syrup (128 mg, 74%): 





J = 7.2 Hz, 1H), 6.43 (d, J = 8.0 Hz, 1H), 4.25-4.14 (m, 2H), 4.03 (dd, J = 10.2, 5.2 Hz, 
1H), 3.38 (d, J = 10.0 Hz, 1H), 2.98 (dd, J = 12.4, 4.8 Hz, 1H), 2.78 (s, 3H), 2.70 (s, 3H), 
2.53 (d, J = 10.2 Hz, 1H), 1.90-1.83 (m, 1H), 1.74-1.70 (m, 1H), 1.65-1.55 (m, 3H), 1.28 
(t, J = 7.2 Hz, 3H), 1.36-1.18 (m, 3H); 13C NMR (100 MHz, CHCl3) δ 175.9, 154.5, 
128.4, 127.3, 125.0, 116.8, 107.4, 83.4, 75.4, 60.4, 56.9, 54.0, 53.7, 50.5, 35.5, 30.5, 25.2, 











ethyl ester (4.91b). The title compound was prepared from 4.52b and 2-methyl indole at 
−18 °C according to the general procedure described above for the preparation of 4.85a. 
Purification by flash chromatography on silica gel with 20:1 hexanes-EtOAc for elution 
gave the title compound in form of two diastereomers as colorless syrups. Diastereomer 
A (33 mg, 12%): Rf 0.52 (15% EtOAc/hexanes); 1H NMR (400 MHz, CHCl3) δ 7.07 (d, J 
= 7.2 Hz, 1H), 6.99 (t, J = 7.2 Hz, 1H), 6.63 (td, J = 7.2, 0.8 Hz, 1H), 6.48 (d, J = 7.2 Hz, 
1H), 4.16 (q, J = 7.2 Hz, 2H), 3.98 (ddd, J = 12.4, 9.6, 6.0 Hz, 1H), 3.92 (ddd, J = 3.2, 
3.2, 0.8 Hz, 1H), 3.56-3.48 (m, 3H), 2.63 (dd, J = 13.2, 6.0 Hz, 1H), 2.20 (dd, J = 6.0, 6.0 
Hz, 1H), 1.83 (q, J = 12.0 Hz, 1H), 1.61-1.51 (m, 5H), 1.38-1.24 (m, 5H), 0.90 (t, J = 7.2 
Hz, 3H); HRMS m/z calcd for C20H28NO3 [M+H]+ 330.2069, found: 330.2063. 





CHCl3) δ 7.05 (d, J = 7.6 Hz, 1H), 7.00 (t, J = 7.6 Hz, 1H), 6.65 (t, J = 7.6 Hz, 1H), 6.48 
(d, J = 7.6 Hz, 1H), 4.18 (qd, J = 7.2, 0.8 Hz, 2H), 3.71 (d, J = 4.4 Hz, 1H), 3.68 (s, br, 
1H), 3.53-3.43 (m, 2H), 3.38 (s, 1H), 3.09 (dd, J = 13.2, 6.0 Hz, 1H), 2.12 (dd, J = 13.6, 
6.0 Hz, 1H), 1.92 (dq, J =1.0, 12.4 Hz, 1H), 1.62-1.55 (m, 2H), 1.58 (s, 3H), 1.42 (dq, J = 
7.2, 7.2 Hz, 2H), 1.28 (dt, J = 1.2, 6.4 Hz, 3H), 0.95 (t, J = 6.4 Hz, 3H); 13C NMR (100 
MHz, CHCl3) δ 173.1, 150.1, 128.0, 127.9, 124.7, 117.9, 108.4, 85.7, 71.1, 68.7, 61.7, 
60.2, 53.4, 33.7, 31.9, 27.7, 19.4, 14.3, 13.9; HRMS m/z calcd for C19H28NO3 [M+H]+ 













carboxylic acid ethyl ester (4.91c). The title compound was prepared from 4.52c and 1-
methyl indole at −18 °C according to the general procedure described above for the 
preparation of 4.85a. Purification by flash chromatography on silica gel with 10:1 
hexanes-EtOAc for elution gave the title compound in form of two diastereomers as 
colorless syrups (124 mg, 69%): Rf 0.72 (50% EtOAc/hexanes); 1H NMR (400 MHz, 
CHCl3) δ 7.16 (d, J = 7.2 Hz, 1H), 7.10 (dt, J = 0.8, 7.6 Hz, 1H), 6.64 (dt, J = 0.8, 7.2 Hz, 
1H), 6.40 (d, J = 8.0 Hz, 1H), 4.56 (dd, J = 10.4, 4.8 Hz, 1H), 4.43-4.31 (m, 2H), 4.26-
4.19 (m, 2H), 3.76 (t, J = 10.4 Hz, 1H), 3.53 (t, J = 10.0 Hz, 1H), 2.80 (s, 3H), 2.62 (dd, J 





11.6, 11.6, 9.6, 9.6 Hz, 1H), 1.31 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CHCl3) δ 
174.0, 151.9, 128.6, 128.3, 124.3, 117.5, 106.6, 92.8, 81.0, 75.5, 60.8, 52.6, 49.6, 46.8, 













carboxylic acid ethyl ester (4.91d). The title compound was prepared from 4.52c and 2-
methyl indole at −18 °C according to the general procedure described above for the 
preparation of 4.85a. Purification by flash chromatography on silica gel with 15:1 
hexanes-EtOAc for elution gave the title compound as a colorless syrup (124 mg, 72%): 
Rf 0.45 (20% EtOAc/hexanes); 1H NMR (400 MHz, CHCl3) δ 7.10 (d, J = 7.2 Hz, 1H), 
7.02 (dt, J = 0.8, 7.6 Hz, 1H), 6.66 (dt, J = 1.2, 7.2 Hz, 1H), 6.50 (d, J = 8.0 Hz, 1H), 4.32 
(dt, J = 2.4, 8.8 Hz, 1H), 4.24-4.16 (m, 3H), 4.03 (s, br, 1H), 3.95 (dd, J = 10.8, 8.0 Hz, 
1H), 3.53 (d, J = 7.6 Hz, 1H),  2.49 (d, J = 12.1 Hz, 1H), 2.35 (dq, J = 6.4, 12.0 Hz, 1H), 
1.98-1.91 (m, 1H), 1.65 (s, 3H), 1.69-1.63 (m, 1H), 1.28 (t, J = 8.4 Hz, 3H); 13C NMR 
(100 MHz, CHCl3) δ 171.9, 151.2, 128.1, 126.4, 125.5, 117.9, 108.2, 88.5, 78.9, 74.9, 















carboxylic acid ethyl ester (4.91e). The title compound was prepared from 4.52h and 1-
methyl indole at −18 °C according to the general procedure described above for the 
preparation of 4.85a. Purification by flash chromatography on silica gel with 15:1 
hexanes-EtOAc for elution gave the title compound in form of two diastereomer as a 
colorless syrup (175 mg, 88%): Rf 0.42 (15% EtOAc/hexanes); 1H NMR (400 MHz, 
CHCl3) δ 7.12-7.05 (m, 2H), 6.59 (t, J = 7.2 Hz, 1H), 6.43 (d, J = 8.0 Hz, 1H), 4.25-4.14 
(m, 2H), 4.03 (dd, J = 10.2, 5.2 Hz, 1H), 3.38 (d, J = 10.0 Hz, 1H), 2.98 (dd, J = 12.4, 4.8 
Hz, 1H), 2.78 (s, 3H), 2.70 (s, 3H), 2.53 (d, J = 10.2 Hz, 1H), 1.90-1.83 (m, 1H), 1.74-
1.70 (m, 1H), 1.65-1.55 (m, 3H), 1.28 (t, J = 7.2 Hz, 3H), 1.36-1.18 (m, 3H); 13C NMR 
(100 MHz, CHCl3) δ 175.9, 154.5, 128.4, 127.3, 125.0, 116.8, 107.4, 83.4, 75.4, 60.4, 
56.9, 54.0, 53.7, 50.5, 35.5, 30.5, 25.2, 24.1, 21.3, 14.3; HRMS m/z calcd for C20H28NO3 
















carboxylic acid ethyl ester (4.91f). The title compound was prepared from 4.52h and 2-
methyl indole at −18 °C according to the general procedure described above for the 
preparation of 4.85a. Purification by flash chromatography on silica gel with 15:1 
hexanes-EtOAc for elution gave the title compound as a colorless syrup (166 mg, 89%): 
Rf 0.67 (20% EtOAc/hexanes); 1H NMR (400 MHz, CHCl3) δ 7.00 (t, J = 7.2 Hz, 1H), 
6.95 (d, J = 7.2 Hz, 1H), 6.61 (td, J = 7.6, 0.8 Hz, 1H), 6.48 (d, J = 8.0 Hz, 1H), 4.22-
4.14 (m, 2H), 3.89 (s, br, 1H), 3.48 (s, 1H), 3.24 (s, 3H), 2.91 (d, J = 12.0 Hz, 1H), 2.13 
(d, J = 14.0 Hz, 1H), 1.81 (td, J = 12.0, 4.0 Hz, 1H), 1.71-1.03 (m, 7H), 1.56 (s, 3H), 1.28 
(t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CHCl3) δ 173.1, 151.0, 127.9, 126.5, 125.7, 
117.3, 108.5, 84.4, 70.7, 59.9, 59.3, 57.7, 48.1, 47.7, 28.9, 28.0, 24.8, 23.8, 20.9, 14.3; 













carboxylic acid ethyl ester (4.91g). The title compound was prepared from 4.52h and 5-
methyl indole at −18 °C according to the general procedure described above for the 
preparation of 4.85a. Purification by flash chromatography on silica gel with 15:1 
hexanes-EtOAc for elution gave the title compound as white solid (185 mg, 77%): Rf 0.74 





1H), 6.52 (d, J = 8.0 Hz, 1H), 4.51 (dd, J = 10.0, 5.6 Hz, 2H), 4.19-4.09 (m, 3H), 3.40 (d, 
J = 10.4 Hz, 1H), 2.98 (dd, J = 12.4, 4.8 Hz, 1H), 2.69 (s, 3H), 2.52 (d, J = 13.2 Hz, 1H), 
2.21 (s, 3H), 1.80-1.70 (m, 2H), 1.62-1.54 (m, 3H), 1.34-1.08 (m, 3H), 1.25 (t, J = 7.2 
Hz, 3H); 13C NMR (100 MHz, CHCl3) δ 175.9, 150.3, 128.6, 127.7, 127.4, 126.1, 110.0, 
83.5, 67.3, 60.3, 58.2, 55.4, 53.6, 50.5, 30.5, 25.2, 24.1, 21.4, 20.7, 14.3; HRMS m/z 













carboxylic acid ethyl ester (4.91h). The title compound was prepared from 4.52h and 7-
methyl indole at −18 °C according to the general procedure described above for the 
preparation of 4.85a. Purification by flash chromatography on silica gel with 15:1 
hexanes-EtOAc for elution gave the title compound as a colorless syrup (225 mg, 81%): 
Rf 0.64 (25% EtOAc/hexanes); 1H NMR (400 MHz, CHCl3) δ 7.02 (d, J = 7.2 Hz, 1H), 
6.87 (d, J = 7.2 Hz, 1H), 6.58 (t, J = 7.2 Hz, 1H), 4.54 (dd, J = 10.8, 5.6 Hz, 1H), 4.23-
4.08 (m, 3H), 4.01 (s, br, 1H), 3.46 (d, J = 10.8 Hz, 1H), 3.00 (dd, J = 12.0, 5.6 Hz, 1H), 
2.66 (s, 3H), 2.51 (d, J = 14.0 Hz, 1H), 2.11 (s, 3H), 1.81-1.54 (m, 5H), 1.38-1.21 (m, 
6H); 13C NMR (100 MHz, CHCl3) δ 176.0, 151.4, 129.1, 126.6, 123.0, 119.3, 118.1, 
83.7, 67.0, 60.4, 58.4, 55.5, 53.7, 50.5, 30.6, 25.2, 24.1, 21.4, 16.9, 14.4; HRMS m/z 














acid ethyl ester (4.91i). The title compound was prepared from 4.52g and 2-methyl 
indole at −18 °C according to the general procedure described above for the preparation 
of 4.85a. Purification by flash chromatography on silica gel with 15:1 hexanes-EtOAc for 
elution gave the title compound in form of two diastereomers as colorless syrups. 
Diastereomer A (51 mg, 27%): Rf 0.54 (25% EtOAc/hexanes); 1H NMR (400 MHz, 
CHCl3) δ 7.04-6.98 (m, 2H), 6.62 (t, J = 7.2 Hz, 1H), 6.49 (d, J = 8.0 Hz, 1H), 4.17 (q, J 
= 7.2 Hz, 2H), 3.82 (s, br, 1H), 3.24 (s, 1H), 3.23 (s, 3H), 3.04 (dd, J =13.2, 5.6 Hz, 1H), 
2.18 (ddd, J = 13.2, 5.6, 2.4 Hz, 1H), 1.74 (t, J = 13.2 Hz, 1H), 1.55 (s, 3H), 1.27 (t, J = 
7.2 Hz, 3H), 1.13 (s, 3H); 13C NMR (100 MHz, CHCl3) δ 173.1, 150.5, 128.0, 126.7, 
126.6, 117.5, 108.7, 85.1, 72.4, 64.2, 60.1, 52.5, 49.2, 38.1, 27.6, 19.3, 14.3; HRMS m/z 
calcd for C17H24NO3 [M+H]+ 290.1756, found: 290.1763. Diastereomer B (103 mg, 
54%): Rf 0.41 (25% EtOAc/hexanes); 1H NMR (400 MHz, CHCl3) δ 7.12 (d, J = 7.2 Hz, 
1H), 7.00 (t, J = 7.2 Hz, 1H), 6.65 (dt, J = 1.2, 7.6 Hz, 1H), 6.50 (d, J = 8.0 Hz, 1H), 4.18 
(q, J = 7.2 Hz, 2H), 3.81 (s, br, 1H), 3.14 (t, J = 6.0 Hz, 1H), 3.12 (s, 3H), 2.76 (dd, J 
=13.2, 6.4 Hz, 1H), 2.15 (t, J = 12.4 Hz, 1H), 1.96 (ddd, J = 12.4, 6.0, 0.8 Hz, 1H), 1.54 
(s, 3H), 1.39 (s, 3H), 1.28 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CHCl3) δ 172.4, 
150.2, 127.9, 127.8, 127.0, 117.7, 108.5, 81.7, 70.8, 65.2, 60.4, 52.9, 51.5, 37.7, 28.3, 















acid ethyl ester (4.91j). The title compound was prepared from 4.52g and 5-methyl 
indole at −18 °C according to the general procedure described above for the preparation 
of 4.85a. Purification by flash chromatography on silica gel with 15:1 hexanes-EtOAc 
for elution gave the title compound in form of three diastereomers as colorless syrups. 
Diastereomer A (41 mg, 21%): Rf 0.74 (25% EtOAc/hexanes); 1H NMR (400 MHz, 
CHCl3) δ 6.98 (s, 1H), 6.85 (d, J = 8.0 Hz, 1H), 6.52 (d, J = 8.0 Hz, 1H), 4.51 (dd, J = 
10.0, 5.6 Hz, 2H), 4.19-4.09 (m, 3H), 3.40 (d, J = 10.4 Hz, 1H), 2.98 (dd, J = 12.4, 4.8 
Hz, 1H), 2.69 (s, 3H), 2.52 (d, J = 13.2 Hz, 1H), 2.21 (s, 3H), 1.80-1.70 (m, 2H), 1.62-
1.54 (m, 3H), 1.34-1.08 (m, 3H), 1.25 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CHCl3) 
δ 175.9, 150.3, 128.6, 127.7, 127.4, 126.1, 110.0, 83.5, 67.3, 60.3, 58.2, 55.4, 53.6, 50.5, 
30.5, 25.2, 24.1, 21.4, 20.7, 14.3; HRMS m/z calcd for C20H28NO3 [M+H]+ 330.2069, 
found: 330.2063; Diastereomer B (57 mg, 30%): Rf 0.55 (25% EtOAc/hexanes); 1H 
NMR (400 MHz, CHCl3) δ 6.86 (s, 1H), 6.80 (d, J = 8.0 Hz, 1H), 6.42 (d, J = 8.0 Hz, 
1H), 4.72 (dq, J = 4.8, 4.8 Hz, 1H), 4.17 (q, J = 7.2 Hz, 2H), 3.91 (s, br, 1H), 3.61 (d, J 
= 8.4 Hz, 1H), 3.22 (s, 3H), 3.25-3.19 (m, 1H), 2.21 (s, 3H), 2.19-2.14 (m, 1H), 1.74 (t, 
J = 13.6 Hz, 1H), 1.27 (t, J = 7.2 Hz, 3H), 1.17 (s, 3H); 13C NMR (100 MHz, CHCl3) δ 
173.3, 128.4, 128.2, 127.1, 127.0, 108.7, 86.2, 65.0, 60.3, 56.8, 49.4, 48.5, 36.2, 29.7, 
20.8, 19.4, 14.3; HRMS m/z calcd for C17H24NO3 [M+H]+ 290.1756, found: 290.1754; 





CHCl3) δ 6.92 (s, 1H), 6.84 (d, J = 8.0 Hz, 1H), 6.48 (d, J = 8.0 Hz, 1H), 4.79 (dd, J = 
10.0, 3.6 Hz, 1H), 4.22-4.09 (m, 2H), 3.99 (s, br, 1H), 3.74 (d, J = 10.0 Hz, 1H), 3.22 (s, 
3H), 2.74 (ddd, J = 7.2, 7.2, 3.6 Hz, 1H), 2.33 (dd, J = 12.8, 6.0 Hz, 1H), 2.23 (s, 3H), 
1.84 (dd, J = 12.8, 7.2 Hz, 1H), 1.27 (t, J = 7.2 Hz, 3H), 1.17 (s, 3H); 13C NMR (100 
MHz, CHCl3) δ 174.0, 149.1, 128.4, 128.1, 127.7, 126.9, 109.2, 86.4, 65.3, 60.6, 56.7, 













acid ethyl ester (4.91k). The title compound was prepared from 4.52g and 7-methyl 
indole at −18 °C according to the general procedure described above for the preparation 
of 4.85a. Purification by flash chromatography on silica gel with 15:1 hexanes-EtOAc for 
elution gave the title compound in form of two diastereomers as colorless syrups. 
Diastereomer A (39 mg, 27%): Rf 0.74 (25% EtOAc/hexanes); 1H NMR (400 MHz, 
CHCl3) δ 6.98 (s, 1H), 6.85 (d, J = 8.0 Hz, 1H), 6.52 (d, J = 8.0 Hz, 1H), 4.51 (dd, J = 
10.0, 5.6 Hz, 2H), 4.19-4.09 (m, 3H), 3.40 (d, J = 10.4 Hz, 1H), 2.98 (dd, J = 12.4, 4.8 
Hz, 1H), 2.69 (s, 3H), 2.52 (d, J = 13.2 Hz, 1H), 2.21 (s, 3H), 1.80-1.70 (m, 2H), 1.62-
1.54 (m, 3H), 1.34-1.08 (m, 3H), 1.25 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CHCl3) δ 





30.5, 25.2, 24.1, 21.4, 20.7, 14.3; HRMS m/z calcd for C20H28NO3 [M+H]+ 330.2069, 
found: 330.2063; Diastereomer B (65 mg, 45%): Rf 0.60 (25% EtOAc/hexanes); IR (thin 
film) ν cm-1; 1H NMR (400 MHz, CHCl3) δ 7.00 (d, J =7.6 Hz, 1H), 6.88 (d, J = 7.2 Hz, 
1H), 6.65 (d, J = 7.2 Hz, 1H), 4.50 (dd, J = 7.2, 6.4 Hz, 1H), 4.19 (q, J = 7.2 Hz, 2H), 
4.01 (s, br, 1H), 3.70 (d, J = 10.8 Hz, 1H), 3.09 (s, 3H), 3.01 (dt, J = 13.2, 7.2 Hz, 1H), 
2.31 (dd, J = 13.6, 7.2 Hz, 1H), 2.10 (s, 3H), 1.70 (dd, J = 13.2, 12.0 Hz, 1H), 1.45 (s, 
3H), 1.29 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CHCl3) δ 175.2, 150.4, 128.7, 126.6, 
122.9, 118.8, 118.4, 83.8, 66.1, 60.6, 59.3, 52.0, 49.9, 38.8, 22.0, 17.0, 14.3; HRMS m/z 











carboxylic acid ethyl ester (4.91l). The title compound was prepared from 4.52g and 2, 
3-dimethyl indole at −18 °C according to the general procedure described above for the 
preparation of 4.85a. Purification by flash chromatography on silica gel with 15:1 
hexanes-EtOAc for elution gave the title compound in form of two diastereomers as 
colorless syrups. Diastereomer A (21 mg, 15%): Rf 0.46 (20% EtOAc/hexanes); 1H 
NMR (400 MHz, CHCl3) δ 7.10 (d, J = 7.6 Hz, 1H), 7.02 (t, J = 7.6 Hz, 1H), 6.69 (t, J = 
7.6 Hz, 1H), 6.57 (d, J = 7.2 Hz, 1H), 4.23-4.08 (m, 3H), 3.15 (dd J = 6.0, 2.8 Hz, 1H),  





(s, 3H); 13C NMR (100 MHz, CHCl3) δ 173.8, 148.5, 133.5, 127.5, 125.4, 118.2,109.4, 
85.1, 74.2, 62.5, 60.4, 53.8, 49.6, 35.5, 22.6, 20.2, 19.5, 14.4; HRMS m/z calcd for 
C18H26NO3 [M+H]+ 304.1913, found: 304.1914; Diastereomer B (52 mg, 37%): Rf 0.57 
(20% EtOAc/hexanes); 1H NMR (400 MHz, CHCl3) δ 7.19 (dd, J = 7.6, 0.8 Hz, 1H), 
6.97 (dt, J = 1.6, 7.2 Hz, 1H), 6.64 (dt, J = 0.8, 7.2 Hz, 1H), 6.44 (d, J = 8.0 Hz, 1H), 4.20 
(q, J = 7.2 Hz, 2H), 3.92 (s, br, 1H), 3.23 (s, 3H), 2.69 (dd, J = 12.8, 7.2 Hz, 1H), 2.00 (t, 
J = 7.6 Hz, 1H), 1.94 (q, J = 6.8 Hz, 1H), 1.49 (s, 3H), 1.30 (s, 3H), 1.29 (t, J = 7.2 Hz, 
3H), 1.23 (s, 3H); 13C NMR (100 MHz, CHCl3) δ 172.4, 148.9, 134.2, 127.6, 127.4, 
117.6, 107.6, 83.6, 71.1, 61.0, 60.3, 54.2, 51.2, 36.8, 25.3, 20.2, 19.0, 14.3; HRMS m/z 













[2-(3-Methyl-1H-indol-2-yl)-cyclohex-2-enyl]-acetic acid ethyl ester (4.93a) and [6-
(2-Methyl-1H-indol-3-yl)-cyclohex-1-enyl]-acetic acid ethyl ester (4.93b). The title 
compounds were prepared from 4.52h and 3-dimethyl indole 4.92 at −18 °C according to 
the general procedure described above for the preparation of 4.85a. Purification by flash 
chromatography on silica gel with 15:1 hexanes-EtOAc for elution gave the title 
compound in form of two diastereomers as colorless syrups. 4.93a: (164mg, 76%): Rf 
0.45 (25% EtOAc/hexanes); 1H NMR (400 MHz, CHCl3) δ 8.00 (s, br, 1H), 7.51 (d, J  = 





1H), 4.02 (dq, J = 3.2, 7.2 Hz, 2H), 3.17-3.10 (m, 1H), 2.34 (dd, J = 15.6, 3.6 Hz, 1H), 
2.30 (s, 3H), 2.26-2.17 (m, 3H), 1.97-1.87 (m, 1H), 1.73-1.64 (m, 3H), 1.67 (t, J = 7.2 
Hz, 3H); 13C NMR (100 MHz, CHCl3) δ 173.2, 135.1, 134.7, 132.5, 130.3, 129.5, 121.6, 
119.1, 118.4, 110.5, 108.3, 60.4, 38.7, 33.6, 27.8, 25.7, 18.6, 14.1, 9.6; 4.93b (17 mg, 
8%): Rf 0.58 (25% EtOAc/hexanes); 1H NMR (400 MHz, CHCl3) δ 7.57 (d, J  = 7.6 Hz, 
1H), 7.39 (d, J  = 8.0 Hz, 1H), 7.22 (dd, J  = 0.8, 8.0 Hz, 1H), 7.13 (dt, J  = 0.8, 8.0 Hz, 
1H), 6.93 (d,  = 0.8 Hz, 1H), 5.92 (dt, J  = 0.8, 8.0 Hz, 1H), 3.97 (dq, J = 2.0, 7.2 Hz, 
2H), 3.28-3.20 (m, 1H), 2.35 (d, J = 0.8 Hz, 3H), 2.33-2.17 (m, 3H), 2.10 (dd, J  = 12.0, 
3.6 Hz, 1H), 2.06-1.99 (m, 1H), 1.78-1.74 (m, 3H), 1.14 (t, J  = 7.6 Hz, 3H); 13C NMR 
(100 MHz, CHCl3) δ 172.3, 137.6, 136.6, 128.8, 124.4, 124.3, 121.7, 119.0, 118.8, 111.3, 







12-Methyl-2,3,4,4a,5,6-hexahydro-indolo[2,1-a]isoquinolin-6-ol (4.94): To a solution 
of the cyclopropane 4.93a (147 mg, 0.49 mmol) in THF (4.0 mL) at −0 °C was added 
DIBAL-H (20% in toluene, 0.9 mL, 0.9 mmol). The resulting mixture was stirred for 1.5 
h and then poured into a vigorously stirred solution of saturated aqueous NH4Cl  (10 mL). 
After 2 min the resulting mixture was extracted with EtOAc (3 × 6 mL). The combined 
organic solution was washed with H2O (2 × 3 mL), brine (5 mL) and dried (MgSO4). 





pressure. Purification of the residue by flash chromatography on silica gel with 10:1 
hexanes-EtOAc for elution gave the product as white solid (104 mg, 85%): Rf 0.28 (25% 
EtOAc/hexanes); 1H NMR (400 MHz, CHCl3) δ 7.53 (d, J = 7.5 Hz, 1H), 7.32 (d, J = 7.9 
Hz, 1H), 7.18 (dt, J = 1.4, 8.2 Hz, 1H), 7.13 (dt, J = 1.0, 8.5 Hz, 1H), 6.30-6.25 (m, 1H), 
5.99 (dd, J = 4.8, 2.8 Hz, 1H), 2.86-2.77 (m, 1H), 2.57 (d, J = 5.2 Hz, 1H), 2.40 (s, 3H), 
2.37-2.28 (m, 2H), 2.20 (dt, J = 13.6, 2.8 Hz, 1H), 2.02-1.98 (m, 1H), 1.91-1.87 (m, 1H), 
1.80 (dd, J = 13.6, 3.6 Hz, 1H), 1.70-1.59 (m, 1H), 1.37-1.26 (m, 1H); 13C NMR (100 
MHz, CHCl3) δ 134.3, 131.0, 130.6, 125.7, 121.8, 120.0, 118.5, 108.6, 107.1, 73.8, 37.8, 







2,2-Di-tert-butyl-4-phenethyl-[1,3,2]-dioxasilinane (5.15). To a solution of diol 5.14165 
(2.59 g, 14.4 mmol) in THF:DMF (2:1, 30 mL) cooled to –30 °C was added tBu2Si(OTf)2 
(5.80 mL, 15.8 mmol) dropwise over 15 min. After 25 min the reaction mixture was 
neutralized with pyridine (2.40 mL, 30.0 mmol), allowed to warm to rt and diluted with 
Et2O (150 mL). The reaction mixture was washed with saturated NaHCO3 solution, H2O, 
brine, dried (MgSO4), and filtered through celite.  Volatiles were removed under reduced 
pressure and the residue was purified by flash chromatography on silica gel using 20:1 
hexanes-EtOAc for elution to provide the title compound as a colorless syrup (4.01 g, 
87%): Rf 0.70 (5% EtOAc/hexanes); 1H NMR (300 MHz, CHCl3) δ 7.35-7.20 (m, 5H), 





1.08 (d, J = 1.2 Hz, 9H), 1.06 (d, J = 1.2 Hz, 9H); 13C NMR (75 MHz, CHCl3) δ 142.7, 
128.8, 128.5, 125.9, 73.0, 64.5, 40.7, 36.8, 31.6, 27.7, 27.4, 22.9, 20.1; HRMS m/z calcd 











BF3•SMe2 (7.5 eq) 





3-(Di-tert-butyl-fluoro-silanyloxy)-5-phenyl-pentan-1-ol (5.16a). To a 10-mL round-
bottomed flask containing 5.15 (350 mg, 1.09 mmol) was added KOAc (300 mg, 3.0 
mmol) and freshly activated molecular sieves (3 Å, 250 mg).  The flask was sealed with a 
rubber septum, flushed with argon and treated sequentially with CHCl3 (2.5 mL), allyl 
trimethylsilane (35 µL, 0.20 mmol) and BF3•Me2S (860 µL, 8.2 mmol, 7.5 eq). After 5.5 
h the mono-deprotection was complete (TLC), and the reaction mixture was transferred 
into a vigorously stirred saturated NaHCO3 solution (10 mL) with the aid of CH2Cl2. The 
heterogeneous solution was filtered through a glass frit and the organic layer was 
separated and washed with H2O, brine and dried (MgSO4). After filtration through a 
small pad of celite, volatiles were removed under reduced pressure. Purification of the 
residual syrup by flash chromatography on silica gel with 15:1 hexanes-EtOAc for 
elution afforded the title compound as a colorless syrup (316 mg, 85%): Rf 0.61 (33% 
EtOAc/hexanes); IR (thin film) ν 3450 (br) cm-1; 1H NMR (300 MHz, CHCl3) δ 7.36-
7.21 (m, 5H), 4.42-4.38 (dddd, J = 5.3, 5.3, 5.3, 5.3 Hz, 1H), 3.92-3.79 (m, 2H), 2.77-
2.72 (m, 2H), 2.36 (br s, 1H), 2.10-1.84 (m, 5H), 1.13 (s, 9H), 1.12 (s, 9H); 13C NMR (75 





39.1 (CH2), 38.9 (CH2), 31.5 (CH2), 27.4 (CH3), 20.7 (d, J = 15.1 Hz, C), 20.4 (d, J = 
15.1 Hz, C); 19F NMR (300 MHz, CHCl3) δ –158.7; HRMS m/z calcd for C19H33FO2Si 




















hydroxy-silanyloxy)-5-phenyl-pentan-1-ol (5.17a) and  1-(Di-tert-butyl-hydroxy-
silanyloxy)-5-phenyl-pentan-3-ol (5.17b). Deprotection of 5.15 with BF3•Et2O 
according to the procedure previously described for preparation of 2.27 except that the 
reaction was performed at rt, provided a mixture of: 5.14, 12 mg, 8%; 5.15, 97 mg, 36%; 
5.16a, 58 mg, 21%; 5.16b, 6 mg, 2%; 5.17a, 25 mg, 9%; and 5.17b, 8 mg, 3%. (5.16b): 
Rf 0.67 (33% EtOAc/ hexanes); IR (thin film) ν 3405 (br) cm-1; 1H NMR (300 MHz, 
CHCl3) δ 7.34-7.18 (m, 1H), 4.16 (dddd, J = 5.8, 5.8, 5.8, 5.8 Hz, 1H), 4.09-4.02 (m, 
1H), 3.98-3.86 (m, 1H), 2.90-2.80 (m, 1H), 2.77-2.67 (m, 1H), 2.62 (d, J = 3.4 Hz, 1H), 
1.90-1.73 (m, 4H), 1.06 (s, 18H); 13C NMR (75 MHz, CHCl3) δ 142.0 (C), 128.7 (CH), 
128.6 (CH), 126.0 (CH), 70.4 (CH), 63.2 (CH2), 39.4 (CH2), 39.2 (CH2), 32.2 (CH2), 27.1 
(CH3), 27.0 (CH3), 20.2 (d, J = 15.0 Hz, C), 20.1 (d, J = 15.0 Hz, C); 19F NMR (300 
MHz, CHCl3) δ –165.3; HRMS m/z calcd for C19H33FO2Si [M+H]+ 341.2312, found: 
341.2312. (5.17a): Rf 0.37 (33% EtOAc/ hexanes); IR (thin film) ν 3420 (br) cm-1; 1H 
NMR (300 MHz, CHCl3) δ 7.34-7.17 (m, 5H), 4.37-4.30 (m, 1H), 4.01-3.92 (ddd, J = 





s, 1H), 2.82-2.61 (m, 2H), 2.00-1.88 (m, 3H), 1.81-1.70 (m, 1H), 1.07 (d, J = 1.0 Hz, 
9H), 1.05 (d, J = 1.0 Hz, 9H); 13C NMR (75 MHz, CHCl3) δ 142.6 (C), 128.7 (CH), 
128.6 (CH), 126.0 (CH), 70.0 (CH), 59.6 (CH2), 39.5 (CH2), 38.3 (CH2), 31.3 (CH2), 27.9 
(CH3), 27.6 (CH3), 21.1 (C), 20.8 (C); HRMS m/z calcd for C19H34O3Si [M+H]+ 
339.2355, found: 339.2355. (5.17b): Rf 0.32 (33% EtOAc/ hexanes); IR (thin film) ν 
3405 (br) cm-1; 1H NMR (300 MHz, CHCl3) δ 7.33-7.17 (m, 5H), 4.18-4.11 (m, 1H), 
4.00-3.89 (m, 2H), 3.19 (br s, 1H), 2.88-2.66 (m, 3H), 1.19-1.62 (m, 4H), 1.05 (s, 9H), 
1.03 (s, 9H); 13C NMR (75 MHz, CHCl3) δ 142.4, 128.7, 128.6, 126.0, 70.4, 62.4, 39.4, 










3-(Di-tert-butyl-fluoro-silanyloxy)-5-pheny-pentanoic acid (5.18). To a rt solution of 
5.16a (150 mg, 0.44 mmol) in acetone (3.5 mL) was added Jones’ reagent177 drop wise 
until a brown color persisted. The resulting solution was then treated with iso-propanol 
drop-wise until the solution became green-blue. To the reaction mixture was added H2O 
and the organic solvent was removed under reduced pressure. The residue was 
redissolved in Et2O and the solution was washed with saturated NaHCO3 solution, H2O, 
brine and dried (MgSO4).  The solution was filtered through celite and volatiles were 
removed under reduced pressure.  Purification of the residual syrup by flash 





compound as a yellow syrup (112 mg, 72%): Rf 0.34 (50% EtOAc/hexanes); IR (thin 
film) ν 3110 (br), 1738 cm-1; 1H NMR (300 MHz, CHCl3) δ 7.33-7.19 (m, 5H), 4.61 
(dddd, J = 5.9, 5.9, 5.9, 5.9 Hz, 1H), 2.78-2.63 (m, 4H), 2.03-1.95 (m, 2H), 1.07 (s, 18H); 
13C NMR (75 MHz, CHCl3) δ 177.1, 141.9, 128.7, 128.6, 126.2, 70.7, 42.1, 39.1, 31.3, 
27.25, 27.21, 20.5 (d, J = 15.3 Hz), 20.4 (d, J = 15.3 Hz); 19F NMR (300 MHz, CHCl3) δ 









3-(Di-tert-butyl-fluoro-silanyloxy)-5-pheny-pentanal (5.19). To a rt suspension of 
pyridinium chlorochromate (133 mg, 0.62 mmol) in CH2Cl2 (3.5 mL) was added a 
solution of 5. 16a (60 mg, 0.18 mmol) in CH2Cl2 (1.2 mL). After 2.5 h florisil and Et2O 
(5 mL) were added to the reaction mixture, which was subsequently filtered through 
florisil.  The volatile components were removed under reduced pressure and purification 
of the residue by flash chromatography on silica gel (20:1 hexanes-EtOAc for elution) 
provided the title compound as a colorless syrup (109 mg, 82%): Rf 0.65 (25% 
EtOAc/hexanes); IR (thin film) ν 1722 cm-1; 1H NMR (300 MHz, CHCl3) δ 9.88 (dd, J = 
2.3, 2.3 Hz, 1H), 7.34-7.20 (m, 5H), 4.66 (dddd, J = 5.8, 5.8, 5.8, 5.8 Hz, 1H), 2.78-2.69 
(m, 4H), 2.00 (ddd, J = 5.8, 2.9, 2.9 Hz, 2H), 1.07 (s, 18H); 13C NMR (75 MHz, CHCl3) 
δ 201.5, 141.7, 128.7, 128.6, 126.3, 69.6, 50.7, 39.4, 31.5, 27.2, 20.6, 20.4; 19F NMR 
(300 MHz, CHCl3) δ –159.1; HRMS m/z calcd for C19H3F1O2Si [M+H]+ 339.2156, 












Di-tert-butyl-fluoro-(3-iodo-1-phenethyl-propoxy)-silane (5.20a). To a rt solution of 
5.16a (160 mg, 0.47 mmol) and p-toluene sulfonyl chloride (106 mg, 0.59 mmol) in 
CH2Cl2 (4.5 mL) was added pyridine (0.5 mL, 6.2 mmol) in one portion. The resulting 
solution was stirred at rt for 20 h and then volatiles were removed under reduced 
pressure. The resulting residue was dissolved in CH2Cl2 and the solution was washed 
with saturated NaHCO3 solution, H2O, brine and dried (MgSO4). After filtration through 
a pad of celite, volatiles were removed under reduced pressure, and the residue was 
dissolved in a mixture of acetone (4.5 mL) and NaI (720 mg, 4.8 mmol, 10.0 equiv).  
After 30 h at reflux, the cooled reaction mixture was treated with saturated NaHCO3 
solution, and the acetone was removed under reduced pressure.  The resulting mixture 
was extracted with EtOAc, and the combined organic layers were washed with H2O, 
brine and dried (MgSO4). After filtration through a pad of celite, volatiles were removed 
under reduced pressure. Purification of the residual syrup by flash chromatography on 
silica gel with 15:1 hexanes-EtOAc for elution provided the title compound as a pale 
yellow syrup (180 mg, 85%): Rf 0.57 (15% EtOAc/hexanes); 1H NMR (300 MHz, 
CHCl3) δ 7.34-7.19 (m, 5H), 4.23 (dddd, J = 6.5, 6.5, 6.5, 6.5 Hz, 1H), 3.30 (t, J = 7.2 
Hz, 2H), 2.74-2.68 (m, 2H), 2.17 (ddd, J = 7.2, 7.2, 7.2 Hz, 2H), 1.96-1.89 (m, 2H), 1.08 
(s, 18H); 13C NMR (75 MHz, CHCl3) δ 142.1 (C), 128.7 (CH), 128.6 (CH), 126.1 (CH), 





(C), 1.9 (CH2); 19F NMR (300 MHz, CHCl3) δ –157.9; HRMS m/z calcd for C19H32FIOSi 









Di-tert-butyl-3-iodo-1-phenethyl-propoxy)-silanol (5.20b). The title compound was 
prepared from 5.17a according to the general procedure described for the preparation of 
5.20a (pale syrup, 81%): Rf 0.47 (15% EtOAc/hexanes); IR (thin film) ν 3590 (br) cm-1; 
1H NMR (300 MHz, CHCl3) δ 7.34-7.19 (m, 5H), 4.15 (dddd, J = 5.7, 5.7, 5.7, 5.7 Hz, 
1H), 3.33 (ddd, J = 7.2, 7.2, 7.2 Hz, 2H), 2.70 (dddd, J = 7.2, 7.2, 7.2, 5.7 Hz, 2H), 2.20-
2.14 (m, 2H), 2.07 (s, 1H), 1.96-1.90 (m, 2H), 1.06 (s, 9H), 1.05 (s, 9H); 13C NMR (75 
MHz, CHCl3) δ 142.3 (C), 128.7 (CH), 128.6 (CH), 126.2 (CH), 72.9 (CH), 41.0 (CH2), 
38.3 (CH2), 31.3 (CH2), 27.9 (CH3), 20.6 (C), 2.8 (CH2); HRMS m/z calcd for 







(2,2-Di-tert-butyl-[1,3,2]dioxasilinan-4-yl)-methanol. The title compound was prepared 
from butane-1,2,4-triol178 according to the general procedure described for the 
preparation of 4 (colorless syrup, 82%): Rf 0.35 (50% EtOAc/hexanes); IR (thin film) ν 





Hz, 2H), 3.58-3.51 (m, 1H), 3.46 (dd, J = 10.1, 7.4 Hz, 1H), 2.37 (br s, 1H), 1.92-1.78 
(m, 1H), 1.59 (dddd, J = 14.1, 2.6, 2.6, 2.6 Hz, 1H), 1.04 (s, 9H), 0.99 (s, 9H); 13C NMR 
(75 MHz, CHCl3) δ 74.6, 67.7, 64.0, 32.5, 27.6, 27.3, 22.9, 20.1; HRMS m/z calcd for 







Acetic acid 2,2-di-tert-butyl-[1,3,2]dioxasilinan-4-ylmethyl ester (5.21a). To a solution 
of (2,2-Di-tert-butyl-[1,3,2]dioxasilinan-4-yl)-methanol (2.52 g, 10.2 mmol) in CH2Cl2 
(22 mL) was added pyridine (2.41 mL, 29.7 mmol) and Ac2O (4.33 mL, 45.9 mmol). 
After 15 h at rt the mixture was poured into a vigorously stirred saturated NaHCO3 
solution (20 mL).  The organic layer was separated and washed with saturated NH4Cl 
solution, H2O, brine, dried (MgSO4) and filtered through celite. Volatile components 
were removed under reduced pressure, and the residual syrup was purified by flash 
chromatography on silica gel using 15:1 hexanes-EtOAc for elution to provide the title 
compound as a pale yellow syrup (2.70 g, 92%): Rf 0.35 (15% EtOAc/hexanes); IR (thin 
film) ν 1744 cm-1; 1H NMR (300 MHz, CHCl3) δ 4.31-4.27 (m, 1H), 4.13-4.08 (m, 3H), 
4.03 (ddd, J = 11.0, 5.2, 1.0 Hz, 1H), 2.06 (s, 3H), 1.95-1.81 (m, 1H), 1.66 (ddd, J = 14.1, 
4.1, 1.5 Hz, 1H), 1.01 (s, 9H), 0.98 (s, 9H); 13C NMR (75 MHz, CHCl3) δ 171.1, 71.9, 
68.4, 63.9, 33.1, 27.5, 27.2, 22.8, 21.1, 20.1; HRMS m/z calcd for C14H28O4Si [M+H]+ 








HO (  )2  
2-(2,2-Di-tert-butyl-[1,3,2]dioxasilinan-4-yl)-ethanol. The title compound was prepared 
from 1,3,5-pentane triol179 according to the general procedure described for the 
preparation of 4 (colorless syrup, 85%): Rf 0.37 (50% EtOAc/hexanes); IR (thin film) ν 
3405 (br) cm-1; 1H NMR (300 MHz, CHCl3) δ 4.36-4.28 (m, 1H), 4.09-4.04 (m, 2H), 
3.89-3.77 (m, 2H), 3.03 (br s, 1H), 1.96-1.74 (m, 2H), 1.67-1.53 (m, 2H), 1.00 (s, 9H), 
0.96 (s, 9H); 13C NMR (75 MHz, CHCl3) δ 75.6, 64.2, 61.9, 39.7, 36.6, 27.4, 27.0, 22.6, 





AcO (  )2
5.21b  
Acetic acid 2-(2,2-di-tert-butyl-[1,3,2]dioxasilinan-4-yl)-ethyl ester (5.21b). The title 
compound was prepared from 2-(2,2-Di-tert-butyl-[1,3,2]dioxasilinan-4-yl)-ethanol 
according to the general procedure described for the preparation of 5.21a (pale yellow 
syrup, 90%): Rf 0.55 (25% EtOAc/ hexanes); IR (thin film) ν 1740 cm-1; 1H NMR (300 
MHz, CHCl3) δ 4.24-4.10 (m, 3H), 4.07 (ddd, J = 5.4, 2.6, 2.6 Hz, 2H), 2.01 (s, 3H), 





NMR (75 MHz, CHCl3) δ 171.4, 70.9, 64.5, 61.4, 37.6, 36.8, 27.6, 27.3, 22.9, 21.2, 20.0; 







Benzoic acid 2,2-di-tert-butyl-[1,3,2]dioxasilinan-4-ylmethyl ester (5.21c). To a 
solution of (2,2-Di-tert-butyl-[1,3,2]dioxasilinan-4-yl)-methanol (1.76 g, 7.2 mmol) in 
CH2Cl2 (20 mL) was added pyridine (1.00 mL, 12.3 mmol) and benzoyl chloride (2.51 
mL, 21.6 mmol). After stirring for 13 h at rt the mixture was worked up as described for 
5.12a. Purification of the residual syrup by flash chromatography on silica gel using 18:1 
hexanes-EtOAc for elution provided the title compound as a colorless syrup (2.23 g, 
89%): Rf 0.45 (20% EtOAc/hexanes); IR (thin film) ν 1720 cm-1; 1H NMR (300 MHz, 
CHCl3) δ 8.10-8.06 (m, 2H), 7.62-7.58 (m, 1H), 7.57-7.44 (m, 2H), 4.49-4.38 (m, 2H), 
4.33-4.26 (m, 1H), 4.18 (ddd, J = 7.8, 2.5, 2.5 Hz, 2H), 2.06-1.94 (m, 1H), 1.79 (ddd, J = 
13.8, 2.5, 2.5 Hz, 1H), 1.06 (s, 9H), 1.03 (s, 9H); 13C NMR (75 MHz, CHCl3) δ 166.6, 
133.2, 130.4, 129.8, 128.6, 72.0, 68.8, 64.0, 33.2, 27.6, 27.2, 22.9, 20.1; HRMS m/z calcd 









BzO (  )2
5.21d  
4-(2-Benzyloxy-ethyl)-2,2-di-tert-butyl-[1,3,2]-dioxasilinane (5.21d). The title 
compound was prepared from 5-benzyloxy-pentane-1,3-diol180 according to the general 
procedure described for the preparation of 5.15 (colorless syrup, 94%): Rf 0.45 (20% 
EtOAc/hexanes); 1H NMR (300 MHz, CHCl3) δ 7.39-7.28 (m, 5H), 4.56 (s, 2 H), 4.34-
4.26 (m, 1H), 4.14-4.10 (m, 2H), 3.77-3.61 (m, 2H), 1.92-1.72 (m, 3H), 1.70-1.62 (m, 
1H), 1.10 (s, 9H), 1.06 (s, 9H); 13C NMR (75 MHz, CHCl3) δ 138.5, 128.3, 127.6, 127.4, 
73.1, 70.8, 66.5, 64.3, 38.7, 36.6, 27.4, 27.1, 22.6, 19.7; HRMS m/z calcd for C20H35O3Si 





AllylO (  )2
5.21e  
4-(2-Allyloxy-ethyl-2,2-di-tert-butyl-[1,3,2]-dioxasilinane (5.21e). To a rt solution of 2-
(2,2-Di-tert-butyl-[1,3,2]dioxasilinan-4-yl)-ethanol (1.22 g, 4.7 mmol) in CH2Cl2 (1.4 
mL) and cyclohexane (2.8 mL) was added allyl trichloroacetimidate181 (1.78 g, 8.9 mmol) 
and catalytic trifluoromethanesulphonic acid (~50 µL). After 3 h the reaction mixture was 





dissolved in CH2Cl2, washed with saturated NaHCO3 solution, H2O, brine and dried 
(MgSO4). After filtration through celite, the volatile components were removed under 
reduced pressure, and the residual syrup was purified by flash chromatography on silica 
gel using 40:1 hexanes-EtOAc for elution to provide the title compound as a colorless 
syrup (1.14 g, 81%): Rf 0.68 (20% EtOAc/hexanes); 1H NMR (300 MHz, CHCl3) δ 5.98-
5.81 (m, 1H), 5.30-5.14 (m, 2H), 4.27-4.19 (m, 1H), 4.10-4.07 (m, 2H), 3.99-3.96 (m, 
2H), 3.66-3.52 (m, 2H), 1.88-1.66 (m, 3H), 1.60 (dddd, J = 14.1, 2.6, 2.6, 2.6 Hz, 1H), 
1.02 (s, 9H), 0.98 (s, 9H); 13C NMR (75 MHz, CHCl3) δ 135.2, 117.0, 72.2, 71.1, 66.6, 
64.6, 38.9, 36.9, 27.7, 27.3, 22.9, 20.0; HRMS m/z calcd for C16H32O3Si [M+H]+ 301. 





PhCH2O (  )2
5.21f  
4-(2-Benzyloxy-ethyl)-2,2-di-tert-butyl-[1,3,2]-dioxasilinane (5.21f). The title 
compound was prepared from 5-benzyloxy-pentane-1,3-diol180 according to the general 
procedure described for the preparation of 5.15 (colorless syrup, 94%): Rf 0.45 (20% 
EtOAc/hexanes); 1H NMR (300 MHz, CHCl3) δ 7.39-7.28 (m, 5H), 4.56 (s, 2 H), 4.34-
4.26 (m, 1H), 4.14-4.10 (m, 2H), 3.77-3.61 (m, 2H), 1.92-1.72 (m, 3H), 1.70-1.62 (m, 
1H), 1.10 (s, 9H), 1.06 (s, 9H); 13C NMR (75 MHz, CHCl3) δ 138.5, 128.3, 127.6, 127.4, 
73.1, 70.8, 66.5, 64.3, 38.7, 36.6, 27.4, 27.1, 22.6, 19.7; HRMS m/z calcd for C20H35O3Si 








CH3O (  )2
5.21g  
2,2-Di-tert-butyl-4-(2-methoxy-ethyl)-[1,3,2]-dioxasilinane (5.21g). The title 
compound was prepared from 2-(2,2-Di-tert-butyl-[1,3,2]dioxasilinan-4-yl)-ethanol and 
methyl trichloroacetimidate (2.0 eq) according to the general procedure described for the 
preparation of 5.21e (colorless syrup, 76%): Rf 0.53 (25% EtOAc/hexanes); 1H NMR 
(300 MHz, CHCl3) δ 4.16 (dddd, J = 5.4, 5.4, 5.4, 2.5 Hz, 1H), 4.06 (ddd, J = 9.0, 2.5, 
2.5 Hz, 2H), 3.49 (m, 2H), 3.31 (s, 3H), 1.81-1.71 (m, 1H), 1.69-1.62 (m, 2H), 1.57 
(dddd, J = 14.2, 2.5, 2.5, 2.5 Hz, 1H), 0.99 (s, 9H), 0.96 (s, 9H); 13C NMR (75 MHz, 
CHCl3) δ 71.2, 69.2, 64.6, 59.0, 38.9, 36.9, 27.7, 27.4, 22.9, 20.0; HRMS m/z calcd for 





TIPSO (  )2
5.21h  
2,2-Di-tert-butyl-4-(2-triisopropylsilanyloxy-ethyl)-[1,3,2]-dioxasilinane (5.21h). To a 
rt solution of 2-(2,2-Di-tert-butyl-[1,3,2]dioxasilinan-4-yl)-ethanol (1.97 g, 7.6 mmol) in 
CH2Cl2 (7.5 mL) were added pyridine (1.22 mL, 15.0 mmol) and triisopropylsilyl  





poured into a vigorously stirred saturated NH4Cl solution (8 mL). The organic layer was 
separated and the aqueous layer was extracted with CH2Cl2. The combined organic layers 
were washed with H2O, brine and dried (MgSO4). After filtration through celite, volatiles 
were removed under reduced pressure. Purification of the residual syrup by flash 
chromatography on silica gel using 30:1 hexanes-EtOAc for elution provided the title 
compound as a colorless syrup (1.91 g, 90%): Rf 0.69 (5% EtOAc/hexanes); 1H NMR 
(300 MHz, CHCl3) δ 4.29 (dddd, J = 12.8, 6.2, 6.2, 2.6 Hz, 1H), 4.13-4.08 (m, 2H), 3.95-
3.79 (m, 2H), 1.91-1.77 (m, 1H), 1.73-1.61 (m, 3H), 1.11-0.98 (m, 39H); 13C NMR (75 
MHz, CHCl3) δ 70.9, 64.4, 59.7, 42.1, 37.0, 27.6, 27.4, 22.8, 20.0, 18.3, 12.2; HRMS m/z 





TBSO (  )2
5.21i  
2,2-Di-tert-butyl-4-[2-(tert-butyl-dimethyl-silanyloxy)-ethyl]-[1,3,2]-dioxasilinane 
(5.21i). The title compound was prepared from 2-(2,2-Di-tert-butyl-[1,3,2]dioxasilinan-4-
yl)-ethanol according to the general procedure described for the preparation of 5.21h 
except using tert-butyldimethylsilyl chloride (1.7 eq) afforded the product as a colorless 
syrup (colorless syrup, 90%): Rf 0.57 (5% EtOAc/ hexanes); 1H NMR (300 MHz, CHCl3) 
δ 4.20 (dddd, J = 12.9, 10.5, 5.7, 5.7 Hz, 1H), 4.08-4.04 (m, 2H), 3.82-3.66 (m, 2H), 
1.85-1.71 (m, 1H), 1.66-1.55 (m, 3H), 0.99 (s, 9H), 0.96 (s, 9H), 0.87 (s, 9H), 0.03 (s, 













Acetic acid 2-(di-tert-butyl-fluoro-silanyloxy)-4-hydroxy-butyl ester (5.22a). The title 
compound was prepared from 5.21a according to the general procedure described for the 
preparation of 5.16a, except that 2.3 equivalents of BF3•Me2S were used (colorless syrup, 
91%): Rf 0.48 (33% EtOAc/hexanes); IR (thin film) ν 3450 (br), 1744 cm-1; 1H NMR 
(300 MHz, CHCl3) δ 4.42 (dddd, J = 4.2, 4.2, 4.2, 4.2 Hz, 1H), 4.09 (dddd, J = 11.2, 
11.2, 11.2, 4.2 Hz, 2H), 3.94-3.71 (m, 2H), 2.39 (br s, 1H), 2.04 (s, 3H), 1.78 (ddd, J = 
11.2, 3.8, 3.8 Hz, 2H), 1.01 (s, 9H), 1.00 (s, 9H); 13C NMR (75 MHz, CHCl3) δ 171.3, 
68.7, 68.0, 58.8, 37.0, 27.2, 27.1, 21.0, 20.5, 20.3; 19F NMR (300 MHz, CHCl3) δ –160.0; 







AcO (  )2
 
Acetic acid 3-(di-tert-butyl-fluoro-silanyloxy)-5-hydroxy-pentyl ester (5.22b). The 
title compound was prepared from 5.21b according to the general procedure described for 





syrup, 87%): Rf 0.55 (25% EtOAc/hexanes); IR (thin film) ν 3450 (br), 1743 cm-1; 1H 
NMR (300 MHz, CHCl3) δ 4.38 (dddd, J = 6.0, 6.0, 6.0, 6.0 Hz, 1H), 4.15 (t, J = 6.5 Hz, 
2H), 3.78-3.74 (m, 2H), 2.01 (s, 3H), 2.00-1.73 (m, 5H), 1.01 (d, J = 0.8 Hz, 9H), 1.00 (d, 
J = 0.8 Hz, 9H); 13C NMR (75 MHz, CHCl3) δ 171.3, 69.4, 61.2, 59.4, 39.3, 36.0, 27.3, 
27.2, 21.2, 20.5 (d, J = 14.7 Hz), 20.4 (d, J = 14.7 Hz); 19F NMR (300 MHz, CHCl3) –









Benzoic acid 2-(di-tert-butyl-fluoro-silanyloxy)-4-hydroxy-butyl ester (5.22c). The 
title compound was prepared from 5.21c according to the general procedure described for 
the preparation of 5.16a, except that 4.0 equivalents of BF3•Me2S were used (colorless 
syrup, 90%): Rf 0.69 (20% EtOAc/hexanes); IR (thin film) ν 3460 (br), 1720 cm-1; 1H 
NMR (300 MHz, CHCl3) δ 8.04 (d, J = 7.3 Hz, 2H), 7.53-7.50 (m, 1H), 7.41 (dd, J = 7.3, 
7.3 Hz, 2H), 4.57 (dddd, J = 5.5, 5.5, 5.5, 5.5 Hz, 1H), 4.37 (d, J = 4.8 Hz, 2H), 3.86-3.78 
(m, 2H), 1.99-1.81 (m, 3H), 1.03 (s, 9H), 1.01 (s, 9H); 13C NMR (75 MHz, CHCl3) δ 
166.7, 133.3, 130.2, 129.9, 128.6, 70.0, 68.4, 59.2, 37.2, 27.2, 27.1, 20.5 (d, J = 14.0 Hz), 
20.3 (d, J = 14.0 Hz); 19F NMR (300 MHz, CHCl3) δ –160.0; HRMS m/z calcd for 










BzO (  )2
 
Benzoic acid 3-(di-tert-butyl-fluoro-silanyloxy)-5-hydroxy-pentyl ester (5.22d). The 
title compound was prepared from 5.21d according to the general procedure described for 
the preparation of 5.16a, except that 5.0 equivalents of BF3•Me2S were used (colorless 
syrup, 82%): Rf 0.67 (15% EtOAc/hexanes); IR (thin film) ν 3420 (br), 1720 cm-1; 1H 
NMR (300 MHz, CHCl3) δ 8.04 (d, J = 7.5 Hz, 2H), 7.61-7.57 (m, 1H), 7.46 (dd, J = 7.5, 
7.5 Hz, 2H), 4.48-4.42 (m, 3H), 3.91-3.77 (ddd, J = 7.6, 6.4, 6.4 Hz, 2H), 2.11 (ddd, J = 
6.4, 6.4, 6.4 Hz, 2H), 1.97-1.84 (m, 3H), 1.82 (br s, 1H), 1.08 (s, 9H), 1.07 (s, 9H); 13C 
NMR (75 MHz, CHCl3) δ 166.8, 133.2, 130.5, 129.8, 128.6, 69.6, 61.7, 59.5, 39.3, 36.1, 
27.6, 27.3, 20.5 (d, J = 15.2 Hz), 20.4 (d, J = 15.2 Hz); 19F NMR (300 MHz, CHCl3) δ –







AllylO (  )2
 
5-Allyloxy-3-(di-tert-butyl-fluoro-silanyloxy)-pentan-1-ol (5.22e). The title compound 
was prepared from 5.21e according to the general procedure described for the preparation 





0.59 (20% EtOAc/hexanes); IR (thin film) ν 3395 (br) cm-1; 1H NMR (300 MHz, CHCl3) 
δ 5.98-5.85 (m, 1H), 5.31-5.16 (m, 2H), 4.44 (dddd, J = 5.8, 5.8, 5.8, 5.8 Hz, 1H), 3.97 
(ddd, J = 5.5, 3.1, 1.6 Hz, 2H), 3.94-3.74 (m, 2H), 3.58-3.52 (m, 2H), 2.15 (br s, 1H), 
1.96-1.77 (m, 4H), 1.07 (d, J = 0.9 Hz, 9H), 1.06 (d, J = 0.9 Hz, 9H); 13C NMR (75 MHz, 
CHCl3) δ 135.0, 117.2, 72.2, 70.3, 66.7, 59.7, 39.3, 37.0, 27.3, 27.2, 20.5 (d, J = 12.1 
Hz), 20.3 (d, J = 12.1 Hz); 19F NMR (300 MHz, CHCl3) δ –159.3; HRMS m/z calcd for 







BnO (  )2
 
5-Benzyloxy 3-(di-tert-butyl-fluoro-silanyloxy)-pentan-1-ol (5.22f). The title 
compound was prepared from 5.21f according to the general procedure described for the 
preparation of 5.16a, except that 6.5 equivalents of BF3•Me2S were used (colorless syrup, 
35%): Rf 0.62 (15% EtOAc/hexanes); IR (thin film) ν 3405 (br)  cm-1; 1H NMR (300 
MHz, CHCl3) δ 7.39-7.28 (m, 5H), 4.60-4.45 (m, 3H), 3.84-3.77 (m, 2H), 3.61 (dd, J = 
6.2, 6.2 Hz, 2H), 2.00-1.84 (m, 4H), 1.69 (br s, 1H), 1.07 (d, J = 0.8 Hz, 9H), 1.05 (d, J = 
0.8 Hz, 9H); 19F NMR (300 MHz, CHCl3) δ –159.3; HRMS m/z calcd for C20H35FO3Si 










H3CO (  )2
 
3-(Di-tert-butyl-fluoro-silanyloxy)-5-methoxy-pentan-1-ol (5.22g). The title compound 
was prepared from 5.21g according to the general procedure described for the preparation 
of 5.16a, except that 3.5 equivalents of BF3•Me2S were used (colorless syrup, 43%): Rf 
0.32 (33% EtOAc/hexanes); IR (thin film) ν 3390 (br) cm-1; 1H NMR (300 MHz, CHCl3) 
δ 4.43 (dddd, J = 6.1, 6.1, 6.1, 6.1 Hz, 1H), 3.85-3.72 (m, 2H), 3.53-3.45 (m, 2H), 3.35 
(s, 3H), 2.04 (br s, 1H), 1.97-1.79 (m, 4H), 1.07 (s, 9H), 1.06 (s, 9H); 13C NMR (75 MHz, 
CHCl3) δ 70.3, 69.1, 59.7, 58.8, 39.3, 37.0, 27.3, 27.2, 20.6 (d, J = 15.1 Hz), 20.5 (d, J = 
15.1 Hz); 19F NMR (300 MHz, CHCl3) δ –159.4; HRMS m/z calcd for C20H36FO3Si 







TIPSO (  )2
 
3-(Di-tert-butyl-fluoro-silanyloxy)-5-triisopropylsilanyloxy-pentyl-1-ol (5.22h). The 
title compound was prepared from 5.21h according to the general procedure described for 
the preparation of 5.16a, except that 7.0 equivalents of BF3•Me2S were used (colorless 





(300 MHz, CHCl3) δ 4.48 (dddd, J = 5.9, 5.9, 5.9, 5.9 Hz, 1H), 3.88-3.76 (m, 3H), 2.03-
1.91 (m, 2H), 1.89-1.77 (m, 1H), 1.63 (br s, 1H), 1.09-1.06 (m, 39H); 13C NMR (75 
MHz, CHCl3) δ 70.6, 60.1, 59.9, 40.1, 39.0, 27.3, 20.6 (d, J = 12.0 Hz), 20.3 (d, J = 12.0 
Hz), 18.2, 12.2; 19F NMR (300 MHz, CHCl3) δ –159.4; HRMS m/z calcd for 








Acetic acid 3-(di-tert-butyl-chloro-silanyloxy)-5-phenyl-pentyl ester (5.26). To a rt 
solution of 5.15 (540 mg, 1.69 mmol) in CHCl3 (5.5 mL) was added BCl3 (2.1 mL, 1.0 M 
in heptane, 2.1 mmol). After 25 min TLC analysis of an aliquot indicated the reaction 
was complete, and the reaction mixture was transferred with the aid of CH2Cl2 into a 
stirring saturated NaHCO3 solution (8 mL).  The organic layer was separated and washed 
with H2O, brine and dried (MgSO4). After filtration through a small pad of celite, 
volatiles were removed under reduced pressure and the residue was purified by flash 
chromatography on silica gel using 10:1 hexanes-EtOAc for elution to provide the 
alcohol 5.24 as a colorless syrup (534 mg, 89%): Rf 0.38 (33% EtOAc/hexanes); 1H 
NMR (300 MHz, CHCl3) δ 7.35-7.20 (m, 5H), 4.36 (dddd, J = 5.7, 5.7, 5.7, 5.7 Hz, 1H), 
3.95-3.88 (m, 1H), 3.84-3.76 (m, 1H), 2.75-2.68 (m, 2 H), 2.05-1.85 (m, 4H), 1.75 (br s, 
1H), 1.14 (s, 9H), 1.13 (s, 9H); 13C NMR (75 MHz, CHCl3) δ 142.3, 128.7, 128.6, 126.1, 





according to the general procedure described for the preparation of 5.21a to afford the 
product as a colorless syrup (544 mg, 91%): Rf 0.67 (10% EtOAc/hexanes); IR (thin film) 
ν1739 cm-1; 1H NMR (300 MHz, CHCl3) δ 7.35-7.18 (m, 5H), 4.32-4.20 (m, 3H), 2.72 
(dddd, J = 13.5, 7.8, 2.7, 2.7 Hz, 2H), 2.08 (s, 3H), 2.03-1.99 (m, 4H), 1.12 (s, 18H); 13C 
NMR (75 MHz, CHCl3) δ 171.3, 142.2, 128.7, 128.6, 126.1, 71.5, 61.3, 38.2, 34.7, 31.1, 








Acetic acid 3-(di-tert-butyl-chloro-silanyloxy)-5-triisopropylsilanyloxy-pentyl ester 
(5.27). The title compound was prepared from 5.21h according to the general procedure 
described for the preparation of 5.26 (80%, two steps). Rf 0.45 (5% EtOAc/hexanes); IR 
(thin film) ν 1740 cm-1; 1H NMR (300 MHz, CHCl3) δ 4.41 (dddd, J = 5.6, 5.6, 5.6, 5.6 
Hz, 1H), 4.21 (dd, J = 6.4, 6.4 Hz, 2H), 3.82 (dd, J = 6.4, 6.4 Hz, 2H), 2.04 (s, 3H), 2.02-
1.88 (m, 3H), 1.84-1.69 (m, 1H), 1.10-1.03 (m, 39H); 13C NMR (75 MHz, CHCl3) δ 
171.3, 69.7, 61.3, 60.0, 39.6, 35.2, 27.6, 27.5, 23.3, 23.2, 21.2, 18.2, 12.2; HRMS m/z 










2,2,4-Tri-tert-butyl-6-methyl-[1,3,2]dioxasilinane (5.31). The title compound was 
prepared from (2S, 4R)-5,5-dimethyl-hexane-2,4-diol182 according to the general 
procedure described for the preparation of 5.15 (colorless syrup, 94%): Rf 0.66 (10% 
EtOAc/hexanes); 1H NMR (300 MHz, CHCl3) δ 4.46 (dddd, J = 6.7, 6.7, 6.7, 6.7 Hz, 
1H), 3.78 (dd, J = 11.0, 0.6 Hz, 1H), 1.97 (ddd, J = 13.8, 11.0, 6.7 Hz, 1H), 1.46 (d, J = 
13.8 Hz, 1H), 1.32 (d, J = 6.7 Hz, 3H), 1.03 (s, 18 H), 0.91 (d, J = 0.8 Hz, 9H); 13C NMR 
(75 MHz, CHCl3) δ 75.5, 68.3, 35.1, 34.8, 27.4, 27.3, 25.6, 23.4, 21.7, 20.8; HRMS m/z 







4-(Di-tert-butyl-fluoro-silanyloxy)-5,5-dimethyl-hexan-2-ol (5.32). The title compound 
was prepared from 5.31 according to the general procedure described for the preparation 
of 5.16a, except that 3.0 equivalents of BF3•Me2S were used (colorless syrup, 93%): Rf 
0.44 (33% EtOAc/hexanes); IR (thin film) ν 3415 (br) cm-1; 1H NMR (300 MHz, CHCl3) 
δ 4.12 (qdd, J = 6.2, 12.2, 2.3 Hz, 1H), 4.02 (dd, J = 8.3, 1.8 Hz, 1H), 1.64-1.55 (m, 1H), 
1.51 (br s, 1H), 1.45 (ddd, J = 14.6, 8.3, 2.5 Hz, 1H), 1.27 (d, J = 6.2 Hz, 3H), 1.05 (s, 
9H), 1.04 (s, 9H), 0.91 (s, 9H); 13C NMR (75 MHz, CHCl3) δ 80.1, 64.6, 42.8, 35.8, 27.5, 
27.3, 26.2, 24.9, 21.1 (d, J = 16.0 Hz), 20.3 (d, J = 16.0 Hz); 19F NMR (300 MHz, 











2,2,4-Tri-tert-butyl-6-methyl-[1,3,2]dioxasilinane (5.33). The title compound was 
prepared from (2S, 4S)-5,5-dimethyl-hexane-2,4-diol182 according to the general 
procedure described for the preparation of 5.15 (colorless syrup, 91%): Rf 0.64 (10% 
EtOAc/hexanes); 1H NMR (300 MHz, CHCl3) δ 4.16 (qdd, J = 6.2, 5.6, 2.3 Hz, 1H), 3.63 
(dd, J = 11.2, 1.8 Hz, 1H), 1.58 (ddd, J = 13.4, 1.6, 1.6 Hz, 1H), 1.32 (ddd, J = 13.4, 11.1, 
11.1 Hz, 1H), 1.20 (d, J = 6.2 Hz, 3H), 1.00 (s, 9H), 0.97 (s, 9H), 0.88 (s, 9H); 13C NMR 
(75 MHz, CHCl3) δ 81.6, 71.0, 37.9, 35.4, 27.8, 27.3, 25.7, 25.2, 23.0, 19.8; HRMS m/z 










4-(Di-tert-butyl-fluoro-silanyloxy)-5,5-dimethyl-hexan-2-ol (5.34). The title compound 
was prepared from 5.33 according to the general procedure described for the preparation 
of 5.16a, except that 5.0 equivalents of BF3•Me2S were used (colorless syrup, 64%): Rf 
0.42 (40% EtOAc/hexanes); IR (thin film) ν 3365 (br) cm-1; 1H NMR (300 MHz, CHCl3) 
δ 4.00-3.91 (m, 1H), 3.80 (ddd, J = 6.1, 3.6, 1.5 Hz, 1H), 1.77 (ddd, J = 14.8, 6.9, 3.6 Hz, 
1H), 1.64-1.55 (m, 3H), 1.17 (d, J = 6.1 Hz, 3H), 1.04 (d, J = 1.0 Hz, 9H), 1.03 (d, J = 
1.0 Hz, 9H), 0.90 (s, 9H); 13C NMR (75 MHz, CHCl3) δ 80.7, 66.7, 44.2, 36.2, 27.4, 
27.1, 25.9, 23.6, 21.1 (d, J = 15.0 Hz), 21.0 (d, J = 15.0 Hz); 19F NMR (300 MHz, 







2,2-Di-tert-butyl-4-isopropyl-6-methyl-[1,3,2]dioxasilinane (5.35). The title compound 
was prepared from (2S, 4R)-5-methyl-hexane-2,4-diol183 according to the general 





EtOAc/hexanes); 1H NMR (300 MHz, CHCl3) δ 4.47-4.36 (m, 1H), 3.85 (ddd, J = 9.0, 
5.9, 2.8 Hz, 1H), 1.97 (ddd, J = 14.2, 9.1, 5.4 Hz, 1H), 1.73-1.62 (m, 1H), 1.52-1.46 (m, 
1H), 1.30 (d, J = 10.0 Hz, 3H), 1.02 (s, 18H), 0.97 (d, J = 6.6 Hz, 3H), 0.92 (d, J = 6.6 
Hz, 3H); 13C NMR (75 MHz, CHCl3) δ 73.7, 67.8, 37.7, 34.5, 27.5, 23.9, 21.5, 21.0, 18.9, 










5.36a 5.36b  
4-(Di-tert-butyl-fluoro-silanyloxy)-5-methyl-hexan-2-ol (5.36a) and 5-(Di-tert-butyl-
fluoro-silanyloxy)-2-methyl-hexan-3-ol (5.36b). The title compounds were prepared 
from 5.35 according to the general procedure described for the preparation of 5.16a, 
except that 2.5 equivalents of BF3•Me2S were used.  Purification of the reaction mixture 
by flash chromatography on silica gel using 10:1 hexanes-EtOAc for elution provided the 
title compounds 5.36a and 5.36b as a colorless syrups. 5.36a (138 mg, 76%): Rf 0.45 
(33% EtOAc/ hexanes); IR (thin film) ν 3365 (br) cm-1; 1H NMR (300 MHz, CHCl3) δ 
4.13 (dddd, J = 4.1, 4.1, 4.1, 4.1 Hz, 1H), 4.06-3.99 (m, 1H), 2.05-2.00 (br s, 1H), 1.92 
(dddd, J = 7.6, 4.1, 4.1, 0.4 Hz, 1H), 1.54-1.43 (m, 2H), 1.18 (d, J = 6.3 Hz, 3H), 1.01 (s, 
18H), 0.87 (dd, J = 6.9, 6.9 Hz, 6H); 13C NMR (75 MHz, CHCl3) δ 75.9, 64.3, 41.2, 33.6, 
27.2, 24.4, 20.5, 20.3, 18.1, 16.8; 19F NMR (300 MHz, CHCl3) δ –157.0; HRMS m/z 





(33% EtOAc/hexanes); IR (thin film) ν 3350 (br) cm-1; 1H NMR (300 MHz, CHCl3) δ 
4.57-4.48 (m, 1H), 3.70 (ddd, J = 9.3, 8.1, 2.7 Hz, 1H), 2.51 (br s, 1H), 1.67-1.47 (m, 
3H), 1.29 (d, J = 6.1 Hz, 3H), 1.03 (d, J = 1.1 Hz, 9H), 1.01 (d, J = 1.1 Hz, 9H), 0.89 (dd, 
J = 6.7, 6.7 Hz, 6H); 13C NMR (75 MHz, CHCl3) δ 72.7, 68.7, 41.7, 33.9, 27.0, 26.9, 
23.3, 20.4 (d, J = 15.3 Hz), 19.8 (d, J = 15.3 Hz), 18.4, 17.6; 19F NMR (300 MHz, 







2,2-Di-tert-butyl-4-isopropyl-6-methyl-[1,3,2]dioxasilinane (5.37). The title compound 
was prepared from (2S, 4S)-5-methyl-hexane-2,4-diol183 according to the general 
procedure described for the preparation of 5.15 (colorless syrup, 92%): Rf 0.61 (10% 
EtOAc/hexanes); 1H NMR (300 MHz, CHCl3) δ 4.20 (qdd, J = 5.9, 11.8, 2.2 Hz, 1H), 
3.78 (ddd, J = 5.4, 5.4, 2.2 Hz, 1H), 1.68-1.58 (m, 2H), 1.42 (ddd, J = 11.1, 11.1, 2.8 Hz, 
1H), 1.22 (d, J = 6.4 Hz, 3H), 1.03 (s, 9H), 1.00 (s, 9H), 0.93 (dd, J = 6.4, 6.4 Hz, 6H); 
13C NMR (75 MHz, CHCl3) δ 78.7, 70.6, 40.7, 35.0, 27.7, 27.3, 25.1, 22.8, 20.0, 18.5, 











4-(Di-tert-butyl-fluoro-silanyloxy)-5-methyl-hexan-2-ol (5.38a). The title compound 
was prepared from 5.37 according to the general procedure described for the preparation 
of 5.16a, except that 2.5 equivalents of BF3•Me2S were used (colorless syrup, 37%): Rf 
0.48 (33% EtOAc/hexanes); IR (thin film) ν 3330 (br) cm-1; 1H NMR (300 MHz, CHCl3) 
δ 4.16 (dddd, J = 4.2, 4.2, 4.2, 0.8 Hz, 1H), 3.92-3.86 (m, 1H), 2.39 (br s, 1H), 1.98 (qdd, 
J = 6.8, 6.8, 6.8 Hz, 1H), 1.68-1.47 (m, 3H), 1.18 (d, J = 6.1 Hz, 3H), 1.05 (d, J = 0.8 Hz, 
9H), 1.03 (d, J = 0.8 Hz, 9H), 0.93 (d, J = 6.8 Hz, 3H), 0.84 (d, J = 6.8 Hz, 3H); 13C 
NMR (75 MHz, CHCl3) δ 79.1, 67.2, 40.5, 33.4, 27.5, 27.4, 24.1, 20.9, 18.1, 16.8; 19F 















The title compound was prepared from 5.22a according to the general procedure 
described for the preparation of 5.19 (pale syrup, 84%): Rf 0.42 (25% EtOAc/hexanes); 





1H), 4.76 (dddd, J = 5.3, 5.3, 5.3, 5.3 Hz, 1H), 4.15 (ddd, J = 5.3, 5.3,5.3 Hz, 2H), 2.71 
(dd, J = 5.9, 2.0 Hz, 2H), 2.05 (s, 3H), 1.03 (d, J = 0.8 Hz, 9H), 1.02 (d, J = 0.8 Hz, 9H); 
13C NMR (75 MHz, CHCl3) δ 200.0, 170.8, 67.5, 67.3, 48.3, 27.1, 27.0, 20.9, 20.5 (d, J = 
15.1 Hz), 20.3 (d, J = 15.1 Hz); 19F NMR (300 MHz, CHCl3) δ –160.8; HRMS m/z calcd 













The title compound was prepared from 5.22e according to the general procedure 
described for the preparation of 5.19 (pale syrup, 85%): Rf 0.50 (20% EtOAc/hexanes); 
IR (thin film) ν 1728 cm-1; 1H NMR (300 MHz, CHCl3) δ 9.84 (dd, J = 2.2, 2.2 Hz, 1H), 
5.96-5.83 (m, 1H), 5.30-5.15 (m, 2H), 4.76 (dddd, J = 5.9, 5.9, 5.9, 5.9 Hz, 1H), 3.95 
(ddd, J = 5.6, 3.0, 1.3 Hz, 2H), 3.55 (dd, J = 5.9, 5.9 Hz, 2H), 2.75 (ddd, J = 16.2, 5.7, 1.9 
Hz, 1H), 2.65 (ddd, J = 16.2, 5.6, 2.8 Hz, 1H), 1.98-1.86 (m, 2H), 1.04 (d, J = 1.0 Hz, 
9H), 1.03 (d, J = 1.0 Hz, 9H); 13C NMR (75 MHz, CHCl3) δ 201.6, 134.9, 117.2, 72.1, 
67.7, 66.2, 51.0, 37.5, 27.2, 27.1, 20.5 (d, J = 11.8 Hz), 20.4 (d, J = 11.8 Hz); 19F NMR 

















The title compound was prepared from 5.32 according to the general procedure described 
for the preparation of 5.18 (pale syrup, 89%): Rf 0.56 (25% EtOAc/hexanes); IR (thin 
film) ν 1726 cm-1; 1H NMR (300 MHz, CHCl3) δ 4.43 (dd, J = 4.9, 4.9 Hz, 1H), 2.60 (dd, 
J = 4.9, 4.9 Hz, 2H), 2.14 (s, 3H), 1.02 (s, 9H), 1.00 (s, 9H), 0.87 (s, 9H); 13C NMR (75 
MHz, CHCl3) δ 206.3, 77.2, 47.7, 35.8, 30.8, 27.3, 27.0, 25.7, 21.0 (d, J = 15.2 Hz), 21.1 
(d, J = 15.2 Hz); 19F NMR (300 MHz, CHCl3) δ –155.9; HRMS m/z calcd for 













The title compound was prepared from 5.36a according to the general procedure 
described for the preparation of 5.18 (pale syrup, 81%): Rf 0.48 (10 % EtOAc/hexanes); 
IR (thin film) ν 1719 cm-1; 1H NMR (300 MHz, CHCl3) δ 4.50 (ddd, J = 6.7, 5.2, 3.6 Hz, 
1H), 2.68 (dd, J = 16.1, 7.0 Hz, 1H), 2.49 (dd, J = 16.1, 5.2 Hz, 1H), 2.17 (s, 3H), 1.90-
1.81 (m, 1H), 1.03 (d, J = 1.0 Hz, 9H), 1.02 (d, J = 1.0 Hz, 9H), 0.94 (d, J = 7.0 Hz, 3H), 





27.4, 27.3, 20.6 (d, J = 15.0 Hz), 20.4 (d, J = 15.0 Hz), 17.9, 17.3; 19F NMR (300 MHz, 
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